
<html lang="en"     class="pb-page"  data-request-id="58feb84d-effd-4368-9a5e-4c5b9374a0f5"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/acs.jmedchem.6b01496;issue:issue:10.1021/jmcmar.2017.60.issue-3;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="The Discovery and Hit-to-Lead Optimization of Tricyclic Sulfonamides as Potent and Efficacious Potentiators of Glycine Receptors" /></meta><meta name="dc.Creator" content="Howard  Bregman" /></meta><meta name="dc.Creator" content="Jeffrey R.  Simard" /></meta><meta name="dc.Creator" content="Kristin L.  Andrews" /></meta><meta name="dc.Creator" content="Shawn  Ayube" /></meta><meta name="dc.Creator" content="Hao  Chen" /></meta><meta name="dc.Creator" content="Hakan  Gunaydin" /></meta><meta name="dc.Creator" content="Angel  Guzman-Perez" /></meta><meta name="dc.Creator" content="Jiali  Hu" /></meta><meta name="dc.Creator" content="Liyue  Huang" /></meta><meta name="dc.Creator" content="Xin  Huang" /></meta><meta name="dc.Creator" content="Paul H.  Krolikowski" /></meta><meta name="dc.Creator" content="Sonya G.  Lehto" /></meta><meta name="dc.Creator" content="Richard T.  Lewis" /></meta><meta name="dc.Creator" content="Klaus  Michelsen" /></meta><meta name="dc.Creator" content="Pamela  Pegman" /></meta><meta name="dc.Creator" content="Matthew H.  Plant" /></meta><meta name="dc.Creator" content="Paul L.  Shaffer" /></meta><meta name="dc.Creator" content="Yohannes  Teffera" /></meta><meta name="dc.Creator" content="Shuyan  Yi" /></meta><meta name="dc.Creator" content="Maosheng  Zhang" /></meta><meta name="dc.Creator" content="Jacinthe  Gingras" /></meta><meta name="dc.Creator" content="Erin F.  DiMauro" /></meta><meta name="dc.Description" content="Current pain therapeutics suffer from undesirable psychotropic and sedative side effects, as well as abuse potential. Glycine receptors (GlyRs) are inhibitory ligand-gated ion channels expressed in..." /></meta><meta name="Description" content="Current pain therapeutics suffer from undesirable psychotropic and sedative side effects, as well as abuse potential. Glycine receptors (GlyRs) are inhibitory ligand-gated ion channels expressed in..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="December 21, 2016" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.6b01496" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2016 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b01496" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.6b01496" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b01496" /></link>
        
    
    

<title>The Discovery and Hit-to-Lead Optimization of Tricyclic Sulfonamides as Potent and Efficacious Potentiators of Glycine Receptors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.6b01496" /></meta><meta property="og:title" content="The Discovery and Hit-to-Lead Optimization of Tricyclic Sulfonamides as Potent and Efficacious Potentiators of Glycine Receptors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/large/jm-2016-01496d_0018.jpeg" /></meta><meta property="og:description" content="Current pain therapeutics suffer from undesirable psychotropic and sedative side effects, as well as abuse potential. Glycine receptors (GlyRs) are inhibitory ligand-gated ion channels expressed in nerves of the spinal dorsal horn, where their activation is believed to reduce transmission of painful stimuli. Herein, we describe the identification and hit-to-lead optimization of a novel class of tricyclic sulfonamides as allosteric GlyR potentiators. Initial optimization of high-throughput screening (HTS) hit 1 led to the identification of 3, which demonstrated ex vivo potentiation of glycine-activated current in mouse dorsal horn neurons from spinal cord slices. Further improvement of potency and pharmacokinetics produced in vivo proof-of-concept tool molecule 20 (AM-1488), which reversed tactile allodynia in a mouse spared-nerve injury (SNI) model. Additional structural optimization provided highly potent potentiator 32 (AM-3607), which was cocrystallized with human GlyRα3cryst to afford the first described potentiator-bound X-ray cocrystal structure within this class of ligand-gated ion channels (LGICs)." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.6b01496"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.6b01496">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.6b01496&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.6b01496&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.6b01496&amp;href=/doi/10.1021/acs.jmedchem.6b01496" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 3</span><span class="cit-fg-pageRange">, 1105-1125</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/3" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.6b01448" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.6b01504" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">The Discovery and Hit-to-Lead Optimization of Tricyclic Sulfonamides as Potent and Efficacious Potentiators of Glycine Receptors</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Howard++Bregman">Howard Bregman</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0001-8062-9770" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jeffrey+R.++Simard">Jeffrey R. Simard</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∇</sup></span><span class="author-xref-symbol "><sup>○</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kristin+L.++Andrews">Kristin L. Andrews</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shawn++Ayube">Shawn Ayube</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hao++Chen">Hao Chen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hakan++Gunaydin">Hakan Gunaydin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span><span class="author-xref-symbol "><sup>¶</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Angel++Guzman-Perez">Angel Guzman-Perez</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jiali++Hu">Jiali Hu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Liyue++Huang">Liyue Huang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xin++Huang">Xin Huang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul+H.++Krolikowski">Paul H. Krolikowski</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sonya+G.++Lehto">Sonya G. Lehto</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∇</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Richard+T.++Lewis">Richard T. Lewis</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol "><sup>□</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Klaus++Michelsen">Klaus Michelsen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span><span class="author-xref-symbol "><sup>◇</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Pamela++Pegman">Pamela Pegman</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span><span class="author-xref-symbol "><sup>+</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Matthew+H.++Plant">Matthew H. Plant</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul+L.++Shaffer">Paul L. Shaffer</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yohannes++Teffera">Yohannes Teffera</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shuyan++Yi">Shuyan Yi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Maosheng++Zhang">Maosheng Zhang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∇</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jacinthe++Gingras">Jacinthe Gingras</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Erin+F.++DiMauro">Erin F. DiMauro</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol "><sup>¶</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text"><sup>†</sup>Departments of Medicinal Chemistry, <sup>‡</sup>Neuroscience, <sup>§</sup>Molecular Engineering, <sup>∥</sup>Discovery Attribute Sciences, <sup>⊥</sup>Biologics, and <sup>#</sup>Pharmacokinetics and Drug Metabolism. Amgen, Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">∇</span> <span class="aff-text">Department of Neuroscience, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: 617-444-5351. E-mail: <a href="/cdn-cgi/l/email-protection#462e243423212b272806272b2123286825292b"><span class="__cf_email__" data-cfemail="91f9f3e3f4f6fcf0ffd1f0fcf6f4ffbff2fefc">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b01496&amp;href=/doi/10.1021%2Facs.jmedchem.6b01496" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 3</span><span class="cit-pageRange">, 1105–1125</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">December 21, 2016</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>12 October 2016</li><li><span class="item_label"><b>Published</b> online</span>21 December 2016</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 9 February 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.6b01496" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01496</a></div><div class="article_header-article-copyright"><strong>Copyright © 2016 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D1105%26pageCount%3D21%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DHoward%2BBregman%252C%2BJeffrey%2BR.%2BSimard%252C%2BKristin%2BL.%2BAndrews%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D60%26issueNum%3D3%26contentID%3Dacs.jmedchem.6b01496%26title%3DThe%2BDiscovery%2Band%2BHit-to-Lead%2BOptimization%2Bof%2BTricyclic%2BSulfonamides%2Bas%2BPotent%2Band%2BEfficacious%2BPotentiators%2Bof%2BGlycine%2BReceptors%26numPages%3D21%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D1125%26publicationDate%3DFebruary%2B2017">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.6b01496"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2471</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">21</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.6b01496" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;The Discovery and Hit-to-Lead Optimization of Tricyclic Sulfonamides as Potent and Efficacious Potentiators of Glycine Receptors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Howard&quot;,&quot;last_name&quot;:&quot;Bregman&quot;},{&quot;first_name&quot;:&quot;Jeffrey&quot;,&quot;last_name&quot;:&quot;R. Simard&quot;},{&quot;first_name&quot;:&quot;Kristin&quot;,&quot;last_name&quot;:&quot;L. Andrews&quot;},{&quot;first_name&quot;:&quot;Shawn&quot;,&quot;last_name&quot;:&quot;Ayube&quot;},{&quot;first_name&quot;:&quot;Hao&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Hakan&quot;,&quot;last_name&quot;:&quot;Gunaydin&quot;},{&quot;first_name&quot;:&quot;Angel&quot;,&quot;last_name&quot;:&quot;Guzman-Perez&quot;},{&quot;first_name&quot;:&quot;Jiali&quot;,&quot;last_name&quot;:&quot;Hu&quot;},{&quot;first_name&quot;:&quot;Liyue&quot;,&quot;last_name&quot;:&quot;Huang&quot;},{&quot;first_name&quot;:&quot;Xin&quot;,&quot;last_name&quot;:&quot;Huang&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;H. Krolikowski&quot;},{&quot;first_name&quot;:&quot;Sonya&quot;,&quot;last_name&quot;:&quot;G. Lehto&quot;},{&quot;first_name&quot;:&quot;Richard&quot;,&quot;last_name&quot;:&quot;T. Lewis&quot;},{&quot;first_name&quot;:&quot;Klaus&quot;,&quot;last_name&quot;:&quot;Michelsen&quot;},{&quot;first_name&quot;:&quot;Pamela&quot;,&quot;last_name&quot;:&quot;Pegman&quot;},{&quot;first_name&quot;:&quot;Matthew&quot;,&quot;last_name&quot;:&quot;H. Plant&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;L. Shaffer&quot;},{&quot;first_name&quot;:&quot;Yohannes&quot;,&quot;last_name&quot;:&quot;Teffera&quot;},{&quot;first_name&quot;:&quot;Shuyan&quot;,&quot;last_name&quot;:&quot;Yi&quot;},{&quot;first_name&quot;:&quot;Maosheng&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Jacinthe&quot;,&quot;last_name&quot;:&quot;Gingras&quot;},{&quot;first_name&quot;:&quot;Erin&quot;,&quot;last_name&quot;:&quot;F. DiMauro&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2016&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;21&quot;,&quot;issue&quot;:&quot;3&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;1105-1125&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.6b01496&quot;},&quot;abstract&quot;:&quot;Current pain therapeutics suffer from undesirable psychotropic and sedative side effects, as well as abuse potential. Glycine receptors (GlyRs) are inhibitory ligand-gated ion channels expressed in nerves of the spinal dorsal horn, where their activation is believed to reduce transmission of painful stimuli. Herein, we describe the identification and hit-to-lead optimization of a novel class of tricyclic sulfonamides as allosteric GlyR potentiators. Initial optimization of high-throughput screening (HTS) hit 1 led to the identification of 3, which demonstrated ex vivo potentiation of glycine-activated current in mouse dorsal horn neurons from spinal cord slices. Further improvement of potency and pharmacokinetics produced in vivo proof-of-concept tool molecule 20 (AM-1488), which reversed tactile allodynia in a mouse spared-nerve injury (SNI) model. Additional structural optimization provided highly potent potentiator 32 (AM-3607), which was cocrystallized with human GlyRα3cryst to afford the first described &quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01496&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01496" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01496&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01496" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01496&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01496" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b01496&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01496&amp;href=/doi/10.1021/acs.jmedchem.6b01496" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.6b01496" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.6b01496" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01496&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.6b01496%26sid%3Dliteratum%253Aachs%26pmid%3D28001399%26genre%3Darticle%26aulast%3DBregman%26date%3D2017%26atitle%3DThe%2BDiscovery%2Band%2BHit-to-Lead%2BOptimization%2Bof%2BTricyclic%2BSulfonamides%2Bas%2BPotent%2Band%2BEfficacious%2BPotentiators%2Bof%2BGlycine%2BReceptors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D3%26spage%3D1105%26epage%3D1125%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292164" title="Pyrrolidines">Pyrrolidines</a>,</li><li><a href="/action/doSearch?ConceptID=291316" title="Mixtures">Mixtures</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292444" title="Molecular structure">Molecular structure</a>,</li><li><a href="/action/doSearch?ConceptID=290716" title="Sulfones">Sulfones</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/3" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/jmcmar.2017.60.issue-3/20170209/jmcmar.2017.60.issue-3.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/medium/jm-2016-01496d_0018.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/large/jm-2016-01496d_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01496&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Current pain therapeutics suffer from undesirable psychotropic and sedative side effects, as well as abuse potential. Glycine receptors (GlyRs) are inhibitory ligand-gated ion channels expressed in nerves of the spinal dorsal horn, where their activation is believed to reduce transmission of painful stimuli. Herein, we describe the identification and hit-to-lead optimization of a novel class of tricyclic sulfonamides as allosteric GlyR potentiators. Initial optimization of high-throughput screening (HTS) hit <b>1</b> led to the identification of <b>3</b>, which demonstrated ex vivo potentiation of glycine-activated current in mouse dorsal horn neurons from spinal cord slices. Further improvement of potency and pharmacokinetics produced in vivo proof-of-concept tool molecule <b>20</b> (AM-1488), which reversed tactile allodynia in a mouse spared-nerve injury (SNI) model. Additional structural optimization provided highly potent potentiator <b>32</b> (AM-3607), which was cocrystallized with human GlyRα3<sub>cryst</sub> to afford the first described potentiator-bound X-ray cocrystal structure within this class of ligand-gated ion channels (LGICs).</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11226" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11226" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Chronic, neuropathic pain represents a major unmet medical need. Current and most effective treatment plans include the administration of agents with undesirable psychotropic and physiological side effects.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The identification of novel anagelsic agents devoid of these side effects would provide an immensely positive societal impact. Strychnine-sensitive glycine receptors have been investigated as key regulators of spinal inhibitory neurotransmission in the adult CNS.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2, 3)</a> GlyRs functionally exist as homopentameric (GlyRα1 and GlyRα3) or heteropentameric (GlyRα1β and GlyRα3β) channels with either a 3:2 or 2:3 ratio of α:β subunits. The reported enrichment of GlyRs in the spinal dorsal horn, the terminal point of afferent nociceptive sensitization and the reported role of GlyRα3 in inflammatory pain processing support targeting this receptor class.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> The β-subunit is believed to localize the channel at the postsynaptic cleft by interacting with gephryn on the neuronal cell surface.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Because of these factors, we targeted potentiators of GlyRα3β heteropentameric channels.</div><div class="NLM_p last">Positive modulators of GlyRs have been suggested as potential therapeutic agents to suppress pain signaling at the level of the spinal cord.<a onclick="showRef(event, 'ref4 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref4 ref6 ref7">(4, 6, 7)</a> Reported GlyR modulators include volatile and intravenous anesthetics,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a><i>n</i>-alcohols,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> avermectins,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> tropeines,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> cannabinoid ligands,<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9, 10)</a> bivalent cations,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> glutamatergic ligands,<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> gelsemine,<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12, 13)</a> mono and disaccharides,<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> and ginkolic acid.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Recent detailed functional behavioral pain studies suggested that the mechanism of analgesia afforded with the cannabinoid class of compounds, and gelsemine was primarily due to potentiation of GlyRα3.<a onclick="showRef(event, 'ref9 ref10 ref12'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref12">(9, 10, 12)</a> Unfortunately, these reported modulators suffer from a lack of potency, selectivity, and/or pharmacokinetic (PK) properties favorable for in vivo profiling. Recently, Pfizer reported the identification of a few small molecule potentiator chemotypes via a high-throughput screening (HTS) campaign, with one sulfonamide displaying selectivity over GABA<sub>A</sub>-R α1/3β3γ2 without the disclosure of hit optimization efforts.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> We sought to identify small molecule GlyRα3 positive modulators with selectivity over other ligand-gated ion channels (LGICs) suitable for oral dosing in a rodent pain model of neuropathic pain to establish target proof-of-concept (POC).</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11604" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11604" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In light of the paucity of reported, lead-like chemical matter for GlyRs, we initiated a HTS in search of potentiators with the goal of demonstrating in vivo POC. Our HTS and subsequent primary screening assay utilized HEK293T cells stably expressing human GlyRα3β. Using a standard membrane potential dye that reports on net changes in membrane potential across the cell membrane due to GlyR-mediated ion flux, we designed an assay that enabled assessment of the ability of compound to directly activate GlyRα3β in the presence of low levels (EC<sub>10</sub>) of the endogenous agonist glycine. The assay could also be performed in the absence of glycine, allowing for the detection of agonist activity. On-target activity was confirmed by reversal of activation with the known pan-GlyR antagonist, strychnine.<a onclick="showRef(event, 'ref17 ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19">(17-19)</a> Compounds identified as on-target potentiators with suitable potency were advanced to a Schild shift assay which measured the ability of the compound to modulate the activity of the agonist glycine, i.e., individual glycine dose–response curves were generated in the presence of compound, applied at a range of concentrations (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>). The minimum tested concentration of potentiator required to left shift the glycine dose–response curve at least 3-fold (hereon referred to as mEC<sub>3</sub>), a statistically relevant shift, was used to rank order potentiators (see <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a> for a representative example). All of the compounds described herein increased the glycine potency (effects in α) but not glycine maximum efficacy (no impact on β) in the Schild shift assay.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Therefore, the latter parameter was not utilized in our SAR analyses. Although the activities obtained in the Schild shift platform correlated well with dose–response values, confirmation of glycine modulation was required for compound advancement.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/medium/jm-2016-01496d_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/large/jm-2016-01496d_0001.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Representative glycine Schild shift plot. In this example, the mEC<sub>3</sub> (or minimum tested compound concentration to elicit a leftward shift in the Gly EC<sub>50</sub> value ≥3×) corresponds to a compound concentration [cpd] of 6.3 μM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/large/jm-2016-01496d_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01496&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Our HTS campaign led to the identification of modestly potent hit <b>1</b> (mEC<sub>3</sub> = 3.1 μM) with high passive permeability and low efflux ratios in breast cancer resistance protein (BCRP) and multidrug resistance protein 1 (MDR1) overexpressed Madin–Darby canine kidney (MDCK) cell lines (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). Hit <b>1</b> suffered from high intrinsic clearance in mouse liver microsomes (MLM CL<sub>int</sub> = 901 μL/min/mg), likely contributing to the observed low plasma exposure following intraperitoneal dosing in mice (plasma <i>C</i><sub>max</sub> unbound = 0.13 μM @ 30 mg/kg). Toward identifying a minimal structural core, replacement of the imidazole ring of the tetracycle with a methyl amide in <b>3</b> afforded improved potentiation (mEC<sub>3</sub> = 0.78 μM) as well as a moderate stereopreference, with the two cis pyrrolidine enantiomers <b>3</b> and <b>4</b> exhibiting a >10-fold potency difference. Like hit <b>1</b>, tricycle <b>3</b> suffered from high metabolic intrinsic clearance and poor in vivo exposure upon intraperitoneal dosing in mice (plasma <i>C</i><sub>max</sub> unbound = 0.07 μM @ 50 mg/kg). Despite the poor PK profile of <b>3</b>, it was considered an attractive lead molecule as the compound exhibited good cellular potency, permeability with low efflux ratio, and physicochemical properties conducive to CNS penetration.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Potency, as measured in HEK293T cells, was optimized for human GlyRα3β, which correlated well with potency against human GlyRα3, GlyRα1β, and GlyRα1 as well as rodent GlyR cell lines for all compounds described herein.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Profiles of Hit and Lead Compounds<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/medium/jm-2016-01496d_0014.gif" alt="" id="fx1" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">Compounds are enantiopure unless otherwise noted as racemic.</p></div></div><div></div></div><div class="NLM_p">An in vitro metabolite profiling study using mouse liver microsomes (MLM) indicated that major metabolic pathways of <b>3</b> were oxidative metabolism on the quinolinone core, pyrrolidine ring, and benzodioxolane moiety.</div><div class="NLM_p">Accordingly, initial efforts focused on suppressing the oxidative metabolism of the tricyclic aryl ring by increasing polarity and/or introducing a substituent at the relatively electron-rich C-6, which was believed to be a metabolic soft site (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). 6-Hydroxy analogue <b>5</b> had decreased MLM CL<sub>int</sub> and 2-fold increased potency (mEC<sub>3</sub> = 0.39 μM). The more polar 6-cyano analogue <b>6</b> had further reduced MLM CL<sub>int</sub> but decreased potency (mEC<sub>3</sub> = 12.5 μM). The nonpolar 6-fluoro analogue <b>7</b> had retained potency but high intrinsic clearance (MLM CL<sub>int</sub> = 761 μL/min/mg). An aza-walk around the quinolinone ring produced analogues with retained or improved potency coupled with markedly improved MLM CL<sub>int</sub>, such as, 5-aza (<b>8</b>, mEC<sub>3</sub> = 0.78 μM, MLM CL<sub>int</sub> = 136 μL/min/mg) and 6-aza (<b>9</b>, mEC3 = 0.20 μM, MLM CL<sub>int</sub> = 151 μL/min/mg). This marked an important achievement: adding polarity and improving metabolic stability while improving activity. A significant loss of potency was observed with the 7-aza and 8-aza analogues, <b>10</b> and <b>11</b> (mEC<sub>3</sub> = 6.3 and 3.1 μM, respectively).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. SAR and in Vitro PK Profiles of Quinolinone Ring<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/medium/jm-2016-01496d_0015.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">Compounds are enantiopure unless otherwise noted as racemic.</p></div></div><div></div></div><div class="NLM_p">As a first step toward electrophysiological ex vivo validation of our in vitro cell-based functional potentiator assay, we assessed <b>9</b> and less active enantiomer (<i>ent</i>)-<b>9</b> in an ex vivo mouse spinal cord slice assay. In addition to good potency, <b>9</b> possessed high passive permeability (cell line Papp ave = 52 μcm/s) and solubility (PBS, FaSSIF = 235, 296 μM), rendering it suitable for this study. Neurons located in the upper layer of the dorsal horn (laminae I and II) were histologically identified and glycinergic profiles were further confirmed upon focal application of glycine (∼EC<sub>30–40</sub> = 20 μM) followed by confirmation of a reversal effect with the application of strychnine (10 μM). To further ensure that detected currents were a result of glycinergic signaling only, neurons were pretreated with a cocktail of inhibitors composed of tetrodotoxin (TTX), 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX), (2<i>R</i>)-amino-5-phosphonovaleric acid (APV), and bicuculine to silence TTX-sensitive sodium channels, α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)/kainite receptors, <i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartic acid (NMDA) receptors, and γ-aminobutyric acid (GABA<sub>A</sub>) receptors, respectively. Bath application of <b>9</b> at 0.5 μM with and without focal glycine application was assessed to confirm the potentiation mechanism. GlyR activation was assessed by calculating the mean ratio of postsynaptic current (PSC) amplitudes of 0.5 μM <b>9</b> or (<i>ent</i>)-<b>9</b> in the presence of 20 μM glycine (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>b)/20 μM glycine application alone (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>a), where a ratio of 1.0 equates to no potentiation. The activation was confirmed as glycine-dependent if the PSC amplitude could be fully reversed by strychnine (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>c). In the presence of <b>9</b> at 0.5 μM, the mean PSC ratio calculated was 4.9 ± 3.7 (mean ratio ± STD; <i>n</i> = 5). This data confirmed that endogenous neuronal glycinergic receptors can be positively modulated by <b>9</b> and served to further validate our in vitro cell-based functional potentiator assays. Less active enantiomer (<i>ent</i>)-<b>9</b> (0.5 μM) did not evoke increased current in the presence of 20 μM glycine, which provided further support that the observed action of <b>9</b> was on mechanism via GlyR potentiation.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/medium/jm-2016-01496d_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/large/jm-2016-01496d_0002.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Potentiation of glycine evoked current in adult mouse spinal neurons. Representative postsynaptic current (PSC) amplitude (pA) modulation recorded from glycinergic neurons in an isolated adult mouse spinal cord slice: (a) glycine (20 μM), (b) glycine (20 μM) + <b>9</b> (0.5 μM) on the top and (ent)-<b>9</b> (0.5 μM) on the bottom, (c) glycine (20 μM) + <b>9</b> (0.5 μM) + strychnine (10 μM). On average, application of 0.5 μM of <b>9</b> led to a 4.9-fold increase of the PSC amplitude. This response was fully reversed in the presence of strychnine (<i>n</i> = 5 neurons, scale bars apply to all electrophysiological traces).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/large/jm-2016-01496d_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01496&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To identify compounds suitable for investigation in mouse models of neuropathic pain, compounds with favorable potency and microsomal stability such as <b>8</b> and <b>9</b> were advanced to mouse PK studies. Target coverage values were calculated using potentiation of mouse GlyRα3 rather than mouse GlyRα3β activities due to lack of heteropentamer protein availability.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> At a 30 mg/kg oral dose, <b>8</b> had poor target coverage (mouse brain <i>C</i><sub>max</sub>(u)/muGlyRα3 EC<sub>50</sub> = 0.006), likely attributed to solubility limited absorption (FaSSIF, PBS solubility = 28, 7 μM). In contrast, <b>9</b> had good solubility (FaSSIF, PBS = 296, 235 μM) and improved oral coverage at 30 mg/kg (mouse brain <i>C</i><sub>max</sub>(u)/muGlyRα3 EC<sub>50</sub> = 0.62). Brain concentrations were measured due to target localization in the CNS. We next directed our efforts toward removing the oxidative metabolism liabilities imparted by the benzodioxolane sulfonamide moiety with the 6-aza substituted tricyclic core in place.</div><div class="NLM_p">To guide our optimization of the sulfonamide portion of the molecule, we utilized emerging trends relating physiochemical properties with CL<sub>int</sub>, Pgp, and BCRP efflux ratios. Analysis of correlation plots (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>) indicated that by targeting cLogD (pH = 7.4)<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> ≤ 2, there was a high likelihood of achieving MLM CL<sub>int</sub> < 200 μL/min/mg, and that by maintaining PSA < 90, Pgp and BCRP efflux ratios <3 were likely to be attained. Analogues containing hydrogen bond donors (depicted with green squares) tended to have poor passive permeability and high efflux. Our strategy toward exploring sulfonamide substitution SAR was guided by these trends and focused on small, systematic modifications relative to lead <b>9</b> with the goal of further improving potency and PK (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>).</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/medium/jm-2016-01496d_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/large/jm-2016-01496d_0003.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Physicochemical properties and in vitro PK trends. Pink, compounds described herein; gray, structurally related tricyclic sulfonamides (compounds not disclosed herein); green squares, analogues containing an H-bond donor. (A) MLM CL<sub>int</sub> vs Log <i>D</i> (pH = 7.4). (B) MDCK human Pgp efflux ratio vs binned PSA. (C) MDCK human BCRP efflux ratio vs binned PSA.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/large/jm-2016-01496d_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01496&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Sulfonamide Substitutions: SAR and PK Profiles</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/medium/jm-2016-01496d_0016.gif" alt="" id="fx3" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last">Fraction unbound (<i>f</i><sub>u</sub>) in mouse brain was determined as described in Berry et al, 2010.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Mouse brains were collected at multiple time points following IP or PO administration. Drug concentrations in the brain were determined according to the method described by Huang et al.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> brain <i>C</i><sub>u</sub> = total brain concentration × <i>f</i><sub>u-brain</sub>.</p></div></div><div></div></div><div class="NLM_p">Toward replacing the benzodioxolane moiety, a known structural alert,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> other 6,5-bicyclic heteroaromatics were initially investigated. Benzimidazole and <i>N</i>-methyl benzimidazole replacements <b>12</b> and <b>13</b> suffered ∼10-fold reduced potency. Compound <b>12</b> had insufficient brain coverage over muGlyRα3 despite improved microsomal stability, likely as a result of poor passive permeability, and <b>13</b> suffered from high efflux. Benzoxazole <b>14</b> had retained potency and improved microsomal stability relative to <b>9</b> but was found to be unstable in mouse plasma and assay buffer.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Benzothiazole <b>15</b> suffered decreased potency (hGlyRα3β mEC<sub>3</sub> = 1.56 μM) and oral coverage over muGlyRα3 and imidazopyridine <b>16</b> had reduced potency (hGlyRα3β mEC<sub>3</sub> = 3.1 μM). The importance of each oxygen atom of the benzodioxolane was assessed by preparing dihydrobenzofurans <b>17</b> and <b>18</b>. Removal of either oxygen afforded a 5-fold drop in potency as well as slightly suppressed oral coverage. Interestingly, benzofuran analogue <b>20</b> (AM-1488)<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> had retained potency relative to <b>9</b> while its regioisomer <b>19</b> had reduced activity. Additionally, suitable coverage levels of <b>20</b> were achieved at lower doses relative to benzodioxolane <b>9</b> (mouse brain <i>C</i><sub>max</sub>(u) /muGlyRα3 EC<sub>50</sub>: 1.2 @ 10 mg/kg vs 0.62 for <b>9</b> @ 30 mg/kg). It is likely that the improved exposure observed for <b>20</b> despite modest MLM stability was a result of saturation of metabolism, supported by greater than dose proportion increases in area under the curve (AUC) exposure when increasing dose from 5 to 10 mg/kg (po) and well over 100% calculated oral bioavailability. As was the case with our initial lead tricyclic sulfonamide, the enantiomer of <b>20</b>, (<i>ent</i>)-<b>20</b>, was significantly less active (hGlyRα3β EC<sub>50</sub> > 20 μM, mEC<sub>3</sub> > 25 μM). Monocyclic sulfonamides, such as <b>21</b>, were identified with modest activity but with relatively high instrinsic clearance (MLM CL<sub>int</sub> = 432 μL/min/mg).</div><div class="NLM_p">Profiling of <b>20</b> across a range of CYS loop family receptors, voltage-gated ion channels, kinases, and GPCRs indicated a high degree of off-target selectivity (see Supporting Information <a href="/doi/suppl/10.1021/acs.jmedchem.6b01496/suppl_file/jm6b01496_si_001.pdf" class="ext-link">Part 4</a>). Additionally, <b>20</b> was selective over hERG, BSEP, CYPs, and PXR. Furthermore, <b>20</b> potentiated glycine-evoked current in adult mouse spinal neurons at 0.5 μM (4.4-fold increase in postsynaptic current amplitude relative to glycine alone).<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div><div class="NLM_p">With suitable mouse PK and a favorable expanded selectivity profile, <b>20</b> was advanced as a potential in vivo proof-of-concept tool and examined in the mouse SNI model of neuropathic pain (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>). In SNI model, surgical ligation of the peroneal and tibial nerves can generate tactile allodynia that can be reversed with a therapeutic agent.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> In this model, active enantiomer <b>20</b> demonstrated significant reversal of tactile allodynia at an oral dose of 20 mg/kg (mouse brain <i>C</i>(u)/muGlyRα3 EC<sub>50</sub>: 1.9), while the inactive enantiomer <b>21</b> did not elicit a significant effect at the same dose and with similar exposure <i>C</i>(u) plasma = 2.3 μM (est. <i>C</i>(u) brain = 0.61 μM). Notably, <b>20</b> did not significantly affect basic movements in naïve mice at an oral dose of 20 mg/kg.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> These results suggest that the reversal of tactile allodynia was via potentiation of GlyRs and further validates GlyRs as a therapeutic target.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/medium/jm-2016-01496d_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/large/jm-2016-01496d_0004.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Reversal of SNI-induced tactile allodynia by <b>20</b> when dosed at 20 mg/kg (po). At 60 min post oral dosing, <b>20</b> dosed at 20 mg/kg (po) produced a significant increase in von Frey threshold (1.53 ± 0.31 g) relative to vehicle (0.82 ± 0.19 g) by ANOVA with Dunnett’s Multiple Comparisons; <i>F</i><sub>2,35</sub> = 4.7, <i>p</i> < 0.05. The less active enantiomer (<i>ent</i>)-<b>20</b> also dosed at 20 mg/kg (po) did not reverse tactile allodynia. The positive control, pregabalin, dosed at 30 mg/kg (po), was not included in the statistical analysis because of low <i>n</i> but appeared effective. Exposure values were generated at 90 min post dose.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/large/jm-2016-01496d_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01496&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">With the goal of improving metabolic stability and with guidance from metabolism identification studies, we pursued substitution of the pyrrolidine ring. Further, substitution at the pyrrolidine 1- or 2-position may impact both the vector and rotational freedom of the sulfonamide moiety potentially impacting activity. Exploration of pyrrolidine ring SAR was conducted concomitantly with the previously described sulfonamide SAR exploration and thus retained the benzodioxolane sulfonamide moiety (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Pyrrolidine Modifications: SAR<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/medium/jm-2016-01496d_0017.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>Table a</sup><p class="last">*Tricycle aryl contains C–H rather than aza at 6-position.</p></div></div><div></div></div><div class="NLM_p">First, substitution at ring fusion carbon “3” was investigated. Both polar and nonpolar substitution at this position (<b>22</b>–<b>24</b>) resulted in markedly reduced potentiation (mEC<sub>3</sub> > 25 μM). Similarly, methyl substitution at the ring fusion carbon “4” as in <b>25</b> was not tolerated (mEC<sub>3</sub> > 25 μM). The chemistry employed en route to the majority of tricyclic core modifications was also suitable for rapidly accessing all eight diastereomeric α-methyl pyrrolidines. In fact, the initial synthesis afforded a nonstatistical mixture of all eight possible stereoisomers at positions “1” and “2”, which were elaborated to a mixture of final compounds which were separated by chromatography, providing compounds <b>26</b>–<b>33</b>. Only one minor isomer out of the eight isolated (<b>32</b>, AM-3607),<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> representing 3% of the isomeric mixture, afforded improved potency, while the other seven isomers suffered a dramatic loss of potency. Furthermore, the potency of active α-methyl isomer <b>32</b> was almost an order of magnitude improved relative to its <i>des</i>-methyl congener <b>9</b> (hGlyRα3β mEC<sub>3</sub> = 0.025 vs 0.2 μM) with an in vitro PK profile of <b>32</b> similar to that of <b>9</b> (MDCK <i>P</i><sub>app</sub> (av), 43.1; MDR1 ER, 1.6; HLM, MLM CL<sub>int</sub>, 83, 254 μL/min/mg). Two-dimensional NMR studies (ROESY and HMBC) indicated that the active analogue possessed a methyl β to the carbonyl which projected into the concave face of the tricyclic ring system.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Molecular modeling studies indicated that in addition to reducing the rotational freedom of the sulfonamide, the α-methyl substitution caused the structure to favor a different orientation of the tricycle, which we hypothesized to be the active binding conformation. For the <i>des</i>-methyl analogue <b>9</b>, the analogous conformation was found to be 3.08 kcal above its global minima (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>).<a onclick="showRef(event, 'ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref32 ref33">(32, 33)</a></div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/medium/jm-2016-01496d_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/large/jm-2016-01496d_0005.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Overlay of global minima conformations of <b>32</b> (magenta) and <b>9</b> (cyan). Figures generated using PyMOL (The PyMOL Molecular Graphics System, version 1.7.05, Schrödinger, LLC).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/large/jm-2016-01496d_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01496&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Toward enhancing our understanding of the binding properties of our molecules, we developed a surface plasmon resonance (SPR) assay using the crystallographic construct of human GlyRα3 channels.<a onclick="showRef(event, 'ref27 ref34'); return false;" href="javascript:void(0);" class="ref ref27 ref34">(27, 34)</a> The binding values we obtained were in good agreement with our measured cell-based assay potency for active leads and their less active isomers (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>), supporting that the compounds act through direct binding to the GlyR receptors. Furthermore, a 17-fold improved <i>K</i><sub>D</sub> is observed for <b>32</b> over <b>20</b>, consistent with the measured GlyRa3 EC<sub>50</sub> values.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. SPR Data for Active Leads and Their Less Active Isomers</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">hGlyRα3 EC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">SPR hGlyRα3 <i>K</i><sub>D</sub><a class="ref internalNav" href="#t5fn1" aria-label="a">a</a> (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="center">0.45</td><td class="colsep0 rowsep0" align="center">0.19 ± 0.03</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>ent</i>)-<b>20</b></td><td class="colsep0 rowsep0" align="center">>25</td><td class="colsep0 rowsep0" align="center">>20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="center">0.050</td><td class="colsep0 rowsep0" align="center">0.011 ± 0.005</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="center">>25</td><td class="colsep0 rowsep0" align="center">>20</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Values are an average of three measurements with SEM values.</p></div></div></div><div class="NLM_p">The X-ray cocrystal structure of <b>32</b> in complex with human GlyRα3 in the presence of the native agonist glycine was solved at high resolution (2.6 Å) (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>).<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> This represented the first public disclosure of a potentiator-bound X-ray cocrystal structure with a human glycine receptor. <b>32</b> is bound in a novel induced-pocket and adopts a conformation very close to its calculated global minima conformation (0.05 kcal/mol difference).<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> The structure indicates H-bonding interactions with the sulfonamide and amide carbonyl groups (water-mediated) as well as hydrophobic interactions with the benzodioxolane, pyrrolidine–naphthyridinone core, and methyl groups. The ligand is bound at the interface between each of the five α-subunit protomers in the extracellular domain and in close proximity to bound glycine (10 Å away), which is in the canonical orthosteric ligand binding pocket. It was shown that upon binding of <b>32</b>, the GlyRα3 protein adopts a conformation which stabilizes glycine, thereby increasing binding affinity. The binding interactions identified in the X-ray crystal structure supported our SAR observations and design hypotheses. For example, the aza-naphthyridone carbonyl is engaged in a water-mediated hydrogen bond and removal of the carbonyl abolished activity (data not shown). Further, the nitrogen of the pyridine ring of the aza-naphthyridone is pointed toward the solvent, supporting the substitutional tolerance for both polar (aza (<b>32</b>), hydroxy (<b>5</b>)) and nonpolar substituents (fluoro, <b>7</b>). The pyridine ring nitrogen of aza-naphthyridones <b>10</b> and <b>11</b> are exposed to the hydrophobic binding pocket, explaining their significantly diminished activities.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/medium/jm-2016-01496d_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/large/jm-2016-01496d_0006.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (A) Potentiator binding pocket in human GlyRα3. The bound conformation of <b>32</b> (green) is overlaid with the calculated minimum energy conformation (magenta). (B) X-ray of potentiator <b>32</b> and glycine bound to GlyRα3 (PDB codes: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5TIO">5TIO</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5TIN">5TIN</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/large/jm-2016-01496d_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01496&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35435" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35435" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">For the majority of the analogues described, a general route toward the tricyclic amine penultimate core was employed. The sequence began with either commercial or prepared quinolinones or naphthyridones (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). The noncommercial 3-ethyl-carboxyl-quinolone and naphthyridone intermediates <b>34</b> were accessed by Friedlander synthesis of 2-formyl or 2-acetyl anilines with ethyl malonate.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> The 3-cyano naphthyridone variant (<b>35</b>) was prepared under similar conditions with the anion of methyl 2-cyanoacetate as the nucleophile. The preparation of 3-fluoro-<i>N</i>-methyl-naphthyridone <b>37</b> began with S<sub>N</sub>Ar of 4-chloronicotinaldehyde with methyl amine providing 4-methylamino-pyridine <b>36</b>. Subsequent Horner–Wadsworth–Emmons olefination with the ylide generated upon deprotonation of ethyl 2-(diethoxyphosphoryl)-2-fluoroacetate followed by intramolecular cyclization of the <i>E</i>-olefin isomer provided <b>37</b>.</div><figure id="sch1" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/medium/jm-2016-01496d_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/large/jm-2016-01496d_0007.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Preparation of Quinolinone and Naphthyridone Intermediates<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/large/jm-2016-01496d_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01496&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) piperidine, EtOH, reflux, 50–98%; (b) NH<sub>3</sub>Me (40% in H<sub>2</sub>O), MeOH–EtOH, 120 °C, sealed tube, 48%; (c) (i) NaH, ethyl 2-(diethoxyphosphoryl)-2-fluoroacetate, THF, (ii) aldehyde <b>36</b>, 21%.</p></p></figure><div class="NLM_p">The general sequence utilized to access tricyclic pyrrolidine cores is described in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a> and was inspired by established routes for the known tricycle core of <b>41a</b>.<a onclick="showRef(event, 'ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref37 ref38">(37, 38)</a> Substituted and modified quinolinones (<b>34</b> or <b>35</b>) were <i>N</i>-methylated with iodomethane in the presence of cesium carbonate in DMF to give <b>38</b>. The key step was a [3 + 2] dipolar cycloaddition of <b>38</b> with the azo-methine ylide generated from the treatment of <i>N</i>-benzyl-1-methoxy-<i>N</i>-((trimethylsilyl)methyl)methanamine with TFA. This reliably provided tricyclic <i>N</i>-benzyl pyrrolidines <b>39</b> as the racemic syn isomers in generally good yields. In the synthesis of <b>39c</b>, the [3 + 2] dipolar cycloaddition and amide <i>N</i>-methylation steps were reversed.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Ester hydrolysis and decarboxylation under acidic conditions afforded <b>40</b>, and benzyl hydrogenolysis with catalytic palladium hydroxide furnished the penultimate tricyclic pyrrolidine core structure <b>41</b>. Because of the sensitivity of the nitrile functionality (R<sup>3</sup> = CN) under reductive conditions, a two-step, one pot debenzylation sequence was employed. Urethane formation by treatment with vinyl carbonochloridate and subsequent debenzylation of the formed salt was followed by urethane hydrolysis under acidic conditions to provide the α-cyano tricyclic core <b>41f</b>.</div><figure id="sch2" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/medium/jm-2016-01496d_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/large/jm-2016-01496d_0008.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Preparation of Tricyclic Pyrrolidine Cores<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/large/jm-2016-01496d_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01496&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) Cs<sub>2</sub>CO<sub>3</sub>, MeI, DMF, 36–100%; (b) TFA, CH<sub>2</sub>Cl<sub>2</sub>, 52–100%, 18% for <b>39e</b>; (c) HCl (aq), 100 °C, 78–100%; (d) Pd(OH)<sub>2</sub>, H<sub>2</sub>, EtOH:H<sub>2</sub>O (5 or 10:1), 40 psi, 40–60 °C, 83–100%; (e) (i) vinyl carbonochloridate, DCM, 0 °C–rt, (ii) EtOH, 6 N HCl, 100 °C, 70%.</p></p></figure><div class="NLM_p">The syntheses of the α-methyl ring fusion, 4-cyano, and 4-hydroxy modified pyrrolidine cores employed late stage functionalization of the ring system (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). Pyrrolidine nitrogen protecting group swap from benzyl to <i>tert</i>-butyl carbonate (Boc) under standard conditions provided <b>42</b>. Treatment with sodium hydride and excess iodomethane affected methylation of both the quinolinone nitrogen and the ring fusion carbon α to the carbonyl, affording α-methylated core tricycle <b>44</b>, following acid-mediated <i>N</i>-boc cleavage. Toward 4-substituted tricyclic core structures, the <i>N</i>-methylated tricycle of <b>42</b> was then regiospecifically brominated in the presence of <i>N</i>-bromosuccinimide to give <b>43</b>, which was cyanated under palladium-mediated conditions to furnish cyano substituted core <b>45</b>. The brominated intermediate <b>43</b> was alternatively converted to boronate ester <b>46</b> and subsequently oxidized with hydrogen peroxide and sodium hydroxide to hydroxylated core tricycle, then treated with HCl in dioxane to cleave the <i>N</i>-boc group and afford tricyclic amine intermediate <b>47</b>.</div><figure id="sch3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/medium/jm-2016-01496d_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/large/jm-2016-01496d_0009.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Preparation of α-Methyl Ring Fusion and 4-Cyano and 4-Hydroxyl Tricyclic Pyrrolidine Cores<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/large/jm-2016-01496d_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01496&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) Pd/C (10%), Pd(OH)<sub>2</sub>, (Boc)<sub>2</sub>O, H<sub>2</sub>, EtOH, 50 psi, 96%; (b) (i) NaH, MeI, DCE, 59%, (ii) NBS, DCM, 92%; (c) (i) NaH, MeI, (ii) HCl in MeOH; (d) (i) Pd(PPh<sub>3</sub>)<sub>4</sub>, Zn(CN)<sub>2</sub>, DMF, 100 °C, (ii) HCl/dioxane, 100%; (e) (Bpin)<sub>2</sub>, PdCl<sub>2</sub>(dppf), KOAc, dioxane, 90 °C, 100%; (f) (i) H<sub>2</sub>O<sub>2</sub>, NaOH, THF/H<sub>2</sub>O, (ii) HCl/dioxane, 60%.</p></p></figure><div class="NLM_p">The syntheses of the 4-fluoro and 5-aza tricyclic pyrrolidine cores began with Still–Gennari modified Horner–Wadsworth–Emmons olefination of 2-nitro-4-fluoro benzaldehyde, affording olefin <b>48</b> as a mixture of <i>E</i> and <i>Z</i> isomers (4:1). Dipolar [3 + 2] cycloaddition of <b>48</b> with <i>N</i>-benzyl azo-methine ylide afforded <i>N</i>-benzyl pyrrolidine ester <b>49</b> (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>). Nitro reduction and intramolecular cyclization afforded tricyclic cores <b>50</b>, which were either methylated at the quinolone nitrogen via a protection, methylation, deprotection sequence to furnish penultimate 4-fluoro tricyclic core <b>51</b> or first sulfonylated at the secondary amine, then <i>N</i>-methylated to afford 5-aza analogue <b>10</b>.</div><figure id="sch4" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/medium/jm-2016-01496d_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/large/jm-2016-01496d_0010.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Preparation of 4-Fluoro Tricyclic Core and 5-Aza Tricyclic Core Analogue <b>10</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/large/jm-2016-01496d_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01496&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) K<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, 93% for <b>48a</b>, 24% for <b>48b</b>; (b) TFA, DCM, 87% for <b>49a</b>, 100% for <b>49b</b>; (c) (i) Pd(OH)<sub>2</sub> or Pd/C, H<sub>2</sub>, EtOH, 60 °C, 55 psi, 100%, (ii) AcOH, 80 °C (for <b>49b</b> only), 99% (d) (i) (Boc)<sub>2</sub>O, Et<sub>3</sub>N, EtOH, (ii) NaH, MeI, DMF, (iii) HCl/dioxane, 56%; (e) (i) benzo[<i>d</i>][1,3]dioxole-5-sulfonyl chloride, Et<sub>3</sub>N, DCM, (ii) NaH, MeI, DMF, 2%.</p></p></figure><div class="NLM_p">The initial route toward α-methyl-pyrrolidine tricyclic pyrrolidine cores followed a very similar synthetic route as described for <i>des</i>-methyl pyrrolidine cores (<a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>). The known methylated azo-methine ylide precursor <b>53</b> was prepared following a published two-step protocol.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Alkylation of neat benzyl amine with (1-chloroethyl)trimethylsilane at 180 °C provided ethyl trimethylsilyl secondary amine <b>52</b>, which was then converted to an imminium salt by treatment with formaldehyde in the presence of potassium carbonate and trapped by methanol to afford <b>53</b>. This sensitive intermediate was used crude and in the presence of TFA decomposed to an azo-methine ylide which underwent dipolar [3 + 2] cycloaddition with naphthyridone <b>38g</b> to provide α-methyl-<i>N</i>-benzyl pyrrolidines as an 1:8:8:1 mixture of racemic stereoisomers. Cleavage of the <i>N</i>-benzyl group under standard hydrogenolysis conditions provided α-methyl-pyrrolidine tricyclic intermediate <b>54</b> as a mixture of stereoisomers. As described earlier, only one of the minor isomeric intermediates ((<i>rac</i>)-<i>cis</i>-<b>54d</b>) of this mixture led to highly potent sulfonamide <b>32</b>. A revised synthesis was therefore developed to improve the relative yield of the active diastereomer (<i>rac</i>)-<i>cis</i>-<b>54d</b> (<a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>).</div><figure id="sch5" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/medium/jm-2016-01496d_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/large/jm-2016-01496d_0011.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Initial Route Towards Isomeric Mixture of α-Methyl Pyrrolidine Tricyclic Core<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/large/jm-2016-01496d_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01496&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) Neat, 180 °C; (b) CH<sub>2</sub>O (aq), K<sub>2</sub>CO<sub>3</sub>, MeOH; (c) (i) <b>38g</b>, TFA, DCM, 33%, (ii) 3 N HCl:dioxane (2:3), 90 °C, (iii) Pd(OH)<sub>2</sub>, H<sub>2</sub>, EtOH:H<sub>2</sub>O (10:1), 40 °C, 40 psi, 96%, (over 2 steps).</p></p></figure><figure id="sch6" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/medium/jm-2016-01496d_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/large/jm-2016-01496d_0012.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Improved Route Towards Isomeric Mixture of α-Methyl Pyrrolidine Tricyclic Core<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/large/jm-2016-01496d_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01496&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) (i) MeI, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 51%, (ii) NaH, trimethylsulfoxonium iodide, THF, DMSO; (b) NaN<sub>3</sub>, Et<sub>3</sub>N, AcOH, DMF, 70 °C; (c) PPh<sub>3</sub>, acetone, 60 °C; (d) NaBH<sub>4</sub>, MeOH/DCE, (30% over 4 steps).</p></p></figure><div class="NLM_p">The complex isomeric mixture of methylated pyrrolidines was a result of both constitutional isomers (methyl group at either α-pyrrolidine position) and stereoisomers (methyl group projected into either the concave or convex face of tricyclic ring system). The active isomer contained a methyl group proximal to the carbonyl group and projected into the concave face of the ring system. By starting with a surrogate for the methyl group already present at the desired position, the regioisomer of choice would ultimately be prepared. Accordingly, commercial 3-acetyl-1,6-naphthyridin-2(1<i>H</i>)-one was <i>N</i>-methylated, then cyclopropanated under Corey–Chaykovsky<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> conditions with the ylide of trimethylsulfoxonium iodide to afford <b>55</b> (<a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>). Cyclopropane ring opening at the least sterically hindered carbon by sodium azide provided azide <b>56</b>. The crude azide was reduced with triphenylphosphine and the liberated amine condensed intramolecularly with the acetyl ketone to provide imine <b>57</b> as a racemic mixture of <i>cis</i>-pyrrolidines. Compound <b>57</b> was susceptible to isomerization and oxidation to the pyrrole upon prolonged exposure to air. Reduction of the <b>57</b> with sodium borohydride afforded a 1:1 mixture of concave:convex methyl diastereomers, providing the penultimate racemic tricyclic intermediates ((<i>rac</i>)-<i>cis</i>-<b>54c</b> and (<i>rac</i>)-<i>cis</i>-<b>54d</b>). This route afforded improved relative ratio of the desired methylated tricyclic core with 25% of the desired single enantiomer as compared to 3% for the initial route.</div><div class="NLM_p">The described tricyclic sulfonamides were prepared under the same general conditions, as generically depicted in <a class="ref internalNav" href="#sch7" aria-label="Scheme 7">Scheme 7</a>. Sulfonylation was accomplished with sulfonyl chloride in the presence of triethylamine in acetonitrile. Either specific isomers or isomeric mixtures of tricyclic penultimate core intermediates were used in analogue synthesis. For example, the single active enantiomer of <b>41c</b> was used in the synthesis of <b>20</b> and the mixture of (<i>rac</i>)-cis-<b>54c</b> and (<i>rac</i>)-<i>cis</i>-<b>54d</b> was used toward the synthesis of <b>32</b>, which was obtained as a single enantiomer following chiral SFC purification. The relative and absolute configurations of the active species are as drawn in the schemes and were determined by two-dimensional NMR (ROESY and HMBC) and the described X-ray cocrystal structure, respectively.</div><figure id="sch7" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/medium/jm-2016-01496d_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/large/jm-2016-01496d_0013.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis of Sulfonamides<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/large/jm-2016-01496d_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01496&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) Sulfonyl chloride, triethylamine, CH<sub>3</sub>CN; (b) triethylamine, CH<sub>3</sub>CN, 54%; (c) (i) triethylamine, CH<sub>3</sub>CN, 75%, (ii) chiral SFC purification.</p></p></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07158" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07158" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Herein, we have detailed the discovery and synthesis of a novel class of orally available and CNS-penetrant tricyclic sulfonamides as selective allosteric potentiators of glycine receptors. Our property-guided hit-to-lead efforts delivered proof-of-concept ex vivo tool compound <b>3</b>, which potentiated postsynaptic currents in mouse spinal neurons of the dorsal horn, and in vivo tool molecule <b>20</b>, which demonstrated oral efficacy in a mouse spared-nerve injury model of neuropathic pain. Concurrent systematic exploration of the effects of core methylation on functional activity and binding affinity delivered highly potent ligand <b>32</b>, which facilitated the generation of the first potentiator-bound hGlyRα3 X-ray cocrystal structure to date. An efficient and scalable synthetic route to provide the penultimate methylated tricyclic intermediate (<i>rac</i>)-<i>cis</i>-<b>54d</b> was developed. This work provided methods and tools suitable for the further investigation of the biology of GlyRs and the generation of GlyR modulators with improved drug-like properties.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36082" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36082" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Functional Testing in FLIPR Assay</h3><div class="NLM_p">HEK293T cells expressing human GlyRα3β were cultured in T 225 cm<sup>2</sup> culture flasks under standard cell culture conditions of 37 °C, 5% v/v CO<sub>2</sub>, and 95% humidity until 80–90% confluent. Prior to the assay, cells are harvested by briefly washing with DPBS followed by addition of TrypLE cell dissociation reagent for 2 min. Cells were then quantified using a ViCell and subsequently diluted in Cell Plating Media to achieve a plated cell density of ∼12000 cells/well. Using a Multidrop Combi, 25 μL of cell suspension was dispensed into Corning CellBIND 384-well ViewPlates and then incubated at 37 °C overnight under the standard cell culture conditions described above. The next day (∼18–24 h after plating), 5 μL of 6× Membrane Potential (MP) blue dye was dispensed into each cell culture plate using a Multidrop Combi. The cell plates were then incubated at 37 °C for 30 min and then allowed to equilibrate to room temperature for an additional 30 min prior to running the assay.</div><div class="NLM_p">The membrane potential dye assay was performed on the FLIPR Tetra. The net membrane potential of the cells changes upon activation of GlyRα3β, resulting in the increased flux of Cl<sup>–</sup> ions out of the cell down a concentration gradient and a robust increase in fluorescence signal. All measurements were made using an exposure time of 0.4 s, 510–545 nm/565–625 nm excitation/emission filter set, excitation intensity of 40%, and camera gain of 50.</div><div class="NLM_p">To examine the ability of compounds to directly activate GlyRα3β as agonists, dose–response plates of compound were prepared at 4× in assay buffer (10 mM Hepes, 60 mM NaCl, 5 mM KCl, 2 mM MgCl<sub>2</sub>, 1 mM CaCl<sub>2</sub>, 10 mM <span class="smallcaps smallerCapital">d</span>-glucose, 160 mM <span class="smallcaps smallerCapital">d</span>-mannitol, pH 7.4) using a 1:2 stepwise dilution series of compounds in standard 384-well polypropylene plates. In a first addition step, 10 μL of 4× compound was transferred to a cell plate containing MP blue dye and fluorescence response (agonism) was measured for 2 min. Potentiation of GlyRα3β was measured in a subsequent addition step by transferring 10 μL of 5× EC<sub>10</sub> glycine to the cell plate and monitoring fluorescence changes for 4 min. The maximum concentration of compound in this assay is 20 μM.</div><div class="NLM_p">Schild assays were used to visualize the modulation of glycine potency by each compound. Glycine dose–response plates were prepared at 4× in assay buffer using a 1:2 stepwise dilution series in standard 384-well polypropylene plates. In this assay format, glycine and compound were premixed, simultaneously delivered to cells, and responses measured for 4 min. Glycine potency was then determined in the presence of varying concentrations of compound.</div><div class="NLM_p">All FLIPR kinetic traces were processed using an area under the curve relative to baseline (AUC-BL) algorithm, where the baseline was the first 10 s of the kinetic measurement prior to a fluorescence change. Compound potencies were determined by normalizing responses to percent of control (POC) using the maximum achievable glycine response and baseline EC<sub>10</sub> glycine response as references. POC normalized data were then plotted against log [compound], and data were fit to a nonlinear regression four-parameter Hill fit to determine the EC<sub>50</sub>. All curve fitting was performed with the GraphPad Prism 6 software. Schild assay dose response curves for glycine were analyzed in a similar manner.</div><div class="NLM_p last">For human and mouse GlyRα3 dose response assay protocols, surface plasmon resonance, off-target profiling, and X-ray crystallography protocols, see Huang et al.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Mouse Spared Nerve Injury Model</h3><div class="NLM_p last">Adult male C57BL/6 mice weighing 20–30 g were cared for in accordance to the Guide for the Care and Use of Laboratory Animals, eighth edition (National Research Council Committee for the Update of the Guide for the Care and Use of Laboratory Animals, 2011). Animals were housed at an Association for Assessment and Accreditation of Laboratory Animal Committee accredited facility in nonsterile ventilated microisolator housing. All research protocols were approved by the Institutional Animal Care and Use Committee. For protocol see Huang, Shaffer, DiMauro, Gingras et al.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> CL<sub>int</sub> Determinations</h3><div class="NLM_p last">CL<sub>int</sub> was determined by spiking drug into a mixture of 0.25 mg/mL mouse liver microsomes, 1 mM reduced nicotinamide adenine dinucleotide phosphate, and 5 mM MgCl in 100 mM potassium phosphate buffer, pH 7.4, and incubating for various time points up to 40 min.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Passive Permeability Determinations</h3><div class="NLM_p last">Bidirectional transport across Madin–Darby canine kidney cells transfected with control vector (VC-MDCK), human <i>MDR1</i> gene (MDR1-MDCK) and human <i>ABCG2</i> gene (BCRP-MDCK) was measured in triplicate at 5 μM. Average apparent permeability value (<i>P</i><sub>app</sub>) of both directions from VC-MDCK was used as passive permeability.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> General Chemistry</h3><div class="NLM_p last">Unless otherwise noted, all materials were obtained from commercial suppliers and used without further purification. Anhydrous solvents were obtained from Aldrich and used directly. All reactions involving air- or moisture-sensitive reagents were performed under a nitrogen or argon atmosphere. Purity and reaction analyses were measured using Agilent 1100 series high performance liquid chromatography (HPLC) systems with UV detection at 254 and 215 nm (System A: Agilent Zorbax SB-C18 3.0 mm × 50 mm, 3.5 μm, 5–95% CH<sub>3</sub>CN in H<sub>2</sub>O with 0.1% TFA for 3.6 min at 1.5 mL/min or Halo Phenyl–Hexyl, 3 mm × 50 mm, 2.7 μm, 5–95% CH<sub>3</sub>CN in H<sub>2</sub>O with 0.1% TFA for 1.01 min at 2.0 mL/min. System B: Waters Xbridge C18, 3 mm × 50 mm, 3.5 μm, 5–95% CH<sub>3</sub>CN in H<sub>2</sub>O with 0.1% formic acid for 3.6 min at 1.5 mL/min.). Purities for final compounds were >95%. Exact mass confirmation was performed on an Agilent 1200 series high performance liquid chromatography (HPLC) system (Santa Clara, CA, U.S.) by flow injection analysis, eluting with a binary solvent system A and B (A, water with 0.1% FA; B, ACN with 0.1% FA) under isocratic conditions (50% A/50% B) at 0.2 mL/min with MS detection by an Agilent 6510-Q time-of-flight (TOF) mass spectrometer (Santa Clara, CA, U.S.). Silica gel chromatography was generally performed with prepacked silica gel cartidges (Biotage, Teledyne-Isco or Interchim). Chiral method development performed on an analytical Thar SFC/MS. Preparative chiral separations performed on Thar SFC Prep 80 or SFC Prep 350 instruments. Library purification methods: Preparative LC/MS, Waters autopurification system; liquid transfer system, Tecan; drying system, Genevac; prep. column: Xbridge (19 mm × 100 mm, C18, 10 μm); flow rate, 40 mL/min; general gradient, 5–95% B, 0.1% additive in both A and B; 10 min gradient. Mobile phase A, water; mobile phase B, acetonitrile; additive, TFA or NH<sub>4</sub>OH. <sup>1</sup>H NMR spectra were recorded on a Bruker AV-400 (400 MHz) spectrometer or a Varian 400 MHz spectrometer at ambient temperature, or the NMR spectra were collected with a Bruker Avance III spectrometer operating at a proton frequency of 500.13 MHz using a 10 mL Protasis CapNMR flow probe. NMR samples were delivered to the flow probe using a Protasis One-Minute NMR automation system comprised of a Discovery Tower Sample Manager and a Waters Liquid Handler is made by CTC, Switzerland (model 2777). All observed protons are reported as parts per million (ppm) downfield from tetramethylsilane (TMS) or other internal reference in the appropriate solvent indicated. Data are reported as follows: chemical shift, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, br = broad, m = multiplet), coupling constants, and number of protons. Low-resolution mass spectral (MS) data were determined on an Agilent 1100 series LCMS with UV detection at 254 and 215 nm and a low resonance electrospray mode (ESI).</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Chirality Naming Convention</h3><div class="NLM_p last">Racemic mixtures are denoted with a “<i>rac</i>” chemical name prefix and refer to racemic mixtures of “cis” 5,6-ring fusions.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> General Procedure for Sulfonylation</h3><div class="NLM_p last">To a solution of the amine in DMF or MeCN was added the sulfonyl chloride at 0 °C followed by dropwise addition of triethylamine at 0 °C. The reaction mixture was stirred at room temperature for 12 h. The resulting DMF suspension was filtered through a 0.45 μm frit. (When MeCN was the reaction solvent, the mixture was concentrated and the residue was suspended in DMF before filtration.) The filtrate was purified with RP-HPLC ramping ACN in H<sub>2</sub>O, NH<sub>4</sub>OH 0.1% to afford the corresponding sulfonamide. Normal phase MPLC purification was alternately employed in some cases using EtOAc:EtOH (76:24) or EtOAc in heptane.</div></div><div id="sec5_7_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Synthesis of Intermediate (3a<i>R</i>,9b<i>R</i>)-5-Methyl-3,3a,5,9b-tetrahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>][1,6]naphthyridin-4(2<i>H</i>)-one (<b>41c</b>).<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></h3><div class="NLM_p last">Chiral separation conditions of <b>41c</b>. Note: This chiral separation was conducted on the free-base. The sample was processed using the following SFC conditions: column, Chiralpak AD, 5 μm, 2 cm i.d. × 15 cm length; flow rate, 80 mL/min; mobile phase, 60% methanol w/0.2% diethylamine, 40% CO<sub>2</sub>; back pressure setting, 100 bar; sample dissolution, 60 g dissolved in 800 mL of methanol; injection volume, 1.75 mL. Analysis: column, Chiralpak AD, 5 μm, 4.6 mm × 100 mm; flow rate, 5 mL/min; mobile phase, 50% methanol w/0.2% diethylamine, 50% CO<sub>2</sub>; back pressure setting, 100 bar. Peak 1 = (3a<i>S</i>,9b<i>S</i>)-<b>41c</b>.</div></div><div id="sec5_7_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> (3a<i>S</i>,9b<i>S</i>)-2-(Benzo[<i>d</i>][1,3]dioxol-5-ylsulfonyl)-5-methyl-3,3a,5,9b-tetrahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>]quinolin-4(2<i>H</i>)-one (<b>3</b>) and (3a<i>R</i>,9b<i>R</i>)-2-(Benzo[<i>d</i>][1,3]dioxol-5-ylsulfonyl)-5-methyl-3,3a,5,9b-tetrahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>]quinolin-4(2<i>H</i>)-one (<b>4</b>)</h3><div class="NLM_p last">To a solution of <b>41a</b><a onclick="showRef(event, 'ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref37 ref38">(37, 38)</a> (0.204 g, 0.855 mmol) in DMF (8.55 mL) was added triethylamine (0.119 mL, 0.855 mmol). The mixture was stirred at rt for 5 min. Then 1,3-benzodioxole-5-sulfonyl chloride (0.207 g, 0.940 mmol) was added at 0 °C followed by dropwise addition of triethylamine (0.238 mL, 1.709 mmol) at 0 °C. The reaction mixture was stirred at room temperature for 4 h. The resulting mixture was diluted with water and extracted with DCM twice. The combined organic layers were washed with brine, dried over MgSO<sub>4</sub>, filtered, and dried under reduced pressure. The crude material was adsorbed onto a plug of silica gel and purified by chromatography, eluting with a gradient of 0–50% EtOAc in heptane, to provide the racemic mixture of <b>3</b> and <b>4</b> (0.283 g, 0.732 mmol, 86% yield) as white solid. This solid was subjected to chiral resolution. Chiral SFC conditions: Chiralcel OJ, 2 cm × 15 cm, 30% methanol w/0.2% DEA, 80 mL/min, pressure drop = 54 bar, 254 nm detection, Sample dissolved in 20 mL of DCM:MeOH (1:1). Sample processed with 1 mL injection volume and cycle time of 2.5 min. Peak assignment determined by SFC on Chiralcel OJ with 30% methanol w/0.2% diethylamine modifier. Absolute configuration assigned by analogy based on in vitro activity and the known stereochemistry of active isomer <b>32</b> as determined by the X-ray cocrystal structure. Peak 1 = <b>3</b> (98 mg) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.25–7.37 (m, 4H), 7.07–7.12 (m, 2H), 7.07–7.14 (m, 2H), 7.01–7.06 (m, 1H), 6.15–6.25 (m, 2H), 3.89–3.96 (m, 1H), 3.63–3.71 (m, 1H), 3.44–3.52 (m, 2H), 3.18 (s, 4H), 2.78–2.89 (m, 1H). MS (ESI) <i>m</i>/<i>z</i> 387.0 (M + H)<sup>+</sup> HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>18</sub>N<sub>2</sub>O<sub>6</sub>S (M + H)<sup>+</sup> 387.1015; found 387.1021. Peak 2 = <b>4</b> (148 mg) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.24–7.38 (m, 4H), 7.08–7.12 (m, 2H), 7.01–7.07 (m, 1H), 6.16–6.23 (m, 2H), 3.86–3.95 (m, 1H), 3.62–3.70 (m, 1H), 3.45–3.53 (m, 2H), 3.18 (s, 4H), 2.80–2.88 (m, 1H). MS <i>m</i>/<i>z</i> (ESI) 387.0 (M + H)<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>18</sub>N<sub>2</sub>O<sub>6</sub>S (M + H)<sup>+</sup> 387.1015; found 387.1012.</div></div><div id="sec5_7_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> (3a<i>S</i>,9b<i>S</i>)-2-(Benzo[<i>d</i>][1,3]dioxol-5-ylsulfonyl)-8-hydroxy-5-methyl-3,3a,5,9b-tetrahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>]quinolin-4(2<i>H</i>)-one (<b>5</b>)</h3><div id="sec5_7_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> Step 1: <i>rac</i>-(3a<i>R</i>,9b<i>R</i>)-<i>tert</i>-Butyl 8-Bromo-5-methyl-4-oxo-3,3a,4,5-tetrahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>]quinoline-2(9b<i>H</i>)-carboxylate (<b>43</b>)</h4><div class="NLM_p last">To a solution of <b>42</b> (1.005 g, 3.49 mmol) in DMF (17.43 mL) at 0 °C was added sodium hydride, 60% suspension in mineral oil (0.137 g, 3.42 mmol). The mixture was stirred at rt for 30 min. Iodomethane (0.217 mL, 3.49 mmol) was added. The reaction mixture was stirred at room temperature for 1 h. The reaction mixture was diluted with satd NH<sub>4</sub>Cl at 0 °C, then stirred at rt for 30 min and extracted with EtOAc 3 times. The combined organics were washed with brine, dried over MgSO<sub>4</sub>, and filtered, and the filtrate was concentrated on vacuo to give 1.1 g of an off-white solid. The crude material was absorbed onto a plug of silica gel and purified by chromatography through a Redi-Sep prepacked silica gel column 40g, eluting with a gradient of 0–35% EtOAc in heptane, to provide <i>rac</i>-(3aR,9bR)-<i>tert</i>-butyl 5-methyl-4-oxo-3,3a,4,5-tetrahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>]quinoline-2(9b<i>H</i>)-carboxylate (0.617 g, 2.041 mmol, 59% yield) as colorless solid; <i>m</i>/<i>z</i> (ESI) 325.2 (M + Na)<sup>+</sup>. To a 100 mL round-bottom flask was added <i>rac</i>-(3a<i>R</i>,9b<i>R</i>)-<i>tert</i>-butyl 5-methyl-4-oxo-3,3a,4,5-tetrahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>]quinoline-2(9b<i>H</i>)-carboxylate (2.0730 g, 6.86 mmol) and <i>N</i>-bromosuccinimide (0.584 mL, 6.86 mmol) in dichloroethane (34.3 mL). The resulting yellow solution was stirred at room temperature for 36 h. The mixture became a yellow suspension. The solvent was removed under reduced pressure. The resulting residue was partitioned between EtOAc and 2 N NaOH. The aqueous layer was extracted with EtOAc twice. The combined organics were washed with brine, dried over MgSO<sub>4</sub>, and filtered, and the filtrate was concentrated under reduced pressure to provide a yellow solid. The crude material was adsorbed onto a plug of silica gel and purified by chromatography through a Redi-Sep prepacked silica gel column 40g, eluting with a gradient of 10–40% EtOAc in heptane, to provide <b>43</b> (2.406 g, 6.31 mmol, 92% yield) as an off-white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.57 (d, <i>J</i> = 2.28 Hz, 1H), 7.49 (dd, <i>J</i> = 2.15, 8.68 Hz, 1H), 7.10 (d, <i>J</i> = 8.71 Hz, 1H), 3.90–4.08 (m, 1H), 3.58–3.77 (m, 2H), 3.49 (dt, <i>J</i> = 6.63, 10.65 Hz, 1H), 3.29 (s, 3H), 2.81–2.94 (m, 1H), 1.32–1.46 (m, 10H). MS (ESI) <i>m</i>/<i>z</i> 325.2 (M – tBu + H)<sup>+l</sup>.</div></div><div id="sec5_7_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> Step 2: <i>rac</i>-<i>tert</i>-Butyl 5-Methyl-4-oxo-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,3a,4,5-tetrahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>]quinoline-2(9b<i>H</i>)-carboxylate (<b>46</b>)</h4><div class="NLM_p last">A reaction vessel was charged with <b>43</b> (0.518 g, 1.359 mmol), bis(pinacolato) diboron (0.690 g, 2.72 mmol), 1,1′-bis(diphenylphosphino)ferrocene palladium(II)dichloride dichloromethane adduct (0.044 g, 0.054 mmol), and potassium acetate (0.400 g, 4.08 mmol), then sealed. The vial was evacuated and backfilled with nitrogen twice prior to the addition of 1,4-dioxane (6.79 mL). The reaction mixture was stirred at 90 °C for 3.5 h. The resulting mixture was diluted with EtOAc and filtered. The filtrate was concentrated to give a dark oil. The crude material was purified with silica gel chromatography eluting with a gradient of 15–30% EtOAc in heptane, to provide <b>46</b> (0.712 g, 1.662 mmol, quantitative) as a white solid. MS (ESI) <i>m</i>/<i>z</i> 372.2 (M – tBu + H)<sup>+</sup>.</div></div><div id="sec5_7_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> Step 3: <i>rac</i>-(3a<i>S</i>,9b<i>S</i>)-8-Hydroxy-5-methyl-3,3a,5,9b-tetrahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>]quinolin-4(2<i>H</i>)-one (<b>47</b>)</h4><div class="NLM_p last">A solution of <b>46</b> (0.205 g, 0.479 mmol) in THF (8 mL), water (2.3 mL), and 1 N NaOH (2.39 mL, 2.393 mmol) was treated with hydrogen peroxide solution (30%, w/w) (0.543 g, 4.79 mmol) at 0 °C. The resulting mixture was allowed to stir and warm to room temperature over 2 h. The resulting mixture was quenched by the addition of saturated NH<sub>4</sub>Cl. Then 1 mL of 1 N HCl was added to adjust the pH to 4. The mixture was extracted with EtOAc 3 times. The combined organics were washed with brine, dried over MgSO<sub>4</sub>, filtered, and dried under reduced pressure to afford <i>rac-tert</i>-butyl 8-hydroxy-5-methyl-4-oxo-3,3a,4,5-tetrahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>]quinoline-2(9b<i>H</i>)-carboxylate (0.209 g, 0.656 mmol, quantitative) as a colorless oil. MS (ESI) <i>m</i>/<i>z</i> 263.1 (M – tBu + H)<sup>+l</sup>. <i>rac</i>-<i>tert</i>-Butyl 8-hydroxy-5-methyl-4-oxo-3,3a,4,5-tetrahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>]quinoline-2(9b<i>H</i>)-carboxylate (105 mg) was dissolved in MeOH (1 mL), and 4 N HCl in dioxane (1 mL, 4 mmol) was added. The reaction mixture was stirred at room temperature for 1h. The solvent was removed under reduced pressure to afford the HCl salt of <b>47</b> (0.073 g, 0.287 mmol, 59.9% yield). MS (ESI) <i>m</i>/<i>z</i> (ESI) 219.3 (M + H)<sup>+</sup></div></div><div id="sec5_7_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> Step 4: (3a<i>S</i>,9b<i>S</i>)-2-(Benzo[<i>d</i>][1,3]dioxol-5-ylsulfonyl)-8-hydroxy-5-methyl-3,3a,5,9b-tetrahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>]quinolin-4(2<i>H</i>)-one (<b>5</b>)</h4><div class="NLM_p last">To <b>47</b> (64 mg, 0.25 mmol) in DMF (2 mL) was added triethylamine (0.11 mL, 0.750 mmol) and benzo[<i>d</i>][1,3]dioxole-5-sulfonyl chloride (0.055 g, 0.250 mmol) following the general sulfonylation procedure to afford the racemic mixture of <b>5</b> (24 mg, 24% yield) which was subjected to chiral resolution. Chiral SFC conditions: Chiralpak AD-H, 2 cm × 15 cm, 45% methanol, 80 mL/min (column back pressure = 78 bar), 100 bar BPR, 255 nm; dissolution, 4 mL 1:1 MeOH:DCM. Peak assignment was determined by SFC on Column, AD-H; solvent, 45% methanol. Absolute configuration assigned by analogy based on in vitro activity and the known stereochemistry of active isomer <b>32</b> as determined by the X-ray cocrystal structure. Peak 2 = <b>5</b> (19 mg): <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.30–7.36 (m, 1H), 7.25–7.29 (m, 1H), 7.07–7.12 (m, 1H), 6.87–6.91 (m, 1H), 6.64–6.70 (m, 2H), 6.15–6.21 (m, 2H), 3.88–3.93 (m, 1H), 3.61–3.66 (m, 1H), 3.41–3.46 (m, 1H), 3.32–3.39 (m, 1H), 3.06–3.13 (m, 4H), 2.73–2.81 (m, 1H). MS (ESI) <i>m</i>/<i>z</i> (ESI) 403.0 (M + H)<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>18</sub>N<sub>2</sub>O<sub>6</sub>S (M + H)<sup>+</sup> 403.0964; found 403.0959.</div></div></div><div id="sec5_7_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> <i>rac</i>-2-(Benzo[<i>d</i>][1,3]dioxol-5-ylsulfonyl)-5-methyl-4-oxo-2,3,3a,4,5,9b-hexahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>]quinoline-8-carbonitrile (<b>6</b>)</h3><div id="sec5_7_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> Step 1: <i>rac</i>-5-Methyl-4-oxo-2,3,3a,4,5,9b-hexahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>]quinoline-8-carbonitrile (<b>45</b>)</h4><div class="NLM_p last">To a 5 mL microwave vial was added <b>43</b> (0.165 g, 0.433 mmol), zinc cyanide (0.027 mL, 0.433 mmol), tetrakis(triphenylphosphine)palladium (0.050 g, 0.043 mmol), and DMF (2.164 mL). The solvent was purged with nitrogen for 5 min and sealed. The vessel was irradiated at 100 °C in a microwave oven for 1 h. The mixture was diluted with EtOAc and filtered. The filtrate was concentrated, and the crude material was purified with silica gel chromatography, eluting with a gradient of 0–40% EtOAc in heptane to provide <i>rac</i>-<i>tert</i>-butyl 8-cyano-5-methyl-4-oxo-3,3a,4,5-tetrahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>]quinoline-2(9b<i>H</i>)-carboxylate as a yellow solid which was suspended in MeOH (4.5 mL) to which 4 N HCl in dioxane (2 mL, 8 mmol) was added. The suspension was stirred at room temperature overnight. The resulting mixture was concentrated to afford <b>45</b> as a hydrochloride salt (0.139 g, 0.527 mmol, quantitative) as a yellow solid which was used without further purification. MS (ESI) <i>m</i>/<i>z</i> 228.3 (M + H)<sup>+</sup></div></div><div id="sec5_7_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> Step 2: <i>rac</i>-2-(Benzo[<i>d</i>][1,3]dioxol-5-ylsulfonyl)-5-methyl-4-oxo-2,3,3a,4,5,9b-hexahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>]quinoline-8-carbonitrile (<b>6</b>)</h4><div class="NLM_p last"><b>45</b> (0.0685 g, 0.260 mmol) in DMF (2 mL) was treated with 1,3-benzodioxole-5-sulfonyl chloride (0.057 g, 0.260 mmol) and triethylamine (0.072 mL, 0.519 mmol) following the general sulfonylation procedure to afford <b>6</b> (17 mg, 16% yield). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.73–7.80 (m, 2H), 7.73–7.80 (m, 2H), 7.30–7.36 (m, 1H), 7.22–7.29 (m, 2H), 7.04–7.12 (m, 1H), 6.15–6.21 (m, 2H), 3.84–3.90 (m, 1H), 3.67–3.74 (m, 1H), 3.53–3.60 (m, 1H), 3.45–3.51 (m, 1H), 3.24–3.29 (m, 1H), 3.20 (s, 3H), 2.88–2.98 (m, 1H). MS (ESI) <i>m</i>/<i>z</i> (ESI) 412.1 (M + H)<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>17</sub>N<sub>3</sub>O<sub>5</sub>S (M + H)<sup>+</sup> 412.0967; found 412.0968.</div></div></div><div id="sec5_7_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> <i>rac</i>-2-(Benzo[<i>d</i>][1,3]dioxol-5-ylsulfonyl)-8-fluoro-5-methyl-3,3a,5,9b-tetrahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>]quinolin-4(2<i>H</i>)-one (<b>7</b>)</h3><div id="sec5_7_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> Step 1: Methyl 3-(5-Fluoro-2-nitrophenyl)acrylate (<b>48a</b>)</h4><div class="NLM_p last">A mixture of methyl <i>p</i>,<i>p</i>-bis(2,2,2-trifluoroethyl)-phosphonoacetate (10.74 mL, 29.6 mmol), 5-fluoro-2-nitrobenzaldehyde (5.0 g, 29.6 mmol), and potassium carbonate (8.19 g, 59.2 mmol) in 1,4-dioxane (233 mL) was refluxed overnight. The mixture was filtered, and the filtrate was concentrated. The residue was partitioned between water and EtOAc and extracted with EtOAc 3 times. The combined organics were washed with brine, dried over MgSO<sub>4</sub>, filtered, and dried under reduced pressure to afford <b>48a</b> (6.1 g, 93% yield) as a black solid. MS (ESI) <i>m</i>/<i>z</i> 226.1 (M + H)<sup>+</sup></div></div><div id="sec5_7_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> Step 2: Methyl 1-Benzyl-4-(5-fluoro-2-nitrophenyl)pyrrolidine-3-carboxylate (<b>49a</b>)</h4><div class="NLM_p last">To a solution of <b>48a</b> (6.1 g, 27.1 mmol) in DCM (201 mL) at 0 °C under nitrogen flow was added trifluoroacetic acid (0.805 mL, 10.84 mmol) and <i>N</i>-(methoxymethyl)-<i>N</i>-(trimethylsilylmethyl)benzylamine (20.79 mL, 81 mmol). The resulting solution was stirred at rt overnight. The resulting mixture was diluted with satd aq NaHCO<sub>3</sub> and extracted with DCM twice. The combined organics were washed with brine, dried over MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude material was purified by silica gel chromatography eluting with a gradient of 10– 50% EtOAc/EtOH/NH<sub>4</sub>OH (73:27:2) in heptane to provide <b>49a</b> (8.41g, 23.47 mmol, 87% yield) as a yellow oil. MS (ESI) <i>m</i>/<i>z</i> 359.1 (M + H)<sup>+</sup>.</div></div><div id="sec5_7_5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> Step 3: <i>rac</i>-8-Fluoro-3,3a,5,9b-tetrahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>]quinolin-4(2<i>H</i>)-one (<b>50a</b>)</h4><div class="NLM_p last">A mixture of <b>49a</b> (8.41 g, 23.47 mmol), palladium hydroxide, 20 wt % Pd (dry basis) on carbon, and wet (0.8 g, 5.70 mmol) in EtOH (100 mL) was stirred at 60 °C under 55 psi of H<sub>2</sub> for 48 h. Additional palladium hydroxide, 20 wt % Pd (dry basis) on carbon, and wet (0.8 g, 5.70 mmol) was added. The mixture was stirred at 60 °C under 55 psi of H<sub>2</sub> for 3 additional days. The resulting mixture was filtered through Celite, and the filtrate was concentrated to provide <b>50a</b> (4.84 g, 23.47 mmol, quantitative) as a yellow solid, which was used without further purification. MS (ESI) <i>m</i>/<i>z</i> 207.2 (M + H)<sup>+</sup>.</div></div><div id="sec5_7_5_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> Step 4: <i>rac</i>-8-Fluoro-5-methyl-3,3a,5,9b-tetrahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>]quinolin-4(2<i>H</i>)-one (<b>51</b>)</h4><div class="NLM_p last">A mixture of <b>50a</b> (4.84 g, 23.47 mmol), di-<i>tert</i>-butyl dicarbonate (7.68 g, 35.2 mmol), and triethylamine (6.53 mL, 46.9 mmol) in EtOH (235 mL) was stirred at rt overnight. The mixture was concentrated under reduced pressure, and the crude material was purified with silica gel chromatography eluting with a gradient of 0–50% EtOAc in heptane to provide <i>rac</i>-<i>tert</i>-butyl 8-fluoro-4-oxo-3,3a,4,5-tetrahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>]quinoline-2(9b<i>H</i>)-carboxylate (4.07 g, 13.29 mmol, 56.6% yield) as light-yellow solid. To a solution of <i>rac</i>-<i>tert</i>-butyl 8-fluoro-4-oxo-3,3a,4,5-tetrahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>]quinoline-2(9b<i>H</i>)-carboxylate (1 g, 3.26 mmol) in DMF (16.32 mL) was added sodium hydride, 60% dispersion in mineral oil (0.131 g, 3.26 mmol) at 0 °C. The mixture was stirred at rt for 1 h prior to the addition of iodomethane (0.203 mL, 3.26 mmol). The reaction mixture was stirred at room temperature overnight. The resulting mixture was diluted with water and extracted with EtOAc three times. The combined organics were washed with brine, dried over MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure to afford <i>rac</i>-<i>tert</i>-butyl 8-fluoro-5-methyl-4-oxo-3,3a,4,5-tetrahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>]quinoline-2(9b<i>H</i>)-carboxylate (1.3 g, 4.06 mmol, 124% yield) as a yellow oil which was dissolved in MeOH (10 mL). Hydrochloric acid, 4.0 M solution in 1,4-dioxane (10 mL, 40.0 mmol) was added. The reaction mixture was stirred at room temperature for 1 h. The resulting mixture was concentrated to afford <b>51</b> (0.897 g, 3.49 mmol, quantitative) as a yellow solid which was used without further purification. MS (ESI) <i>m</i>/<i>z</i> 221.0 (M + H)<sup>+</sup>.</div></div><div id="sec5_7_5_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> Step 5: <i>rac</i>-(3a<i>R</i>,9b<i>R</i>)-2-(Benzo[<i>d</i>][1,3]dioxol-5-ylsulfonyl)-8-fluoro-5-methyl-3,3a,5,9b-tetrahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>]quinolin-4(2<i>H</i>)-one (<b>7</b>)</h4><div class="NLM_p last">Compound <b>51</b> (0.072 g, 0.280 mmol) was dissolved in DMF (2 mL) and treated with 1,3-benzodioxole-5-sulfonyl chloride (0.062 g, 0.280 mmol) and triethylamine (0.117 mL, 0.841 mmol) following the general sulfonylation procedure to afford <b>7</b> (77 mg, 0.19 mmol, 68% yield). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.33 (dd, <i>J</i> = 1.69, 8.17 Hz, 1H), 7.27 (d, <i>J</i> = 1.62 Hz, 1H), 7.17–7.23 (m, 1H), 7.04–7.17 (m, 3H), 6.18 (d, <i>J</i> = 8.76 Hz, 2H), 3.87 (dd, <i>J</i> = 1.98, 10.02 Hz, 1H), 3.60–3.75 (m, 1H), 3.41–3.60 (m, 2H), 3.13–3.22 (m, 4H), 2.89 (t, <i>J</i> = 9.93 Hz, 1H). MS (ESI) <i>m</i>/<i>z</i> 405.0 (M + H)<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>17</sub>FN<sub>2</sub>O<sub>5</sub>S (M + H)<sup>+</sup> 405.0920; found 405.0921.</div></div></div><div id="sec5_7_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> (6a<i>S</i>,9a<i>R</i>)-8-(Benzo[<i>d</i>][1,3]dioxol-5-ylsulfonyl)-5-methyl-7,8,9,9a-tetrahydro-5<i>H</i>-pyrrolo[3,4-<i>c</i>][1,5]naphthyridin-6(6a<i>H</i>)-one (<b>8</b>)</h3><div id="sec5_7_6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> Step 1: Ethyl 2-Oxo-1,2-dihydro-1,5-naphthyridine-3-carboxylate (<b>34b</b>)</h4><div class="NLM_p last">A mixture of 3-amino-pyridine-2-carbaldehyde (2 g, 16.38 mmol), diethyl malonate (4.97 mL, 32.8 mmol) and piperidine (0.404 mL, 4.09 mmol) in EtOH (27.3 mL) was refluxed for 18 h. The mixture was slowly cooled to rt with stirring and then filtered. The solid collected was washed with a small amount of EtOH and then with heptane to afford <b>34b</b> (2.246 g, 10.29 mmol, 62.9% yield) as a light-yellow solid. MS (ESI) <i>m</i>/<i>z</i> 219.2 (M + H)<sup>+</sup>.</div></div><div id="sec5_7_6_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> Step 2: Ethyl 1-Methyl-2-oxo-1,2-dihydro-1,5-naphthyridine-3-carboxylate (<b>38b</b>)</h4><div class="NLM_p last">To a solution of <b>34b</b> (4.7 g, 21.54 mmol) in DMF (150 mL) was added sodium hydride, 60% dispersion in mineral oil (1.034 g, 25.8 mmol) portionwise at 0 °C. The reaction mixture was stirred at room temperature for 30 min. Iodomethane (1.405 mL, 22.62 mmol) was added dropwise via syringe. The reaction mixture was stirred at room temperature overnight. Additional iodomethane (0.1 mL) was added. After stirring at rt for 2 h, 5 mL of water was added and the resulting mixture stirred for 10 min. The solvents were removed under reduced pressure, and the resulting residue was suspended in water and extracted with DCM three times. The combined organics were washed with brine, dried over MgSO<sub>4</sub>, filtered, and dried under reduced pressure to afford 12 g of a green solid which was recrystallized from EtOAc to afford <b>38b</b> (3.55 g, 15.29 mmol, 71.0% yield). MS (ESI) <i>m</i>/<i>z</i> 233.1 (M + H)<sup>+</sup>.</div></div><div id="sec5_7_6_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> Step 3: <i>rac</i>-Ethyl 8-Benzyl-5-methyl-6-oxo-6,6a,7,8,9,9a-hexahydro-5<i>H</i>-pyrrolo[3,4-<i>c</i>][1,5]naphthyridine-6a-carboxylate (<b>39b</b>)</h4><div class="NLM_p last">To a solution of <b>38b</b> (3.55 g, 15.29 mmol) in DCM (113 mL) at 0 °C under N<sub>2</sub> was added trifluoroacetic acid (0.454 mL, 6.11 mmol) and <i>N</i>-(methoxymethyl)-<i>N</i>-(trimethylsilylmethyl)benzylamine (19.55 mL, 76 mmol). The resulting solution was stirred at rt overnight. The reaction mixture was diluted with satd aq NaHCO<sub>3</sub> and extracted with DCM twice. The combined organics were washed with brine, dried over MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude material was purified by silica gel chromatography eluting with a gradient of 10–50% EtOAc/EtOH/NH<sub>4</sub>OH (73:27:2) in heptane to provide <b>39b</b> (5.70 g, 15.60 mmol, 102% yield) as light-yellow oil. MS (ESI) <i>m</i>/<i>z</i> 366.3 (M + H)<sup>+</sup>.</div></div><div id="sec5_7_6_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> Step 4: <i>rac</i>-8-Benzyl-5-methyl-7,8,9,9a-tetrahydro-5<i>H</i>-pyrrolo[3,4-<i>c</i>][1,5]naphthyridin-6(6a<i>H</i>)-one (<b>40b</b>)</h4><div class="NLM_p last">A solution of <b>39b</b> (5.70 g, 15.60 mmol) in hydrochloric acid 6.0 N (130 mL, 780 mmol) was refluxed for 12 h. The mixture was concentrated under reduced pressure to afford <b>40b</b> (5.7 g, 15.56 mmol, quantitative) as an off-white solid. MS (ESI) <i>m</i>/<i>z</i> 294.4 (M + H)<sup>+</sup>.</div></div><div id="sec5_7_6_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> Step 5: <i>rac</i>-5-Methyl-7,8,9,9a-tetrahydro-5<i>H</i>-pyrrolo[3,4-<i>c</i>][1,5]naphthyridin-6(6a<i>H</i>)-one (<b>41b</b>)</h4><div class="NLM_p last">A mixture of <b>40b</b> (5.7 g, 15.56 mmol) and palladium hydroxide, 20 wt % pd (dry basis) on carbon, wet (0.57 g, 0.812 mmol) in EtOH (50 mL), and water (10 mL) was stirred at 60 °C under 42 psi of H<sub>2</sub> for 12 h. The mixture was filtered through Celite and washed with water. The filtrate was concentrated to afford <b>41b</b> (4.32 g, 15.64 mmol, 101% yield) as an off-white solid which was used without further purification. MS (ESI) <i>m</i>/<i>z</i> 204.1 (M + H)<sup>+</sup>.</div></div><div id="sec5_7_6_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> Step 6: (6a<i>S</i>,9a<i>R</i>)-8-(Benzo[<i>d</i>][1,3]dioxol-5-ylsulfonyl)-5-methyl-7,8,9,9a-tetrahydro-5<i>H</i>-pyrrolo[3,4-<i>c</i>][1,5]naphthyridin-6(6a<i>H</i>)-one (<b>8</b>)</h4><div class="NLM_p last"><b>41b</b> (0.3 g, 1.086 mmol) in MeCN (3.62 mL) was treated with benzo[<i>d</i>][1,3]dioxole-5-sulfonyl chloride (0.240 g, 1.086 mmol) and triethylamine (0.606 mL, 4.35 mmol) following the general sulfonylation procedure to afford a racemic mixture of <b>8</b> (0.2 g, 0.516 mmol, 47.5% yield). This was subjected to chiral resolution. Chiral SFC conditions: Chiralpak OJ-H, 2 cm × 25 cm, 25% methanol (0.1% DEA)/CO<sub>2</sub>, 60 mL/min, 100 bar, 220 nm, inj vol 1.5 mL, 4 mg/mL 2:1 DCM/methanol. Peak assignment determined by SFC: Chiralpak OJ-H, 25% methanol w/0.2% diethylamine. Absolute configuration assigned by analogy based on in vitro activity and the known stereochemistry of active isomer <b>32</b> as determined by the X-ray cocrystal structure. Peak 1 = <b>8</b> (115 mg): <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.12–8.16 (m, 1H), 7.46–7.50 (m, 1H), 7.30–7.35 (m, 2H), 7.25–7.26 (m, 1H), 7.06–7.09 (m, 1H), 6.18–6.21 (m, 2H), 3.58–3.64 (m, 3H), 3.53–3.57 (m, 1H), 3.46–3.52 (m, 1H), 3.34–3.38 (m, 1H), 3.18–3.21 (m, 3H), 3.18–3.20 (m, 3H). MS (ESI) <i>m</i>/<i>z</i> 388.1 (M + H)<sup>+</sup>. HRMS calcd for C<sub>18</sub>H<sub>17</sub>N<sub>3</sub>O<sub>5</sub>S (M + H)<sup>+</sup> 388.0967; found 388.0970.</div></div></div><div id="sec5_7_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> (3a<i>S</i>,9b<i>S</i>)-2-(Benzo[<i>d</i>][1,3]dioxol-5-ylsulfonyl)-5-methyl-3,3a,5,9b-tetrahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>][1,6]naphthyridin-4(2<i>H</i>)-one (<b>9</b>)</h3><div class="NLM_p last">To (3a<i>S</i>,9b<i>S</i>)-<b>41c</b> (0.073 M solution in MeCN (53 mL, 3.87 mmol) was added 1,3-benzodioxole-5-sulfonyl chloride (0.854 g, 3.87 mmol) followed by triethylamine (1.076 mL, 7.74 mmol). The reaction mixture was stirred at room temperature over 3 days. The mixture was concentrated under reduced pressure. The resulting residue was suspended in water and stirred for 30 min then filtered. The solid was washed with water and heptane successively. The solid was dried on vacuo to afford <b>9</b> (1.320 g, 3.41 mmol, 88% yield) as an off-white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.32–8.44 (m, 2H), 7.28–7.41 (m, 2H), 7.04–7.17 (m, 2H), 6.16–6.24 (m, 2H), 3.87–3.93 (m, 1H), 3.68–3.75 (m, 1H), 3.52–3.62 (m, 1H), 3.46–3.51 (m, 1H), 3.24–3.31 (m, 1H), 3.17 (s, 3H), 2.83–2.94 (m, 1H). MS (ESI) <i>m</i>/<i>z</i> 388.1 (M + H)<sup>+</sup>. HRMS calcd for C<sub>18</sub>H<sub>17</sub>N<sub>3</sub>O<sub>5</sub>S (M + H)<sup>+</sup> 388.0967; found 388.0963.</div></div><div id="sec5_7_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> <i>rac</i>-2-(Benzo[<i>d</i>][1,3]dioxol-5-ylsulfonyl)-5-methyl-3,3a,5,9b-tetrahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>][1,7]naphthyridin-4(2<i>H</i>)-one (<b>10</b>)</h3><div id="sec5_7_8_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> Step 1: (<i>E</i>)-Methyl 3-(3-nitropyridin-4-yl)acrylate (<b>48b</b>)</h4><div class="NLM_p last">A mixture of 3-nitroisonicotinaldehyde (1 g, 6.57 mmol), methyl <i>p</i>,<i>p</i>-bis(2,2,2-trifluoroethyl)-phosphonoacetate (2.385 mL, 6.57 mmol) and potassium carbonate (1.817 g, 13.15 mmol) in 1,4-dioxane (51.8 mL) was refluxed overnight. The resulting mixture was concentrated under reduced pressure. The residue was dissolved in EtOAc and washed with satd aq NaHCO<sub>3</sub> and brine, dried with MgSO<sub>4</sub>, filtered, and dried under reduced pressure. The crude material was purified with silica gel chromatography, eluting with a gradient of 20–50% EtOAc in heptane to provide <b>48b</b> (0.335 g, 1.609 mmol, 24.5% yield) as yellow solid. MS (ESI) <i>m</i>/<i>z</i> 209.1 (M + H)<sup>+</sup>.</div></div><div id="sec5_7_8_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> Step 2: Methyl 1-Benzyl-4-(3-nitropyridin-4-yl)pyrrolidine-3-carboxylate (<b>49b</b>)</h4><div class="NLM_p last">To a solution of <b>48b</b> (0.335 g, 1.609 mmol) in DCM (11.92 mL) at 0 °C under N<sub>2</sub> was added trifluoroacetic acid (0.048 mL, 0.644 mmol) and <i>N</i>-(methoxymethyl)-<i>N</i>-(trimethylsilylmethyl)benzylamine (2.059 mL, 8.05 mmol), and the resulting solution stirred at rt overnight. The mixture was diluted with satd NaHCO<sub>3</sub> and extracted with DCM twice. The combined organics were washed with brine, dried over MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude material was purified by silica gel chromatography eluting with a gradient of 0% to 40% EtOAc in heptane to provide <b>49b</b> (0.563 g, 1.649 mmol, quantitative) as yellow oil. MS (ESI) <i>m</i>/<i>z</i> 342.3 (M + H)<sup>+</sup>.</div></div><div id="sec5_7_8_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> Step 3: <i>rac</i>-3,3a,5,9b-Tetrahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>][1,7]naphthyridin-4(2<i>H</i>)-one (<b>50b</b>)</h4><div class="NLM_p last">To a 100 mL pressure vessel was added <b>49b</b> (0.563 g, 1.649 mmol), EtOH (15 mL), and palladium 10 wt % on activated carbon (0.100 g, 0.940 mmol). The reaction mixture was stirred at 60 °C under 55 psi of H<sub>2</sub> overnight. Additional palladium 10 wt % on activated carbon (0.100 g, 0.940 mmol) was added. The reaction mixture was stirred at 60 °C under 55 psi of H<sub>2</sub> for an additional 48 h. The mixture was filtered through Celite and concentrated to afford 307 mg of a colorless oil. LCMS indicated complete hydrogenolysis but incomplete cyclization. The material was dissolved in AcOH (5 mL) and was stirred at 80 °C for 2 days. The resulting mixture was concentrated to provide a brown oil which was purified by strong cation exchange (SCX) catch and release by washing with MeOH, then eluting product with 2 M NH<sub>3</sub> in MeOH to afford <b>50b</b> (0.310 g, 1.638 mmol, 99% yield) as a yellow solid. MS (ESI) <i>m</i>/<i>z</i> 190.3 (M + H)<sup>+</sup>.</div></div><div id="sec5_7_8_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> Step 4: <i>rac</i>-2-(Benzo[<i>d</i>][1,3]dioxol-5-ylsulfonyl)-5-methyl-3,3a,5,9b-tetrahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>][1,7]naphthyridin-4(2<i>H</i>)-one (<b>10</b>)</h4><div class="NLM_p last">To a solution of <b>50b</b> (0.103 g, 0.544 mmol) in DCM (4 mL) was added 1,3-benzodioxole-5-sulfonyl chloride (0.120 g, 0.544 mmol) and triethylamine (0.151 mL, 1.089 mmol) at 0 °C. The reaction mixture was stirred at room temperature overnight. The resulting mixture was diluted with water and extracted with EtOAc three times. The combined organics were washed with brine, dried over MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude material was purified with silica gel chromatography eluting with a gradient of 0–80% EtOAc/EtOH/NH<sub>4</sub>OH (73:17:2) in heptane to provide 2-(benzo[<i>d</i>][1,3]dioxol-5-ylsulfonyl)-3,3a,5,9b-tetrahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>][1,7]naphthyridin-4(2<i>H</i>)-one (0.027 g, 0.072 mmol, 13% yield) as a tan solid. To this solid (0.027 g, 0.072 mmol) in DMF (1.45 mL) at 0 °C was added sodium hydride, 60% in mineral oil (2.89 mg, 0.072 mmol). The reaction mixture was stirred at room temperature for 30 min prior to the addition of iodomethane (4.49 μL, 0.072 mmol). The reaction mixture was stirred at room temperature for 2 h. The reaction was quenched by the addition of a couple of drops of MeOH. The mixture was filtered through a 0.45 μm frit and purified with RP-HPLC ramping ACN in H<sub>2</sub>O, with NH<sub>4</sub>OH 0.1% to afford compound <b>10</b> (4 mg, 14% yield). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.34–8.38 (m, 1H), 8.20–8.25 (m, 1H), 7.26–7.35 (m, 3H), 7.25–7.35 (m, 3H), 7.06–7.11 (m, 1H), 6.16–6.21 (m, 2H), 3.80–3.85 (m, 1H), 3.66–3.72 (m, 1H), 3.53–3.59 (m, 1H), 3.45–3.51 (m, 1H), 3.45–3.51 (m, 1H), 3.23 (s, 4H), 2.95–3.00 (m, 1H), 2.92–3.03 (m, 1H). MS (ESI) <i>m</i>/<i>z</i> 388.0 (M + H)<sup>+</sup>. HRMS calcd for C<sub>18</sub>H<sub>17</sub>N<sub>3</sub>O<sub>5</sub>S (M + H)<sup>+</sup> 388.0967; found 388.0970.</div></div></div><div id="sec5_7_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> <i>rac</i>-2-(Benzo[<i>d</i>][1,3]dioxol-5-ylsulfonyl)-5-methyl-3,3a,5,9b-tetrahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>][1,7]naphthyridin-4(2<i>H</i>)-one (<b>11</b>)</h3><div id="sec5_7_9_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> Step 1: Ethyl 1-Methyl-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxylate (<b>38d</b>)</h4><div class="NLM_p last">A mixture of ethyl 2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxylate (5.0566 g, 23.17 mmol) and cesium carbonate (11.33 g, 34.8 mmol) in DMF (232 mL) was stirred at rt for 2 h with overhead stirring. Iodomethane (1.583 mL, 25.5 mmol) was added dropwise, and the resulting reaction mixture was stirred at room temperature for 16 h. The solvent was removed under reduced pressure and water was added and the mixture stirred for 30 min, providing a suspension which was filtered. The solid was washed with water and heptane and dried to afford 4.410 g of solid. The filtrate was extracted with DCM three times. The combined organics was washed with brine, dried over MgSO<sub>4</sub>, filtered, and concentrated to afford 1.025 g of yellow solid. The solids were combined to afford <b>38d</b> (5.435 g, 23.40 mmol, quantitative). MS (ESI) <i>m</i>/<i>z</i> 233.0 (M + H)<sup>+</sup>.</div></div><div id="sec5_7_9_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> Step 2: <i>rac-</i>Ethyl 2-Benzyl-5-methyl-4-oxo-2,3,3a,4,5,9b-hexahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>][1,8]naphthyridine-3a-carboxylate (<b>39d</b>)</h4><div class="NLM_p last">To a solution of <b>38d</b> (5.435 g, 23.40 mmol) in DCM (173 mL) at 0 °C under N<sub>2</sub> was added trifluoroacetic acid (0.695 mL, 9.36 mmol) and <i>N</i>-(methoxymethyl)-<i>N</i>-(trimethylsilylmethyl)benzylamine (29.9 mL, 117 mmol). The resulting solution was stirred at rt overnight. The resulting mixture was diluted with satd aq NaHCO<sub>3</sub> and extracted with DCM twice. The combined organics were washed with brine, dried over MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude material was purified with silica gel chromatography eluting with a gradient of 10–50% EtOAc/EtOH/NH<sub>4</sub>OH (73:27:2) in heptane to provide <b>39d</b> (9.08 g, 24.7 mmol, quantitative) as light-yellow oil. MS (ESI) <i>m</i>/<i>z</i> 366.2 (M + H)<sup>+</sup>.</div></div><div id="sec5_7_9_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> Step 3: <i>rac</i>-2-Benzyl-5-methyl-3,3a,5,9b-tetrahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>][1,8]naphthyridin-4(2<i>H</i>)-one (<b>40d</b>)</h4><div class="NLM_p last">A solution of <b>39d</b> (9.08 g, 24.85 mmol) in 6 N hydrochloric acid (207 mL, 1242 mmol) was refluxed for 16 h. The resulting mixture was concentrated to afford <b>40d</b> (9.02 g, 24.63 mmol, 99% yield) as a tan solid which was used without further purification. MS (ESI) <i>m</i>/<i>z</i> 294.3 (M + H)<sup>+</sup>.</div></div><div id="sec5_7_9_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> Step 4: <i>rac-</i>5-Methyl-3,3a,5,9b-tetrahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>][1,8]naphthyridin-4(2<i>H</i>)-one (<b>41d</b>)</h4><div class="NLM_p last">A mixture of <b>40d</b> (9.02 g, 24.63 mmol) and palladium hydroxide, 20 wt % pd (dry basis) on carbon, wet (0.9 g, 1.282 mmol) in EtOH (50 mL) and water (10 mL) were stirred at 60 °C under 42 psi of H<sub>2</sub> for 12 h. The mixture was concentrated under reduced pressure to afford <b>41d</b> (6.65 g, 24.08 mmol, 98% yield) as an off white solid which was used without further purification. MS (ESI) <i>m</i>/<i>z</i> 204.1 (M + H)<sup>+</sup>.</div></div><div id="sec5_7_9_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> Step 5: <i>rac</i>-2-(Benzo[<i>d</i>][1,3]dioxol-5-ylsulfonyl)-5-methyl-3,3a,5,9b-tetrahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>][1,7]naphthyridin-4(2<i>H</i>)-one (<b>11</b>)</h4><div class="NLM_p last"><b>41d</b> (0.066 g, 0.203 mmol) in DMF (2 mL) was treated with benzo[<i>d</i>][1,3]dioxole-5-sulfonyl chloride (0.045 g, 0.203 mmol) and triethylamine (0.121 mL, 0.869 mmol) following the general sulfonylation procedure to afford <b>11</b> (0.088 mmol, 47% yield). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.27 (dd, <i>J</i> = 1.47, 4.86 Hz, 1H), 7.70 (d, <i>J</i> = 6.11 Hz, 1H), 7.33 (dd, <i>J</i> = 1.55, 8.11 Hz, 1H), 7.28 (d, <i>J</i> = 1.53 Hz, 1H), 7.00–7.12 (m, 2H), 6.19 (d, <i>J</i> = 4.64 Hz, 2H), 3.86 (dd, <i>J</i> = 2.15, 10.18 Hz, 1H), 3.62–3.75 (m, 1H), 3.40–3.58 (m, 2H), 3.15–3.29 (m, 4H), 2.91 (t, <i>J</i> = 9.87 Hz, 1H). MS (ESI) <i>m</i>/<i>z</i> 388.0 (M + H)<sup>+</sup>. HRMS calcd for C<sub>18</sub>H<sub>17</sub>N<sub>3</sub>O<sub>5</sub>S (M + H)<sup>+</sup> 388.0967; found 388.0961.</div></div></div><div id="sec5_7_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> (3a<i>S</i>,9b<i>S</i>)-2-((1<i>H</i>-Benzo[<i>d</i>]imidazol-5-yl)sulfonyl)-5-methyl-3,3a,5,9b-tetrahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>][1,6]naphthyridin-4(2<i>H</i>)-one (<b>12</b>)</h3><div class="NLM_p last"><i>rac</i>-<b>41c</b> (0.156 g, 0.565 mmol) in DMF (3.77 mL) was treated with triethylamine (0.393 mL, 2.82 mmol) and 1<i>H</i>-benzo[<i>d</i>]imidazole-5-sulfonyl chloride hydrochloride (0.143 g, 0.565 mmol) following the general sulfonylation procedure to afford the racemic mixture of <b>12</b> (0.199 g, 0.52 mmol, 92% yield). Chiral SFC conditions: Chiralcel OJ-H solvent, 35% methanol w/0.2% diethylamine. Absolute configuration assigned by analogy based on in vitro activity and the known stereochemistry of active isomer <b>32</b> as determined by the X-ray cocrystal structure. Peak 1 = <b>12</b> (49 mg), >96% ee: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.47–8.50 (m, 1H), 8.36–8.39 (m, 1H), 8.32–8.35 (m, 1H), 8.00–8.08 (m, 1H), 7.76–7.83 (m, 1H), 7.58–7.70 (m, 1H), 7.00–7.07 (m, 1H), 3.92–3.98 (m, 1H), 3.72–3.78 (m, 1H), 3.47–3.55 (m, 2H), 3.22–3.28 (m, 1H), 3.03 (s, 3H), 2.84–2.92 (m, 1H). MS (ESI) <i>m</i>/<i>z</i> 384.2 (M + H)<sup>+</sup>. HRMS calcd for C<sub>18</sub>H<sub>17</sub>N<sub>5</sub>O<sub>3</sub>S (M + H)<sup>+</sup> 384.1130; found 384.1127.</div></div><div id="sec5_7_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> (3a<i>S</i>,9b<i>S</i>)-5-Methyl-2-((1-methyl-1<i>H</i>-benzo[<i>d</i>]imidazol-5-yl)sulfonyl)-3,3a,5,9b-tetrahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>][1,6]naphthyridin-4(2<i>H</i>)-one (<b>13</b>)</h3><div class="NLM_p last">To a suspension of <i>rac</i>-<b>41c</b> (0.159 g, 0.576 mmol) in MeCN (3.84 mL) was added triethylamine (0.320 mL, 2.303 mmol). The reaction mixture was stirred at room temperature for 5 min prior to the addition of 1-methyl-1<i>H</i>-benzo[<i>d</i>]imidazole-5-sulfonyl chloride (0.133 g, 0.576 mmol). The resulting mixture was stirred at rt for 2 h then concentrated under reduced pressure. The resulting residue was suspended in water and filtered. The solid was washed with water and heptane successively and dried to give the racemic mixture of <b>13</b> (0.108 g, 0.27 mmol, 47% yield) as a white solid which was subjected to chiral purification conditions. Chiral SFC conditions: Chiralcel OJ-H solvent, 35% methanol, 70 mL/min, 220 nm, 179 bar, 108 mg dissolved in 6 mL of DCM/MeOH (3:2), 0.25 mL injected, and 40% methanol, 186 bar 1 mL injected. Peak assignment was determined by SFC on column OJ-H solvent, 20% methanol with ammonia. Absolute configuration assigned by analogy based on in vitro activity and the known stereochemistry of active isomer <b>32</b> as determined by the X-ray cocrystal structure. Peak 1 = <b>13</b> (53 mg) as a white solid: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.41–8.47 (m, 1H), 8.35–8.39 (m, 1H), 8.30–8.35 (m, 1H), 8.06–8.11 (m, 1H), 7.80–7.84 (m, 1H), 7.71–7.77 (m, 1H), 7.02–7.05 (m, 1H), 7.01–7.06 (m, 1H), 3.93 (s, 4H), 3.72–3.80 (m, 1H), 3.44–3.53 (m, 2H), 3.32 (s, 3H), 3.23–3.28 (m, 1H), 2.86–2.93 (m, 1H), 2.86–2.95 (m, 1H). MS (ESI) <i>m</i>/<i>z</i> 398.1 (M + H)<sup>+</sup>. HRMS calcd for C<sub>19</sub>H<sub>19</sub>N<sub>5</sub>O<sub>3</sub>S (M + H)<sup>+</sup> 398.1287; found 398.1290.</div></div><div id="sec5_7_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> (3a<i>S</i>,9b<i>S</i>)-2-(Benzo[<i>d</i>]oxazol-5-ylsulfonyl)-5-methyl-3,3a,5,9b-tetrahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>][1,6]naphthyridin-4(2<i>H</i>)-one (<b>14</b>)</h3><div id="sec5_7_12_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> Step 1: <i>rac</i>-2-((4-Hydroxy-3-nitrophenyl)sulfonyl)-5-methyl-3,3a,5,9b-tetrahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>][1,7]naphthyridin-4(2<i>H</i>)-one</h4><div class="NLM_p last">To a suspension of <i>rac</i>-<b>41c</b> (0.380 g, 1.376 mmol) in MeCN (9.17 mL) was added triethylamine (0.383 mL, 2.75 mmol). The reaction mixture was stirred at room temperature for 5 min prior to the addition of 4-hydroxy-3-nitrobenzene-1-sulfonyl chloride (0.327 g, 1.376 mmol). The resulting mixture was stirred at rt for 2 h. The mixture was concentrated to afford crude 2-((4-hydroxy-3-nitrophenyl)sulfonyl)-5-methyl-3,3a,5,9b-tetrahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>][1,7]naphthyridin-4(2<i>H</i>)-one (1.24 g) as a yellow solid which was used without further purification. MS (ESI) <i>m</i>/<i>z</i> 405.1 (M + H)<sup>+</sup>.</div></div><div id="sec5_7_12_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> Step 2: <i>rac</i>-2-((3-Amino-4-hydroxyphenyl)sulfonyl)-5-methyl-3,3a,5,9b-tetrahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>][1,7]naphthyridin-4(2<i>H</i>)-one</h4><div class="NLM_p last">A mixture of the 2-((4-hydroxy-3-nitrophenyl)sulfonyl)-5-methyl-3,3a,5,9b-tetrahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>][1,7]naphthyridin-4(2<i>H</i>)-one (1.24 g) and palladium hydroxide, 20 wt % pd (dry basis) on carbon, wet (0.124 g, 0.177 mmol) in acetic acid (1 mL, 17.32 mmol), EtOH (10 mL), and water (10 mL) was stirred at 40 °C under 42 psi of hydrogen gas overnight. The mixture was filtered through Celite and washed with EtOH and water. The filtrate was concentrated, and the residue was dissolved in MeOH and concentrated to facilitate removal of acetic acid. This was repeated 3 times until the residue became a dark solid. The material was further dried under high vacuo to provide 1.24 g of crude 2-((3-amino-4-hydroxyphenyl)sulfonyl)-5-methyl-3,3a,5,9b-tetrahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>][1,7]naphthyridin-4(2<i>H</i>)-one which was used without further purification. MS (ESI) <i>m</i>/<i>z</i> 375.2 (M + H)<sup>+</sup>.</div></div><div id="sec5_7_12_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> Step 3: (3a<i>S</i>,9b<i>S</i>)-2-(Benzo[<i>d</i>]oxazol-5-ylsulfonyl)-5-methyl-3,3a,5,9b-tetrahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>][1,6]naphthyridin-4(2<i>H</i>)-one (<b>14</b>)</h4><div class="NLM_p last">A mixture of 2-((3-amino-4-hydroxyphenyl)sulfonyl)-5-methyl-3,3a,5,9b-tetrahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>][1,7]naphthyridin-4(2<i>H</i>)-one in ethyl orthoformate (10 mL, 60.1 mmol) was stirred at 120 °C for 5 h, and the resulting mixture was dried under reduced pressure. The residue was partitioned between water and EtOAc and extracted with EtOAc three times. The combined organics were washed with brine, dried over MgSO<sub>4</sub>, filtered, and dried under reduced pressure. The crude material was purified with silica gel chromatography eluting with a gradient of 20–100% EtOAc/EtOH/NH<sub>4</sub>OH (73:27:2) in heptane to provide 0.2 g of the racemic product as white solid. Chiral SFC conditions: column OJ-H (2 cm × 25 cm), 40% methanol (0.1%)/CO<sub>2</sub>, 100 bar, 60 mL/min, 220 nm, inj vol 2 mL, 10 mg/mL, 1:1 DCM:methanol. Peak assignment was determined by SFC on column OJ-H 40% methanol. Peak 1 contained the desired enantiomeric product (86 mg). Absolute configuration assigned by analogy based on in vitro activity and the known stereochemistry of active isomer <b>32</b> as determined by the X-ray cocrystal structure. This material was further purified with RP-HPLC ramping ACN in H<sub>2</sub>O, NH<sub>4</sub>OH 0.1% to afford <b>14</b> (36 mg). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.95–9.02 (m, 1H), 8.35–8.39 (m, 1H), 8.30–8.34 (m, 1H), 3.92–3.99 (m, 1H), 3.75–3.82 (m, 1H), 3.50–3.60 (m, 2H), 3.34–3.44 (m, 1H).). MS (ESI) <i>m</i>/<i>z</i> 385.0 (M + H)<sup>+</sup>. HRMS calcd for C<sub>18</sub>H<sub>16</sub>N<sub>4</sub>O<sub>4</sub>S (M + H)<sup>+</sup> 385.0971; found 385.0970.</div></div></div><div id="sec5_7_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> (3a<i>S</i>,9b<i>S</i>)-2-(Benzo[<i>d</i>]thiazol-6-ylsulfonyl)-5-methyl-3,3a,5,9b-tetrahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>][1,6]naphthyridin-4(2<i>H</i>)-one (<b>15</b>)</h3><div class="NLM_p last">(3aS,9bS)-<b>41c</b> (0.0736 M solution in MeCN, 6 mL, 0.442 mmol) was treated with 1,3-benzothiazole-6-sulfonyl chloride (103 mg, 0.442 mmol) and triethylamine (0.123 mL, 0.883 mmol) following the general sulfonylation procedure to afford <b>15</b> (0.121 g, 0.30 mmol, 68% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.66 (s, 1H), 8.74–8.80 (m, 1H), 8.32–8.42 (m, 2H), 8.24–8.31 (m, 1H), 7.89–7.97 (m, 1H), 6.98–7.08 (m, 1H), 3.94–4.02 (m, 1H), 3.75–3.84 (m, 1H), 3.51–3.63 (m, 2H), 3.25–3.30 (m, 1H), 3.25–3.30 (m, 1H), 2.94–3.03 (m, 4H). MS (ESI) <i>m</i>/<i>z</i> 401.0 (M + H)<sup>+</sup>. HRMS calcd for C<sub>18</sub>H<sub>16</sub>N<sub>4</sub>O<sub>3</sub>S<sub>2</sub> (M + H)<sup>+</sup> 401.0742; found 401.0738.</div></div><div id="sec5_7_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> (3a<i>S</i>,9b<i>S</i>)-2-(Imidazo[1,2-<i>a</i>]pyridin-7-ylsulfonyl)-5-methyl-3,3a,5,9b-tetrahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>][1,6]naphthyridin-4(2<i>H</i>)-one (<b>16</b>)</h3><div class="NLM_p last">(3a<i>S</i>,9b<i>S</i>)-<b>41c</b> (0.05 g, 0.246 mmol) in MeCN (3 mL) was treated with imidazo[1,2-<i>a</i>]pyridine-7-sulfonyl chloride (0.107 g, 0.492 mmol) and triethylamine (0.068 mL, 0.492 mmol) following the general sulfonylation procedure to afford <b>16</b> (0.027 g, 0.07 mmol, 29% yield). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.74 (d, <i>J</i> = 7.07 Hz, 1H), 8.30–8.44 (m, 2H), 8.21 (s, 1H), 7.99 (s, 1H), 7.84 (s, <i>J</i> = 6.42 Hz, 1H), 7.22 (d, <i>J</i> = 7.20 Hz, 1H), 7.05 (d, <i>J</i> = 5.64 Hz, 1H), 3.99 (d, <i>J</i> = 10.25 Hz, 1H), 3.75–3.89 (m, 1H), 3.52–3.70 (m, 2H), 3.17–3.29 (m, 1H), 2.98–3.09 (m, 4H). MS (ESI) <i>m</i>/<i>z</i> 384.2 (M + H)<sup>+</sup>. HRMS calcd for C<sub>18</sub>H<sub>17</sub>N<sub>5</sub>O<sub>3</sub>S (M + H)<sup>+</sup> 384.1130; found 384.1128.</div></div><div id="sec5_7_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> (3a<i>S</i>,9b<i>S</i>)-2-((2,3-Dihydrobenzofuran-6-yl)sulfonyl)-5-methyl-3,3a,5,9b-tetrahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>][1,6]naphthyridin-4(2<i>H</i>)-one (<b>17</b>)</h3><div class="NLM_p last">(3a<i>S</i>,9b<i>S</i>)-<b>41c</b> (0.0736 M solution in MeCN, 18.64 mL, 1.372 mmol) was treated with 2,3-dihydrobenzofuran-6-sulfonyl chloride (0.3 g, 1.372 mmol) and triethylamine (0.382 mL, 2.74 mmol) following the general sulfonylation procedure to afford <b>17</b> (0.310 g, 0.804 mmol, 59% yield). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.37–8.41 (m, 1H), 8.31–8.37 (m, 1H), 8.31–8.37 (m, 1H), 7.44 (d, <i>J</i> = 7.66 Hz, 1H), 7.22–7.29 (m, 1H), 7.03–7.15 (m, 2H), 4.57–4.70 (m, 2H), 3.87–3.94 (m, 1H), 3.66–3.74 (m, 1H), 3.51–3.59 (m, 1H), 3.44–3.50 (m, 1H), 3.25–3.29 (m, 3H), 3.24–3.28 (m, 2H), 3.16 (s, 3H), 2.88 (t, <i>J</i> = 10.06 Hz, 1H). MS (ESI) <i>m</i>/<i>z</i> 386.0 (M + H)<sup>+</sup>. HRMS calcd for C<sub>19</sub>H<sub>19</sub>N<sub>3</sub>O<sub>4</sub>S (M + H)<sup>+</sup> 386.1175; found 386.1176.</div></div><div id="sec5_7_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> (3a<i>S</i>,9b<i>S</i>)-2-((2,3-Dihydrobenzofuran-5-yl)sulfonyl)-5-methyl-3,3a,5,9b-tetrahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>][1,6]naphthyridin-4(2<i>H</i>)-one (<b>18</b>)</h3><div class="NLM_p last">(3a<i>S</i>,9b<i>S</i>)-<b>41c</b> (0.0736 M solution in MeCN, 6 mL, 0.442 mmol) was treated with 2,3-dihydro-1-benzofuran-5-sulfonyl chloride (0.100 g, 0.442 mmol) and triethylamine (0.123 mL, 0.883 mmol) following the general sulfonylation procedure to afford <b>18</b> (0.081 g, 0.21 mmol, 48% yield). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.28–8.49 (m, 2H), 7.66 (s, 1H), 7.55 (dd, <i>J</i> = 1.56, 8.37 Hz, 1H), 7.07 (d, <i>J</i> = 5.45 Hz, 1H), 6.92 (d, <i>J</i> = 8.37 Hz, 1H), 4.66 (dt, <i>J</i> = 2.01, 8.82 Hz, 2H), 3.88 (dd, <i>J</i> = 1.75, 10.19 Hz, 1H), 3.61–3.75 (m, 1H), 3.38–3.58 (m, 2H), 3.27 (t, <i>J</i> = 8.50 Hz, 3H), 3.15 (s, 3H), 2.87 (t, <i>J</i> = 10.02 Hz, 1H). MS (ESI) <i>m</i>/<i>z</i> 386.0 (M + H)<sup>+</sup>. HRMS calcd for C<sub>19</sub>H<sub>19</sub>N<sub>3</sub>O<sub>4</sub>S (M + H)<sup>+</sup> 386.1175; found 386.1174.</div></div><div id="sec5_7_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> (3a<i>S</i>,9b<i>S</i>)-2-(Benzofuran-6-ylsulfonyl)-5-methyl-3,3a,5,9b-tetrahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>][1,6]naphthyridin-4(2<i>H</i>)-one (<b>19</b>)</h3><div class="NLM_p last">To a solution of <b>17</b> (100 mg, 0.259 mmol) in THF (1 mL) was added ceric ammonium nitrate (CAN) (284 mg, 0.519 mmol) and the resulting suspension shaken at 60 °C. After 3 h, additional CAN (4 equiv, 568 mg) was added and the mixture was shaken over three nights at room temperature. The resulting material was loaded directly onto a 25g ultra snap column and purified ramping DCM:MeOH (90:10) in DCM (0–100%, monitoring at 215 nm) affording product along with impurities. Repurification with RP-HPLC (ACN in H<sub>2</sub>O, 5–95%, 0.1% NH<sub>4</sub>OH modifier) provided <b>19</b> as a colorless film (10 mg, 10%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.56 (br s, 2H), 8.29 (d, <i>J</i> = 2.1 Hz, 1H), 8.06 (s, 1H), 7.90 (d, <i>J</i> = 8.2 Hz, 1H), 7.70 (d, <i>J</i> = 8.2 Hz, 1H), 7.35 (br s, 1H), 7.16 (s, 1H), 3.96 (d, <i>J</i> = 10.2 Hz, 1H), 3.82–3.75 (m, 1H), 3.71–3.63 (m, 1H), 3.55 (dd, <i>J</i> = 6.7, 10.1 Hz, 1H), 3.34 (t, <i>J</i> = 6.7 Hz, 1H), 3.12 (s, 3H), 3.05 (t, <i>J</i> = 10.1 Hz, 1H) MS (ESI) <i>m</i>/<i>z</i> 384.0 (M + H)<sup>+</sup>. HRMS calcd for C<sub>19</sub>H<sub>17</sub>N<sub>3</sub>O<sub>4</sub>S (M + H)<sup>+</sup> 384.1018; found 384.1022.</div></div><div id="sec5_7_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> (3a<i>R</i>,9b<i>R</i>)-2-(Benzofuran-5-ylsulfonyl)-5-methyl-3,3a,5,9b-tetrahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>][1,6]naphthyridin-4(2<i>H</i>)-one (<b>20</b>) and (3a<i>S</i>,9b<i>S</i>)-2-(Benzofuran-5-ylsulfonyl)-5-methyl-3,3a,5,9b-tetrahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>][1,6]naphthyridin-4(2<i>H</i>)-one (<i>ent</i>-<b>20</b>)</h3><div class="NLM_p last">To a vial charged with <i>rac</i>-<b>41c</b> (3.00 g, 14.76 mmol) was added MeCN (98 mL), Et<sub>3</sub>N (8.23 mL, 59.0 mmol), and benzofuran-5-sulfonyl chloride (3.36 g, 15.50 mmol), respectively. The mixture was stirred at room temperature overnight, affording a white suspension (solution pinkish). To the mixture was added silica gel, and the mixture dried under reduced pressure. The adsorbed material was purified on MPLC ramping EtOAc:EtOH (76:24) in heptane (50–100%, 10% DCM throughout), affording racemic product (3.14 g, 55%). Chiral separation SFC conditions: Regis Whelk-O (s,s), 2 cm × 25 cm, 55% methanol w/0.2% DEA 80 mL/min (column back pressure = 117 bar), 100 bar BPR, 252 nm detection, dissolution 250 mL of 1:1 MeOH:DCM, sample processed with 4.0 mL injections and 4 min cycle time. Analytical data: Column dimensions, 4.6 mm × 100 mm; flow rate, 5 mL/min; instrument, SFC/MS-1. Column oven, 40 °C. Absolute configuration assigned by analogy based on in vitro activity and the known stereochemistry of active isomer <b>32</b> as determined by the X-ray cocrystal structure. Peak 1 = <i>ent</i>-<b>20</b>: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.37 (d, <i>J</i> = 5.8 Hz, 1H), 8.34 (s, 1H), 8.19 (dd, <i>J</i> = 2.0, 8.7 Hz, 2H), 7.83 (d, <i>J</i> = 8.6 Hz, 1H), 7.75 (d, <i>J</i> = 8.8 Hz, 1H), 7.15 (dd, <i>J</i> = 0.8, 2.2 Hz, 1H), 7.03 (d, <i>J</i> = 5.7 Hz, 1H), 3.94 (dd, <i>J</i> = 1.7, 10.2 Hz, 1H), 3.79–3.70 (m, 1H), 3.60–3.45 (m, 2H), 3.26 (d, <i>J</i> = 6.6 Hz, 1H), 3.03 (s, 3H), 2.90 (t, <i>J</i> = 10.1 Hz, 1H). MS (ESI) <i>m</i>/<i>z</i> 384.1 (M + H)<sup>+</sup>. HRMS calcd for C<sub>19</sub>H<sub>17</sub>N<sub>3</sub>O<sub>4</sub>S 384.1018, found 384.102. Peak 2 = <b>20</b>: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.37 (d, <i>J</i> = 5.8 Hz, 1H), 8.34 (s, 1H), 8.19 (dd, <i>J</i> = 2.0, 8.7 Hz, 2H), 7.83 (d, <i>J</i> = 8.6 Hz, 1H), 7.75 (d, <i>J</i> = 8.8 Hz, 1H), 7.15 (dd, <i>J</i> = 0.8, 2.2 Hz, 1H), 7.03 (d, <i>J</i> = 5.7 Hz, 1H), 3.94 (dd, <i>J</i> = 1.7, 10.2 Hz, 1H), 3.79–3.70 (m, 1H), 3.60–3.45 (m, 2H), 3.26 (d, <i>J</i> = 6.6 Hz, 1H), 3.03 (s, 3H), 2.90 (t, <i>J</i> = 10.1 Hz, 1H). MS (ESI) <i>m</i>/<i>z</i> 384.1 (M + H)<sup>+</sup>. HRMS calcd for C<sub>19</sub>H<sub>17</sub>N<sub>3</sub>O<sub>4</sub>S 384.1018, found 384.1016.</div></div><div id="sec5_7_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> (3a<i>S</i>,9b<i>S</i>)-2-((3-Chloro-4-fluorophenyl)sulfonyl)-5-methyl-3,3a,5,9b-tetrahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>][1,6]naphthyridin-4(2<i>H</i>)-one (<b>21</b>)</h3><div class="NLM_p last">(3a<i>S</i>,9b<i>S</i>)- <b>41c</b> (0.0736 M solution in MeCN, 5 mL, 0.368 mmol) was treated with 3-chloro-4-fluorobenzenesulfonyl chloride (0.084 g, 0.368 mmol) and triethylamine (0.102 mL, 0.736 mmol) following the general sulfonylation procedure to afford <b>21</b> (0.091 g, 62% yield). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.40 (d, <i>J</i> = 6.22 Hz, 1H), 8.36–8.37 (m, 1H), 8.01 (dd, <i>J</i> = 2.14, 6.81 Hz, 1H), 7.84 (ddd, <i>J</i> = 2.24, 4.46, 8.61 Hz, 1H), 7.65 (t, <i>J</i> = 8.61 Hz, 1H), 7.07 (d, <i>J</i> = 5.64 Hz, 1H), 3.89–4.00 (m, 1H), 3.70–3.81 (m, 1H), 3.59–3.69 (m, 1H), 3.55 (dd, <i>J</i> = 6.49, 10.38 Hz, 1H), 3.24–3.29 (m, 1H), 3.12 (s, 3H), 2.94 (t, <i>J</i> = 10.12 Hz, 1H). <i>m</i>/<i>z</i> 418.0 (M + Na)<sup>+</sup>. HRMS calcd for C<sub>17</sub>H<sub>16</sub>ClFN<sub>3</sub>O<sub>3</sub>S 396.0585, found 396.0578.</div></div><div id="sec5_7_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> <i>rac</i>-2-(Benzo[<i>d</i>][1,3]dioxol-5-ylsulfonyl)-3a-fluoro-5-methyl-3,3a,5,9b-tetrahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>][1,6]naphthyridin-4(2<i>H</i>)-one (<b>22</b>)</h3><div id="sec5_7_20_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> Step 1: 4-(Methylamino)nicotinaldehyde (<b>36</b>)</h4><div class="NLM_p last">To a vial charged with 4-chloronicotinaldehyde (0.884 g, 6.24 mmol) was added 2-methoxyethanol (3.57 mL) and methylamine, 40 wt % solution in water (13.51 mL, 156 mmol), respectively. The vessel was sealed and heated at 120 °C for 6 h. The orange solution was dried under reduced pressure and 1 N HCl (15 mL) was added, and the resulting mixture heated at 50 °C for 2 h. The mixture was cooled in an ice water bath and basified by the addition of satd aq NaHCO<sub>3</sub> (∼10 mL). The solution was extracted 2× with EtOAc. The combined organics were dried with Na<sub>2</sub>SO<sub>4</sub>, filtered, and dried under reduced pressure, affording <b>36</b> as a yellow oil which was used without further purification (0.408g, 48%). MS (ESI) <i>m</i>/<i>z</i> 137.1 (M + H)<sup>+</sup>.</div></div><div id="sec5_7_20_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> Step 2: 3-Fluoro-1-methyl-1,6-naphthyridin-2(1<i>H</i>)-one (<b>37</b>)</h4><div class="NLM_p last">A flask charged with dry THF (9.08 mL) was cooled in an ice–water bath prior to the addition of NaH (60% in mineral oil) (0.180 g, 4.50 mmol). To the suspension was added 2-fluoro-2-phosphonoacetic acid triethyl ester (0.912 mL, 4.50 mmol), faster than dropwise. The mixture was stirred for 30 min, then cooled in an ice/salt bath prior to the dropwise addition of a suspension of <b>36</b> (0.408 g, 3.00 mmol) in THF (5 mL), faster than dropwise while still stirring at ∼−10 °C. The mixture was allowed to stir for 1.5 h with slow warming. To the mixture was added water (∼5 mL) and the resulting orange solution dried under reduced pressure. The resulting residue was triturated with water, the filtrate was dried under reduced pressure and loaded onto a reverse phase column (55g, C18) and purified ramping ACN in H<sub>2</sub>O (0–100%, 0.1% NH<sub>4</sub>OH) with product eluting very early. This material was repurified by catch and release with a 10g SCX column, loading with DCM/MeOH, washing with MeOH and eluting product with 2 M NH<sub>3</sub> in MeOH, affording <b>37</b> (110 mg, 21%) as a light-orange solid. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 8.78 (s, 1H), 8.62 (d, <i>J</i> = 5.96 Hz, 1H), 7.46 (d, <i>J</i> = 8.29 Hz, 1H), 7.22 (d, <i>J</i> = 6.01 Hz, 1H), 3.75 (s, 3H). MS (ESI) <i>m</i>/<i>z</i> 179.1 (M + H)<sup>+</sup>.</div></div><div id="sec5_7_20_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> Step 3: <i>rac</i>-2-Benzyl-3a-fluoro-5-methyl-3,3a,5,9b-tetrahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>][1,6]naphthyridin-4(2<i>H</i>)-one (<b>39g</b>)</h4><div class="NLM_p last">To a vial charged with <b>37</b> (0.11 g, 0.617 mmol) was added DCM (1.764 mL) and TFA (0.019 mL, 0.247 mmol) and the resulting yellow suspension cooled in an ice–water bath prior to the addition of <i>N</i>-(methoxymethyl)-<i>N</i>-(trimethylsilylmethyl)benzyl-amine (0.237 mL, 0.926 mmol), faster than dropwise. The mixture was stirred and allowed to slowly warm to room temperature (ice melt). After 3 h, additional <i>N</i>-(methoxymethyl)-<i>N</i>-(trimethylsilylmethyl)benzyl-amine (3 eq, 474 μL) was added and stirring continued at room temperature for 3 h then overnight at 40 °C. The mixture was dried under reduced pressure and purified by catch and release with a 10g SCX column, washing with MeOH, and then 2 M NH<sub>3</sub> in MeOH. The basic wash was dried under reduced pressure, affording <b>39g</b> (0.154g, 80%). MS (ESI) <i>m</i>/<i>z</i> 312.0 (M + H)<sup>+</sup>.</div></div><div id="sec5_7_20_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> Step 4: <i>rac</i>-3a-Fluoro-5-methyl-3,3a,5,9b-tetrahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>][1,6]naphthyridin-4(2<i>H</i>)-one (<b>41g</b>)</h4><div class="NLM_p last">To a pressure vessel charged with <b>39g</b> (0.154 g, 0.495 mmol) as a turbid solution in EtOH (2.248 mL) was added water (0.225 mL) and palladium hydroxide, 20 wt % Pd (dry basis) on carbon, wet, Degussa type e101 ne/w (0.035 g, 0.049 mmol). The resulting mixture was heated to 40 °C under 40 psi of H<sub>2</sub> for 3 h. The mixture was filtered through Celite and dried under reduced pressure. The mixture was purified by catch and release with a 10g SCX column washing with MeOH, then 2 M NH<sub>3</sub> in MeOH to afford <b>41g</b> which was used without further purification, (95 mg, 0.429 mmol) (95 mg, 87%).</div></div><div id="sec5_7_20_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> Step 5: <i>rac</i>-2-(Benzo[<i>d</i>][1,3]dioxol-5-ylsulfonyl)-3a-fluoro-5-methyl-3,3a,5,9b-tetrahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>][1,6]naphthyridin-4(2<i>H</i>)-one (<b>22</b>)</h4><div class="NLM_p last">To a vial charged with <b>41g</b> (95 mg, 0.429 mmol) was added MeCN (2863 μL), Et<sub>3</sub>N (239 μL, 1.718 mmol), and benzo[<i>d</i>][1,3]dioxole-5-sulfonyl chloride (95 mg, 0.429 mmol), respectively. The mixture was stirred at room temp for 1 h then dried under reduced pressure and purified with a 55g RP C-18 column, directly loading with IPA/DMSO and ramping with ACN in H<sub>2</sub>O (0.1% in NH<sub>4</sub>OH), providing product with minor close impurities. The material was repurified with RP-HPLC ramping ACN in H<sub>2</sub>O (5–75%, 0.1% TFA), providing <b>22</b> as a white solid (85 mg, 49%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.51 (d, <i>J</i> = 7.59 Hz, 2H), 7.22–7.35 (m, 3H), 7.02 (d, <i>J</i> = 8.11 Hz, 1H), 6.19 (s, 2H), 4.05 (d, <i>J</i> = 11.74 Hz, 2H), (broad water peak over 3 aliphatic H), 3.29 (s, 3H). MS (ESI) <i>m</i>/<i>z</i> 405.9 (M + H)<sup>+</sup>. HRMS calcd for C<sub>18</sub>H<sub>16</sub>FN<sub>3</sub>O<sub>5</sub>S = 406.0873, found 406.0875.</div></div></div><div id="sec5_7_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> (3a<i>R</i>,9b<i>S</i>)-2-(Benzo[<i>d</i>][1,3]dioxol-5-ylsulfonyl)-3a,5-dimethyl-3,3a,5,9b-tetrahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>]quinolin-4(2<i>H</i>)-one (<b>23</b>)</h3><div id="sec5_7_21_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> Step 1: <i>rac</i>-<i>tert</i>-Butyl 4-Oxo-3,3a,4,5-tetrahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>]quinoline-2(9b<i>H</i>)-carboxylate (<b>42</b>)</h4><div class="NLM_p last">To a mixture of <i>rac</i>-2-benzyl-3,3a,5,9b-tetrahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>]quinolin-4(2<i>H</i>)-one (12 g, 0.0431 mmol), Pd/C (1.2 g, 10% on carbon), and Pd(OH)<sub>2</sub> (1.2 g) in EtOH (120 mL) was added (Boc)<sub>2</sub>O (14.09 mL, 0.064 mol, 1.5 equiv) and the mixture stirred at 50 psi under H<sub>2</sub> for 24 h. The resulting mixture was filtered and concentrated and the crude material was purified by column chromatography using petroleum ether:ethyl acetate (1:1) to afford <b>42</b> as an off-white solid (12 g, 96% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.36 (s, 1H), 7.27 (d, <i>J</i> = 7.5 Hz, 1H), 7.19 (td, <i>J</i> = 7.7, 1.4 Hz, 1H), 7.00–6.87 (m, 2H), 3.93 (t, <i>J</i> = 9.8 Hz, 1H), 3.60 (d, <i>J</i> = 8.5 Hz, 2H), 3.46 (ddd, <i>J</i> = 16.8, 10.5, 6.7 Hz, 1H), 3.14 (t, <i>J</i> = 6.7 Hz, 1H), 2.81 (td, <i>J</i> = 12.2, 10.4, 6.9 Hz, 1H), 1.38 (d, <i>J</i> = 14.5 Hz, 9H). MS (ESI) <i>m</i>/<i>z</i> 189.4 (M + H – Boc)<sup>+</sup>.</div></div><div id="sec5_7_21_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> Step 2: <i>rac</i>-3a,5-Dimethyl-3,3a,5,9b-tetrahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>]quinolin-4(2<i>H</i>)-one (<b>44</b>)</h4><div class="NLM_p last">To a solution of <b>42</b> (0.5 g, 1.734 mmol) in DMF (8.67 mL) at 0 °C was added sodium hydride 60% suspension in mineral oil (0.173 g, 4.34 mmol). The mixture was stirred at rt for 30 min prior to the addition of iodomethane (0.269 mL, 4.34 mmol). The resulting reaction mixture was stirred at room temperature for 2 h then quenched by the addition of satd aq NH<sub>4</sub>Cl with ice bath cooling then extracted with diethyl ether three times. The combined organics were washed with brine, dried over MgSO<sub>4</sub>, filtered, and dried under reduced pressure. To this residue was added 8 mL of 4 M HCl in MeOH (made from AcCl and MeOH), and the resulting solution was stirred at room temperature overnight. The resulting mixture was dried under reduced pressure and the residue purified by catch and release with an SCX column washing with MeOH, then 2 M NH<sub>3</sub> in MeOH. The basic wash was dried under reduced pressure to provide <b>44</b> (0.365 g, 1.688 mmol, 97% yield) as a thick brown oil. MS (ESI) <i>m</i>/<i>z</i> 217.2 (M + 1)<sup>+</sup>.</div></div><div id="sec5_7_21_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> Step 3: (3a<i>R</i>,9b<i>S</i>)-2-(Benzo[<i>d</i>][1,3]dioxol-5-ylsulfonyl)-3a,5-dimethyl-3,3a,5,9b-tetrahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>]quinolin-4(2<i>H</i>)-one (<b>23</b>)</h4><div class="NLM_p last">A solution of <b>44</b> (0.1 g, 0.462 mmol) in DMF (2 mL) was treated with 1,3-benzodioxole-5-sulfonyl chloride (0.112 g, 0.509 mmol) and triethylamine (0.193 mL, 1.387 mmol) following the general sulfonylation procedure to afford the racemate of <b>23</b> (0.143 g, 0.358 mmol, 77% yield). Then 50 mg of this material was subjected to chiral resolution by SFC on column (S,S) Whelk-O, 5 μ, 2 cm × 25 cm, 45% methanol w/0.2% DEA, 80 mL/min, 81 bar pressure drop, 100 bar BPR, 251 nm, sample dissolved in DCM:MeOH (1:1, 10 mL). Sample processed with 1.0 mL injection volume and cycle time of 6 min. Peak assignment determined by SFC on (S,S) Whelk-O with 45% methanol w/0.2% DEA modifer. Absolute configuration assigned by analogy based on in vitro activity and the known stereochemistry of active isomer <b>32</b> as determined by the X-ray cocrystal structure. Peak 1 = compound <b>23</b> (20 mg). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.25–7.38 (m, 4H), 7.03–7.16 (m, 3H), 6.15–6.22 (m, 2H), 4.10–4.16 (m, 1H), 3.63–3.70 (m, 1H), 3.21–3.28 (m, 1H), 3.10–3.18 (m, 4H), 2.77–2.87 (m, 1H), 0.95 (s, 3H). MS (ESI) <i>m</i>/<i>z</i> 401.1 (M + H)<sup>+</sup>. HRMS calcd for C<sub>20</sub>H<sub>20</sub>N<sub>2</sub>O<sub>5</sub>S (M + H)<sup>+</sup> 401.1171; found 401.1170.</div></div></div><div id="sec5_7_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83"> <i>rac</i>-2-(Benzo[<i>d</i>][1,3]dioxol-5-ylsulfonyl)-5-methyl-4-oxo-2,3,3a,4,5,9b-hexahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>][1,6]naphthyridine-3a-carbonitrile (<b>24</b>)</h3><div id="sec5_7_22_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84"> Step 1: 2-Oxo-1,2-dihydro-1,6-naphthyridine-3-carbonitrile (<b>35</b>)</h4><div class="NLM_p last">To a vial charged with 4-amino-3-formylpyridine (0.90 g, 7.37 mmol) was added EtOH (12.28 mL), cyanoacetic acid methyl ester (1.312 mL, 14.74 mmol), and piperidine (0.182 mL, 1.842 mmol). The vial was sealed and heated with shaking to 120 °C overnight, affording a yellow precipitate. The mixture was cooled to room temperature and the solid collected via vacuum filtration and washed with heptane to afford <b>35</b> as a yellow solid (1.237 g, 7.23 mmol, 98% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 12.70 (br s, 1 H), 8.89 (d, <i>J</i> = 0.7 Hz, 1 H), 8.92 (d, <i>J</i> = 0.7 Hz, 1 H), 8.59 (d, <i>J</i> = 5.9 Hz, 1 H), 7.26 (td, <i>J</i> = 0.7, 5.8 Hz, 1 H). MS (ESI) <i>m</i>/<i>z</i> 172.1 (M + H)<sup>+</sup>.</div></div><div id="sec5_7_22_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85"> Step 2: 1-Methyl-2-oxo-1,2-dihydro-1,6-naphthyridine-3-carbonitrile (<b>38f</b>)</h4><div class="NLM_p last">To a vial charged with <b>35</b> (1.237 g, 7.23 mmol) was added DMF (20.65 mL) and Cs<sub>2</sub>CO<sub>3</sub> (2.59 g, 7.95 mmol). The mixture was stirred at room temperature for 15 min prior to the addition of iodomethane (0.565 mL, 9.03 mmol). The resulting orange suspension was stirred for 1 h at room temp. The mixture was added to ice and the resulting solid collected via vacuum filtration and washed with water and the solid dried under a nitrogen/vacuum sweep, affording <b>38f</b> as a tan solid (1.121 g, 6.05 mmol, 84% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 8.97 (d, <i>J</i> = 0.5 Hz, 1 H), 8.91 (s, 1 H), 8.72 (d, <i>J</i> = 6.1 Hz, 1 H), 7.60 (d, <i>J</i> = 6.2 Hz, 1 H), 3.62 (s, 3 H). MS (ESI) <i>m</i>/<i>z</i> 186.0 (M + H)<sup>+</sup>.</div></div><div id="sec5_7_22_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i86" class="anchor-spacer"></div><h4 class="article-section__title" id="_i86"> Step 3: <i>rac</i>-2-Benzyl-5-methyl-4-oxo-2,3,3a,4,5,9b-hexahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>][1,6]naphthyridine-3a-carbonitrile (<b>39f</b>)</h4><div class="NLM_p last">To a vial charged with <b>38f</b> (1.12 g, 6.05 mmol) was added DCM (17.28 mL) and TFA (0.186 mL, 2.419 mmol) and the resulting yellow suspension cooled in an ice–water bath prior to the addition of <i>N</i>-(methoxymethyl)-<i>N</i>-(trimethylsilylmethyl)benzyl-amine (2.321 mL, 9.07 mmol), faster than dropwise. The mixture was stirred and allowed to slowly warm to room temperature (ice melt). After 4 h, additional <i>N</i>-(methoxymethyl)-<i>N</i>-(trimethylsilylmethyl)benzyl-amine (1 equiv) was added and stirring at room temperature continued for 1 h. The reaction mixture was dried under reduced pressure, and the material was dissolved in MeOH/H<sub>2</sub>O, filtered through a 0.45 μm frit, and loaded onto a Redisep load column and purified with a 120g RP Interchim C18, 30 μm, column ramping ACN in H<sub>2</sub>O (0–100%, 0.1% NH<sub>4</sub>OH), providing <b>39f</b> as a yellow sticky foam (996 mg, 52%). MS (ESI) <i>m</i>/<i>z</i> 319.2 (M + H)<sup>+</sup>.</div></div><div id="sec5_7_22_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i87" class="anchor-spacer"></div><h4 class="article-section__title" id="_i87"> Step 4: <i>rac</i>-5-Methyl-4-oxo-2,3,3a,4,5,9b-hexahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>][1,6]naphthyridine-3a-carbonitrile (<b>41f</b>)</h4><div class="NLM_p last">To a vial charged with <b>39f</b> (0.10 g, 0.314 mmol) was added DCM (1.256 mL) and the resulting solution cooled in an ice–water bath prior to the addition of carbonochloridate (0.068 mL, 0.754 mmol) which was stirred for 10 min at 0 °C then overnight at 40 °C. The mixture was dried under reduced pressure and EtOH (1.5 mL) and 6 N HCl (0.3 mL) were added and the mixture shaken at 100 °C overnight. The mixture was cooled to room temperature and added to IPA (∼30 mL), affording a light-brown precipitate which was collected by vacuum filtration, rinsing with minimal IPA, providing <b>41f</b> as a brown solid (50 mg, 0.219 mmol, 69.7% yield). MS (ESI) <i>m</i>/<i>z</i> 229.2 (M + H)<sup>+</sup>.</div></div><div id="sec5_7_22_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88"> Step 5: <i>rac</i>-2-(Benzo[<i>d</i>][1,3]dioxol-5-ylsulfonyl)-5-methyl-4-oxo-2,3,3a,4,5,9b-hexahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>][1,6]naphthyridine-3a-carbonitrile (<b>24</b>)</h4><div class="NLM_p last">To a vial charged with <b>41f</b> (48 mg, 0.210 mmol) was added MeCN (1402 μL), Et<sub>3</sub>N (117 μL, 0.841 mmol), and 1,3-benzodioxole-5-sulfonyl chloride (46.4 mg, 0.210 mmol), respectively. The mixture was shaken at room temperature for 90 min. The resulting mixture was dried under reduced pressure, dissolved in DMSO, filtered through a 0.45 μm frit, and purified with RP-HPLC ramping ACN in H<sub>2</sub>O, NH<sub>4</sub>OH 0.1%. Under these basic conditions, ∼50% of the product decomposed to the <i>des</i>-CN compound according to LC-MS. Repurification with RP-HPLC ramping ACN in H<sub>2</sub>O, TFA 0.1% afforded <b>24</b> (18 mg, 16%). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>CN) δ = 3.33–3.39 (m, 4 H) 3.87–3.93 (m, 2 H) 4.18 (t, <i>J</i> = 8.17 Hz, 1 H) 4.24 (d, <i>J</i> = 10.77 Hz, 1 H) 6.15 (s, 2 H) 7.01 (d, <i>J</i> = 8.17 Hz, 1 H) 7.25 (d, <i>J</i> = 1.82 Hz, 1 H) 7.33–7.43 (m, 2 H) 8.55 (s, 1 H) 8.62 (d, <i>J</i> = 6.36 Hz, 1 H). MS (ESI) <i>m</i>/<i>z</i> 413.0 (M + H)<sup>+</sup>, HRMS calcd for C<sub>19</sub>H<sub>16</sub>N<sub>4</sub>O<sub>5</sub>S = 412.424, found 413.092.</div></div></div><div id="sec5_7_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i89" class="anchor-spacer"></div><h3 class="article-section__title" id="_i89"> <i>rac</i>-2-(Benzo[<i>d</i>][1,3]dioxol-5-ylsulfonyl)-5,9b-dimethyl-3,3a,5,9b-tetrahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>][1,6]naphthyridin-4(2<i>H</i>)-one (<b>25</b>)</h3><div id="sec5_7_23_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i90" class="anchor-spacer"></div><h4 class="article-section__title" id="_i90"> Step 1: Ethyl 4-Methyl-2-oxo-1,2-dihydro-1,6-naphthyridine-3-carboxylate (<b>34f</b>)</h4><div class="NLM_p last">To a microwave vial was added 1-(4-aminopyridin-3-yl)ethanone (1.00 g, 7.34 mmol), diethyl malonate (5.58 mL, 36.7 mmol), and piperidine (0.182 mL, 1.836 mmol), respectively. The mixture was irradiated at 180 °C for 15 min, affording a tan precipitate. To the vessel was added water and the solid collected by vacuum filtration and washed with water to provide <b>34f</b> as a tan solid (0.848 g, 3.65 mmol, 49.7% yield), which was used without further purification. MS (ESI) <i>m</i>/<i>z</i> 233.1 (M + H)<sup>+</sup>.</div></div><div id="sec5_7_23_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i91" class="anchor-spacer"></div><h4 class="article-section__title" id="_i91"> Step 2: Ethyl 1,4-Dimethyl-2-oxo-1,2-dihydro-1,6-naphthyridine-3-carboxylate (<b>38e</b>)</h4><div class="NLM_p last">To a vial charged with <b>34f</b> (0.675 g, 2.91 mmol) was added Cs<sub>2</sub>CO<sub>3</sub> (1.326 g, 4.07 mmol) and DMF (8.30 mL), and the resulting suspension was cooled in an ice–water bath prior to the addition of iodomethane (0.182 mL, 2.91 mmol) dropwise. The mixture was allowed to stir while slowly warming to room temperature (ice melt) over 2 h. The mixture was diluted with water and purified by catch and release with a 10g SCX column, washing with MeOH, then 2 M NH<sub>3</sub> in MeOH to elute <b>38e</b>, obtained as a yellow solid (0.550 g, 2.233 mmol, 77% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 9.07 (s, 1 H), 8.68 (d, <i>J</i> = 5.9 Hz, 1 H), 7.54 (d, <i>J</i> = 6.0 Hz, 1 H), 4.35 (q, <i>J</i> = 7.2 Hz, 2 H), 3.60 (s, 3 H), 2.50 (s, 3 H), 1.31 (t, <i>J</i> = 7.1 Hz, 3 H). MS (ESI) <i>m</i>/<i>z</i> 247.1 (M + H)<sup>+</sup>.</div></div><div id="sec5_7_23_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i92" class="anchor-spacer"></div><h4 class="article-section__title" id="_i92"> Step 3: <i>rac</i>-Ethyl 2-Benzyl-5,9b-dimethyl-4-oxo-2,3,3a,4,5,9b-hexahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>][1,6]naphthyridine-3a-carboxylate (<b>39e</b>)</h4><div class="NLM_p last">To a vial charged with <b>38e</b> (0.500 g, 2.030 mmol) was added DCM (5.80 mL) and the resulting solution cooled in an ice–water bath prior to the addition of TFA (0.063 mL, 0.812 mmol) and <i>N</i>-(methoxymethyl)-<i>N</i>-(trimethylsilylmethyl)benzyl-amine (2.60 mL, 10.15 mmol), faster than dropwise. The mixture was stirred and allowed to warm to room temperature (ice melt) over 4 h. The mixture was purified by catch and release by loading directly onto a 10g SCX column which was washed with MeOH, then 2 M NH<sub>3</sub> in MeOH. The basic wash was dried under reduced pressure and the mixture purified with a 55g C-18 RP column ramping ACN in H<sub>2</sub>O (0–100%, 0.1% NH<sub>4</sub>OH), affording <b>39e</b> as a yellow oil (0.134 g, 0.353 mmol, 17.39% yield). MS (ESI) <i>m</i>/<i>z</i> 380.1 (M + H)<sup>+</sup>.</div></div><div id="sec5_7_23_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i93" class="anchor-spacer"></div><h4 class="article-section__title" id="_i93"> Step 4: <i>rac</i>-2-Benzyl-5,9b-dimethyl-3,3a,5,9b-tetrahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>][1,6]naphthyridin-4(2<i>H</i>)-one (<b>40e</b>)</h4><div class="NLM_p last">To a vial charged with <b>39e</b> (0.134 g, 0.353 mmol) was added 6 N HCl (0.177 mL). The vial was sealed and shaken at 130 °C. After 2 h, additional 6 N HCl (2 mL) was added and the mixture heated to 130 °C, under nitrogen. After 2 more hours of concentration, HCl (2 mL) was added and the solution was stirred for 20 h at 130 °C. The resulting mixture was cooled in an ice–water bath while stirring and brought to basic pH by the addition of 6N NaOH. The resulting slurry was dried under reduced pressure and the solid (containing salts) shaken with DCM/MeOH and filtered to remove most of the salts. The filtrate was dried under reduced pressure and purified by catch and release with a 5g SCX column, loading with MeOH/DCM and washing with MeOH, water, MeOH, then 2 M NH<sub>3</sub> in MeOH, affording product elution. The solution was dried under reduced pressure and the resulting material (<b>40e</b>) used without further purification, obtained as a brown oil (85 mg, 78%). MS (ESI) <i>m</i>/<i>z</i> 308.1 (M + H)<sup>+</sup>.</div></div><div id="sec5_7_23_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i94" class="anchor-spacer"></div><h4 class="article-section__title" id="_i94"> Step 5: <i>rac</i>-5,9b-Dimethyl-3,3a,5,9b-tetrahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>][1,6]naphthyridin-4(2<i>H</i>)-one (<b>41e</b>)</h4><div class="NLM_p last">To a pressure vessel charged with <b>40e</b> (0.085 g, 0.277 mmol) as a turbid solution in EtOH (1.257 mL) was added water (0.126 mL) and palladium hydroxide, 20 wt % Pd (dry basis) on carbon, wet, Degussa type e101 ne/w (0.019 g, 0.028 mmol). The resulting mixture was heated to 40 °C under 40 psi of H<sub>2</sub> for 4 h. The mixture was filtered through Celite and dried under reduced pressure. The crude material was purified by catch and release with a 5g SCX column washing with MeOH, then 2 M NH<sub>3</sub> in MeOH to afford <b>41e</b> with some minor impurities (∼75% pure, 50 mg, 83% yield). The material was used without further purification. MS (ESI) <i>m</i>/<i>z</i> 218.1 (M + H)<sup>+</sup>.</div></div><div id="sec5_7_23_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i95" class="anchor-spacer"></div><h4 class="article-section__title" id="_i95"> Step 6: <i>rac</i>-2-(Benzo[<i>d</i>][1,3]dioxol-5-ylsulfonyl)-5,9b-dimethyl-3,3a,5,9b-tetrahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>][1,6]naphthyridin-4(2<i>H</i>)-one (<b>25</b>)</h4><div class="NLM_p last">To a vial charged with <b>41e</b> (50 mg, 0.230 mmol) was added MeCN (1534 μL), Et<sub>3</sub>N (128 μL, 0.921 mmol), and benzo[<i>d</i>][1,3]dioxole-5-sulfonyl chloride (50.8 mg, 0.230 mmol), respectively. The mixture was stirred at room temperature overnight. The yellow solution was dried under reduced pressure, dissolved in DMSO, filtered through a 0.25 μm frit, and purified with RP-HPLC ramping ACN in H<sub>2</sub>O (0–100%, 0.1% NH<sub>4</sub>OH), affording <b>25</b> as a pale-yellow film (25 mg, 0.062 mmol, 27.1% yield). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.40 (br s, 2H), 7.27 (dd, <i>J</i> = 1.72, 8.14 Hz, 1H), 7.20 (d, <i>J</i> = 1.62 Hz, 1H), 6.94–7.12 (m, 2H), 6.18 (d, <i>J</i> = 4.41 Hz, 2H), 3.58–3.70 (m, 2H), 3.46 (dd, <i>J</i> = 6.78, 10.09 Hz, 1H), 3.20 (s, 3H), 3.17 (s, 1H), 3.05 (t, <i>J</i> = 7.27 Hz, 1H), 1.22 (s, 3H). MS (ESI) <i>m</i>/<i>z</i> 402.1 (M + H)<sup>+</sup>, HRMS calcd for C<sub>19</sub>H<sub>19</sub>N<sub>3</sub>O<sub>5</sub>S 402.1124, found 402.1119.</div></div></div><div id="sec5_7_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i96" class="anchor-spacer"></div><h3 class="article-section__title" id="_i96"> Synthesis of (<i>rac</i>)-<i>cis</i>-<b>52a</b>, (<i>rac</i>)-<i>cis</i>-<b>52b</b>, (<i>rac</i>)-<i>cis</i>-<b>52c</b>, and (<i>rac</i>)-<i>cis</i>-<b>52d</b> via Initial Route, and Sulfonamides <b>26</b>–<b>33</b></h3><div id="sec5_7_24_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i97" class="anchor-spacer"></div><h4 class="article-section__title" id="_i97"> Step 1: <i>N</i>-Benzyl-1-(trimethylsilyl)ethanamine (<b>52</b>)</h4><div class="NLM_p last">See Manzano et al., ref <a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">39</a>.</div></div><div id="sec5_7_24_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i98" class="anchor-spacer"></div><h4 class="article-section__title" id="_i98"> Step 2: <i>N</i>-Benzyl-<i>N</i>-(methoxymethyl)-1-(trimethylsilyl)ethanamine (<b>53</b>)</h4><div class="NLM_p last">See Manzano et al., ref <a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">39</a>.</div></div><div id="sec5_7_24_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i99" class="anchor-spacer"></div><h4 class="article-section__title" id="_i99"> Step 3: Ethyl 1-Methyl-2-oxo-1,2-dihydro-1,6-naphthyridine-3-carboxylate (<b>38g</b>)</h4><div class="NLM_p last">To a flask charged with <b>34c</b> (5.08 g, 23.28 mmol) was added DMF (46.6 mL) and cesium carbonate (2.79 mL, 34.9 mmol). The resulting mixture was stirred for 15 min at room temperature, affording a thick yellow suspension which was cooled in an ice–water bath and placed under nitrogen prior to the addition of MeI (1.601 mL, 25.6 mmol), faster than dropwise. The resulting mixture was allowed to stir and warm slowly to room temperature (ice melt). After 2 h, the reaction was quenched by the addition of ice. The aqueous solution was extracted with EtOAc two times. The combined organics were dried with Na<sub>2</sub>SO<sub>4</sub>, filtered, and dried under reduced pressure. The organic layer was purified by catch and release with a 25g SCX column washing with MeOH, then 2 M NH<sub>3</sub> in MeOH, affording <b>38g</b> as a light-yellow solid (2.8 g, 36%). <i>m</i>/<i>z</i> (ESI) 233.1 (M + H)<sup>+</sup></div></div><div id="sec5_7_24_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i100" class="anchor-spacer"></div><h4 class="article-section__title" id="_i100"> Step 4: Diastereomeric Mixture of <i>cis</i>-Ring Fusion Isomers, <i>rac</i>-Ethyl 2-Benzyl-1,5-dimethyl-4-oxo-2,3,3a,4,5,9b-hexahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>][1,6]naphthyridine-3a-carboxylate and <i>rac</i>-Ethyl 2-Benzyl-3,5-dimethyl-4-oxo-2,3,3a,4,5,9b-hexahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>][1,6]naphthyridine-3a-carboxylate</h4><div class="NLM_p last">To a flask charged with <b>38g</b> (0.6 g, 2.58 mmol) was added DCM (7.38 mL) and TFA (0.080 mL, 1.033 mmol). The mixture was cooled to 0 °C prior to the addition of a solution of <i>N</i>-benzyl-<i>N</i>-(methoxymethyl)-1-(trimethylsilyl)ethanamine (1.624 g, 6.46 mmol) in DCM (1 mL), faster than dropwise. The mixture was stirred overnight at room temperature. The mixture was diluted with DCM, adsorbed onto silica gel, and purified with a 100g ultra snap column ramping EtOAc:EtOH (76:24) in heptane (0–30%, isocratic at 30%, then 30%–70%), affording product as a sticky yellow oil as a nonstatistical mixture of four racemic diastereomers (0.327 g, 0.862 mmol, 33.4% yield). MS (ESI) <i>m</i>/<i>z</i> 380.1 (M + H)<sup>+</sup>.</div></div><div id="sec5_7_24_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i101" class="anchor-spacer"></div><h4 class="article-section__title" id="_i101"> Step 5: Diastereomeric Mixture of <i>cis</i>-Ring Fusion Isomers of 2-Benzyl-1,5-dimethyl-3,3a,5,9b-tetrahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>][1,6]naphthyridin-4(2<i>H</i>)-one and 2-Benzyl-3,5-dimethyl-3,3a,5,9b-tetrahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>][1,6]naphthyridin-4(2<i>H</i>)-one</h4><div class="NLM_p last">To a vial charged with <i>rac</i>-ethyl 2-benzyl-1,5-dimethyl-4-oxo-2,3,3a,4,5,9b-hexahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>][1,6]naphthyridine-3a-carboxylate/<i>rac</i>-ethyl 2-benzyl-3,5-dimethyl-4-oxo-2,3,3a,4,5,9b-hexahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>][1,6]naphthyridine-3a-carboxylate (291 mg, 0.767 mmol) was added 1,4-dioxane (4.18 mL) and 3 N HCl (2.8 mL), respectively. The vessel was sealed and heated at 90 °C over three nights. The resulting yellow solution was dried under reduced pressure and was used directly without further purification in the next step (yield not determined). MS (ESI) <i>m</i>/<i>z</i> 308.1 (M + H)<sup>+</sup>.</div></div><div id="sec5_7_24_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i102" class="anchor-spacer"></div><h4 class="article-section__title" id="_i102"> Step 6: <i>rac</i>-3,5-Dimethyl-3,3a,5,9b-tetrahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>][1,6]naphthyridin-4(2<i>H</i>)-one and 1,5-Dimethyl-3,3a,5,9b-tetrahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>][1,6]naphthyridin-4(2<i>H</i>)-one/1,5-Dimethyl-3,3a,5,9b-tetrahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>][1,6]naphthyridin-4(2<i>H</i>)-one, (<i>rac</i>)-cis-<b>54a</b>–<b>d</b></h4><div class="NLM_p last">To a pressure vessel charged with <i>rac</i>-2-benzyl-1,5-dimethyl-3,3a,5,9b-tetrahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>][1,6]naphthyridin-4(2<i>H</i>)-one/<i>rac</i>-2-benzyl-3,5-dimethyl-3,3a,5,9b-tetrahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>][1,6]naphthyridin-4(2<i>H</i>)-one (0.261 g, 0.849 mmol (crude) as a turbid solution in EtOH (3.86 mL) was added water (0.386 mL) and palladium hydroxide, 20 wt % pd (dry basis) on carbon, wet, Degussa type e101 ne/w (0.060 g, 0.085 mmol). The resulting mixture was heated to 40 °C under 40 psi of H<sub>2</sub> for 3 h. The mixture was filtered through Celite and dried under reduced pressure. The crude residue was further purified by catch and release with a 5g SCX column washing with MeOH then 2 M NH<sub>3</sub> in MeOH, affording (<i>rac</i>)-<i>cis</i>-<b>54a</b>–<b>d</b> as pale-yellow upon drying under reduced pressure (160 mg, 0.736 mmol, 96% yield, 2 steps). MS (ESI) <i>m</i>/<i>z</i> 218.1 (M + H)<sup>+</sup>.</div></div><div id="sec5_7_24_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i103" class="anchor-spacer"></div><h4 class="article-section__title" id="_i103"> Step 7: Sulfonamides <b>26</b>–<b>33</b></h4><div class="NLM_p">To a vial charged with (<i>rac</i>)-<i>cis</i>-<b>54a</b>–<b>d</b> (160 mg, 0.736 mmol) was added MeCN (4.9 mL), Et<sub>3</sub>N (0.4 mL, 2.95 mmol), and benzo[<i>d</i>][1,3]dioxole-5-sulfonyl chloride (162 mg, 0.736 mmol), respectively. The mixture was stirred at room temp for 2 h. The resulting mixture was dried under reduced pressure and purified with a 50g ultra snap column ramping EtOAc:EtOH (76:24) in heptane (0–100%, isocratic at 100%), affording desired product as a mixture of diastereomers light-yellow foam (211 mg, 71%). See the <a href="/doi/suppl/10.1021/acs.jmedchem.6b01496/suppl_file/jm6b01496_si_001.pdf" class="ext-link">Supporting Information</a> for chiral separation conditions and NMR structural confirmations.</div><div class="NLM_p">Yields and analytical data for the individual diastereomers:</div><div id="sec5_7_25" class="NLM_sec NLM_sec_level_4"><div id="ac_i104" class="anchor-spacer"></div><h5 class="article-section__title" id="_i104"> (1<i>S</i>,3a<i>S</i>,9b<i>S</i>)-2-(Benzo[<i>d</i>][1,3]dioxol-5-ylsulfonyl)-1,5-dimethyl-3,3a,5,9b-tetrahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>][1,6]naphthyridin-4(2<i>H</i>)-one (<b>26</b>) (Absolute Stereochemistry Arbitrarily Assigned)</h5><div class="NLM_p last">Obtained 5 mg, 1.7% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.41 (d, <i>J</i> = 5.29 Hz, 1H), 8.32 (s, 1H), 7.24 (dd, <i>J</i> = 1.66, 8.19 Hz, 1H), 7.18 (d, <i>J</i> = 1.55 Hz, 1H), 6.98–7.06 (m, 2H), 6.17 (d, <i>J</i> = 11.71 Hz, 2H), 3.99 (d, <i>J</i> = 11.51 Hz, 1H), 3.69 (dd, <i>J</i> = 6.27, 11.25 Hz, 1H), 3.27–3.30 (m, 1H), 3.11–3.22 (m, 2H), 2.98 (s, 3H), 1.39 (d, <i>J</i> = 5.91 Hz, 3H). MS (ESI) <i>m</i>/<i>z</i> 402.2 (M + H)<sup>+</sup>. HRMS calcd for C<sub>19</sub>H<sub>19</sub>N<sub>3</sub>O<sub>5</sub>S 402.1124, found 402.1118.</div></div><div id="sec5_7_26" class="NLM_sec NLM_sec_level_4"><div id="ac_i105" class="anchor-spacer"></div><h5 class="article-section__title" id="_i105"> (1<i>R</i>,3a<i>R</i>,9b<i>R</i>)-2-(Benzo[<i>d</i>][1,3]dioxol-5-ylsulfonyl)-1,5-dimethyl-3,3a,5,9b-tetrahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>][1,6]naphthyridin-4(2<i>H</i>)-one (<b>27</b>) (Absolute Stereochemistry Arbitrarily Assigned)</h5><div class="NLM_p last">Obtained 5 mg, 1.7% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.41 (d, <i>J</i> = 5.60 Hz, 1H), 8.32 (s, 1H), 7.24 (dd, <i>J</i> = 1.92, 8.14 Hz, 1H), 7.18 (d, <i>J</i> = 1.76 Hz, 1H), 6.98–7.06 (m, 2H), 6.17 (dd, <i>J</i> = 0.93, 11.92 Hz, 2H), 3.99 (dd, <i>J</i> = 1.55, 11.30 Hz, 1H), 3.69 (dd, <i>J</i> = 6.32, 11.20 Hz, 1H), 3.29 (s, 1H), 3.11–3.23 (m, 2H), 2.98 (s, 3H), 1.39 (d, <i>J</i> = 6.01 Hz, 3H). MS (ESI) <i>m</i>/<i>z</i> 402.2 (M + H)<sup>+</sup>. HRMS calcd for C<sub>19</sub>H<sub>19</sub>N<sub>3</sub>O<sub>5</sub>S 402.1124, found 402.1122.</div></div><div id="sec5_7_27" class="NLM_sec NLM_sec_level_4"><div id="ac_i106" class="anchor-spacer"></div><h5 class="article-section__title" id="_i106"> (1<i>R</i>,3a<i>S</i>,9b<i>S</i>)-2-(Benzo[<i>d</i>][1,3]dioxol-5-ylsulfonyl)-1,5-dimethyl-3,3a,5,9b-tetrahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>][1,6]naphthyridin-4(2<i>H</i>)-one (<b>28</b>) (Absolute Stereochemistry Arbitrarily Assigned)</h5><div class="NLM_p last">Obtained 28 mg, 9.5%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.42 (d, <i>J</i> = 5.60 Hz, 1H), 8.32 (s, 1H), 7.44 (dd, <i>J</i> = 1.87, 8.19 Hz, 1H), 7.40 (d, <i>J</i> = 1.66 Hz, 1H), 7.16 (d, <i>J</i> = 8.09 Hz, 1H), 7.13 (d, <i>J</i> = 5.70 Hz, 1H), 6.21 (dd, <i>J</i> = 1.04, 4.56 Hz, 2H), 3.99–4.11 (m, 2H), 3.40 (d, <i>J</i> = 8.71 Hz, 1H), 3.32 (m, 2H), 3.28 (s, 3H), 0.69 (d, <i>J</i> = 6.74 Hz, 3H). MS (ESI) <i>m</i>/<i>z</i> 402.0 (M + H)<sup>+</sup>. HRMS calcd for C<sub>19</sub>H<sub>19</sub>N<sub>3</sub>O<sub>5</sub>S 402.1124, found 402.1123.</div></div><div id="sec5_7_28" class="NLM_sec NLM_sec_level_4"><div id="ac_i107" class="anchor-spacer"></div><h5 class="article-section__title" id="_i107"> (1<i>S</i>,3a<i>R</i>,9b<i>R</i>)-2-(Benzo[<i>d</i>][1,3]dioxol-5-ylsulfonyl)-1,5-dimethyl-3,3a,5,9b-tetrahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>][1,6]naphthyridin-4(2<i>H</i>)-one (<b>29</b>) (Absolute Stereochemistry Arbitrarily Assigned)</h5><div class="NLM_p last">Obtained 31 mg, 10.4%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.42 (d, <i>J</i> = 5.70 Hz, 1H), 8.32 (s, 1H), 7.44 (dd, <i>J</i> = 1.87, 8.19 Hz, 1H), 7.40 (d, <i>J</i> = 1.66 Hz, 1H), 7.16 (d, <i>J</i> = 8.19 Hz, 1H), 7.13 (d, <i>J</i> = 5.70 Hz, 1H), 6.21 (dd, <i>J</i> = 0.93, 4.56 Hz, 2H), 3.99–4.12 (m, 2H), 3.38–3.45 (m, 1H), 3.32 (m, 2H), 3.28 (s, 3H), 0.69 (d, <i>J</i> = 6.74 Hz, 3H). MS (ESI) <i>m</i>/<i>z</i> 402.2 (M + H)<sup>+</sup>. HRMS calcd for C<sub>19</sub>H<sub>19</sub>N<sub>3</sub>O<sub>5</sub>S 402.1124, found 402.1121.</div></div><div id="sec5_7_29" class="NLM_sec NLM_sec_level_4"><div id="ac_i108" class="anchor-spacer"></div><h5 class="article-section__title" id="_i108"> (3<i>R</i>,3a<i>S</i>,9b<i>S</i>)-2-(Benzo[<i>d</i>][1,3]dioxol-5-ylsulfonyl)-3,5-dimethyl-3,3a,5,9b-tetrahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>][1,6]naphthyridin-4(2<i>H</i>)-one (<b>30</b>) (Absolute Stereochemistry Arbitrarily Assigned)</h5><div class="NLM_p last">Obtained 34 mg, 11.5%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.35–8.41 (m, 2H), 8.35–8.41 (m, 1H), 7.25 (dd, <i>J</i> = 1.87, 8.19 Hz, 1H), 7.18 (d, <i>J</i> = 1.87 Hz, 1H), 6.99–7.05 (m, 2H), 6.17 (dd, <i>J</i> = 0.93, 11.71 Hz, 2H), 4.29 (dq, <i>J</i> = 1.61, 6.51 Hz, 1H), 3.90 (td, <i>J</i> = 7.55, 10.08 Hz, 1H), 3.69 (dd, <i>J</i> = 7.72, 9.59 Hz, 1H), 3.02 (s, 3H), 2.96 (dd, <i>J</i> = 1.35, 7.26 Hz, 1H), 2.83 (t, <i>J</i> = 10.00 Hz, 1H), 1.38 (d, <i>J</i> = 6.63 Hz, 3H). MS (ESI) <i>m</i>/<i>z</i> 402.2 (M + H)<sup>+</sup>. HRMS calcd for C<sub>19</sub>H<sub>19</sub>N<sub>3</sub>O<sub>5</sub>S 402.1124, found 402.1125.</div></div><div id="sec5_7_30" class="NLM_sec NLM_sec_level_4"><div id="ac_i109" class="anchor-spacer"></div><h5 class="article-section__title" id="_i109"> (3<i>S</i>,3a<i>R</i>,9b<i>R</i>)-2-(Benzo[<i>d</i>][1,3]dioxol-5-ylsulfonyl)-3,5-dimethyl-3,3a,5,9b-tetrahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>][1,6]naphthyridin-4(2<i>H</i>)-one (<b>31</b>) (Absolute Stereochemistry Arbitrarily Assigned)</h5><div class="NLM_p last">Obtained 46 mg, 15.5%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.36–8.40 (m, 2H), 7.25 (dd, <i>J</i> = 1.87, 8.19 Hz, 1H), 7.18 (d, <i>J</i> = 1.66 Hz, 1H), 6.99–7.04 (m, 2H), 6.17 (dd, <i>J</i> = 0.88, 11.77 Hz, 2H), 4.29 (dq, <i>J</i> = 1.71, 6.58 Hz, 1H), 3.90 (td, <i>J</i> = 7.48, 10.13 Hz, 1H), 3.65–3.73 (m, 1H), 3.02 (s, 3H), 2.96 (dd, <i>J</i> = 1.45, 7.26 Hz, 1H), 2.83 (t, <i>J</i> = 10.05 Hz, 1H), 1.38 (d, <i>J</i> = 6.63 Hz, 3H). MS (ESI) <i>m</i>/<i>z</i> 402.2 (M + H)<sup>+</sup>, HRMS calcd for C<sub>19</sub>H<sub>19</sub>N<sub>3</sub>O<sub>5</sub>S 402.1124, found 402.1118.</div></div><div id="sec5_7_31" class="NLM_sec NLM_sec_level_4"><div id="ac_i110" class="anchor-spacer"></div><h5 class="article-section__title" id="_i110"> (3<i>S</i>,3a<i>S</i>,9b<i>S</i>)-2-(Benzo[<i>d</i>][1,3]dioxol-5-ylsulfonyl)-3,5-dimethyl-3,3a,5,9b-tetrahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>][1,6]naphthyridin-4(2<i>H</i>)-one (<b>32</b>)</h5><div class="NLM_p last">Obtained 5 mg, 1.7%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.53 (s, 1H), 8.43 (d, <i>J</i> = 5.49 Hz, 1H), 7.42 (dd, <i>J</i> = 1.87, 8.09 Hz, 1H), 7.39 (d, <i>J</i> = 1.66 Hz, 1H), 7.16 (d, <i>J</i> = 8.19 Hz, 1H), 7.09 (d, <i>J</i> = 5.60 Hz, 1H), 6.21 (s, 2H), 4.08 (dd, <i>J</i> = 1.76, 10.78 Hz, 1H), 3.89–3.99 (m, 1H), 3.69 (t, <i>J</i> = 7.46 Hz, 1H), 3.54 (dd, <i>J</i> = 6.58, 10.83 Hz, 1H), 3.26 (s, 3H), 3.05 (t, <i>J</i> = 9.07 Hz, 1H), 0.84 (d, <i>J</i> = 6.74 Hz, 3H). MS (ESI) <i>m</i>/<i>z</i> 402.2 (M + H)<sup>+</sup>, HRMS calcd for C<sub>19</sub>H<sub>19</sub>N<sub>3</sub>O<sub>5</sub>S 402.1124, found 402.1127.</div></div><div id="sec5_7_32" class="NLM_sec NLM_sec_level_4"><div id="ac_i111" class="anchor-spacer"></div><h5 class="article-section__title" id="_i111"> (3<i>R</i>,3a<i>R</i>,9b<i>R</i>)-2-(Benzo[<i>d</i>][1,3]dioxol-5-ylsulfonyl)-3,5-dimethyl-3,3a,5,9b-tetrahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>][1,6]naphthyridin-4(2<i>H</i>)-one (<b>33</b>)</h5><div class="NLM_p last">Obtained 6 mg, 2%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.53 (s, 1H), 8.43 (d, <i>J</i> = 5.60 Hz, 1H), 7.42 (dd, <i>J</i> = 1.87, 8.09 Hz, 1H), 7.39 (d, <i>J</i> = 1.76 Hz, 1H), 7.16 (d, <i>J</i> = 8.19 Hz, 1H), 7.09 (d, <i>J</i> = 5.70 Hz, 1H), 6.21 (s, 2H), 4.08 (dd, <i>J</i> = 1.87, 10.78 Hz, 1H), 3.94 (qd, <i>J</i> = 6.74, 9.42 Hz, 1H), 3.69 (t, <i>J</i> = 7.31 Hz, 1H), 3.54 (dd, <i>J</i> = 6.58, 10.83 Hz, 1H), 3.26 (s, 3H), 3.05 (t, <i>J</i> = 9.07 Hz, 1H), 0.84 (d, <i>J</i> = 6.74 Hz, 3H). MS (ESI) <i>m</i>/<i>z</i> 402.1 (M + H)<sup>+</sup>. HRMS calcd for C<sub>19</sub>H<sub>19</sub>N<sub>3</sub>O<sub>5</sub>S = 401.44, found 402.1125</div></div></div></div><div id="sec5_7_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i112" class="anchor-spacer"></div><h3 class="article-section__title" id="_i112"> Synthesis of (<i>rac</i>)-<i>cis</i>-<b>52c</b> and (<i>rac</i>)-<i>cis</i>-<b>52d</b> via Improved Route (through Intermediates <b>55</b>, <b>56</b>, <b>57</b>)<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></h3><div class="NLM_p">Chiral separation conditions for <b>54</b>: column, Chiralpak AD-H, 2 cm × 15 cm; modifier and percentage, 35% IPA w/0.2% DEA; flow rate (mL/min), 80; pressure drop (bar), 79; BPR (bar), 100; detection (nm), 257. Sample dissolution: ∼80 mL of 1:1:1 dichloromethane:IPA:MeOH. Test Injections: 0.25 mL (∼9 mg), 0.5 mL (∼18 mg). Then 3 mL ofDEA was added to sample solution to free base. Sample processing: volume (mL), 1; cycle time (min), 6. Desired peak was peak 3.</div><div id="sec5_7_33_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i113" class="anchor-spacer"></div><h4 class="article-section__title" id="_i113"> Peak 1: (3<i>R</i>,3a<i>R</i>,9b<i>R</i>)-3,5-Dimethyl-3,3a,5,9b-tetrahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>][1,6]naphthyridin-4(2<i>H</i>)-one (<b>54</b>-d-Enantiomer of Active Intermediate)</h4><div class="NLM_p last">Obtained 428 mg. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.35 (d, <i>J</i> = 0.62 Hz, 1H), 8.33 (dd, <i>J</i> = 0.88, 5.65 Hz, 1H), 7.02 (d, <i>J</i> = 5.70 Hz, 1H), 3.54–3.65 (m, 2H), 3.43 (dd, <i>J</i> = 7.26, 11.51 Hz, 1H), 3.25 (s, 3H), 3.10–3.21 (m, 2H), 0.74 (d, <i>J</i> = 6.84 Hz, 3H).</div></div><div id="sec5_7_33_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i114" class="anchor-spacer"></div><h4 class="article-section__title" id="_i114"> Peak 2: (3<i>S</i>,3a<i>R</i>,9b<i>R</i>)-3,5-Dimethyl-3,3a,5,9b-tetrahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>][1,6]naphthyridin-4(2<i>H</i>)-one (<b>54</b>-c-Less Active Diastereomer Peak 1 (Enantiomer Arbitrarily Assigned))</h4><div class="NLM_p last">Obtained 304 mg. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.31–8.38 (m, 2H), 7.04 (d, <i>J</i> = 5.60 Hz, 1H), 3.37–3.53 (m, 2H), 3.24 (s, 4H), 2.63 (dd, <i>J</i> = 6.06, 9.90 Hz, 1H), 2.52–2.57 (m, 1H), 1.26 (d, <i>J</i> = 6.43 Hz, 3H).</div></div><div id="sec5_7_33_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i115" class="anchor-spacer"></div><h4 class="article-section__title" id="_i115"> Peak 3: (3<i>S</i>,3a<i>S</i>,9b<i>S</i>)-3,5-Dimethyl-3,3a,5,9b-tetrahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>][1,6]naphthyridin-4(2<i>H</i>)-one (<b>54</b>-d-Active Intermediate)</h4><div class="NLM_p last">Obtained 267 mg. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.35 (d, <i>J</i> = 0.62 Hz, 1H), 8.33 (dd, <i>J</i> = 0.88, 5.65 Hz, 1H), 7.02 (d, <i>J</i> = 5.70 Hz, 1H), 3.54–3.65 (m, 2H), 3.43 (dd, <i>J</i> = 7.26, 11.51 Hz, 1H), 3.25 (s, 3H), 3.10–3.21 (m, 2H), 0.74 (d, <i>J</i> = 6.84 Hz, 3H).</div></div><div id="sec5_7_33_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i116" class="anchor-spacer"></div><h4 class="article-section__title" id="_i116"> Peak 4: (3<i>R</i>,3a<i>S</i>,9b<i>S</i>)-3,5-Dimethyl-3,3a,5,9b-tetrahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>][1,6]naphthyridin-4(2<i>H</i>)-one (<b>54</b>-c-Less Active Diastereomer Peak 2 (Enantiomer Arbitrarily Assigned)</h4><div class="NLM_p">Obtained 298 mg. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.31–8.38 (m, 2H), 7.04 (d, <i>J</i> = 5.60 Hz, 1H), 3.37–3.53 (m, 2H), 3.24 (s, 4H), 2.63 (dd, <i>J</i> = 6.06, 9.90 Hz, 1H), 2.52–2.57 (m, 1H), 1.26 (d, <i>J</i> = 6.43 Hz, 3H).</div><div class="NLM_p last">.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div></div><div id="sec5_7_33_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i117" class="anchor-spacer"></div><h4 class="article-section__title" id="_i117"> (3<i>S</i>,3a<i>S</i>,9b<i>S</i>)-2-(Benzo[<i>d</i>][1,3]dioxol-5-ylsulfonyl)-3,5-dimethyl-3,3a,5,9b-tetrahydro-1<i>H</i>-pyrrolo[3,4-<i>c</i>][1,6]naphthyridin-4(2<i>H</i>)-one (<b>32</b>)</h4><div class="NLM_p last">See Huang et al., ref <a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">27</a>.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i118"><a href="/doi/suppl/10.1021/acs.jmedchem.6b01496">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18655" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18655" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.6b01496" class="ext-link">10.1021/acs.jmedchem.6b01496</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline"><b>26</b>–<b>33</b>, detailed chiral separation conditions; AM-3607, a detailed suite of 1D and 2D NMR data (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01496/suppl_file/jm6b01496_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01496/suppl_file/jm6b01496_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01496/suppl_file/jm6b01496_si_001.pdf">jm6b01496_si_001.pdf (1.62 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01496/suppl_file/jm6b01496_si_002.csv">jm6b01496_si_002.csv (2.45 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.6b01496" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68034" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68034" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Howard Bregman</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Medicinal Chemistry, ‡Neuroscience, §Molecular Engineering, ∥Discovery Attribute
Sciences, ⊥Biologics, and #Pharmacokinetics and Drug Metabolism. Amgen,
Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Neuroscience, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8062-9770" title="Orcid link">http://orcid.org/0000-0001-8062-9770</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#ddb5bfafb8bab0bcb39dbcb0bab8b3f3beb2b0"><span class="__cf_email__" data-cfemail="1d757f6f787a707c735d7c707a7873337e7270">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jeffrey R. Simard</span> - <span class="hlFld-Affiliation affiliation">Department
of Neuroscience, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kristin L. Andrews</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Medicinal Chemistry, ‡Neuroscience, §Molecular Engineering, ∥Discovery Attribute
Sciences, ⊥Biologics, and #Pharmacokinetics and Drug Metabolism. Amgen,
Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Neuroscience, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shawn Ayube</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Medicinal Chemistry, ‡Neuroscience, §Molecular Engineering, ∥Discovery Attribute
Sciences, ⊥Biologics, and #Pharmacokinetics and Drug Metabolism. Amgen,
Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Neuroscience, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hao Chen</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Medicinal Chemistry, ‡Neuroscience, §Molecular Engineering, ∥Discovery Attribute
Sciences, ⊥Biologics, and #Pharmacokinetics and Drug Metabolism. Amgen,
Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Neuroscience, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hakan Gunaydin</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Medicinal Chemistry, ‡Neuroscience, §Molecular Engineering, ∥Discovery Attribute
Sciences, ⊥Biologics, and #Pharmacokinetics and Drug Metabolism. Amgen,
Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Neuroscience, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Angel Guzman-Perez</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Medicinal Chemistry, ‡Neuroscience, §Molecular Engineering, ∥Discovery Attribute
Sciences, ⊥Biologics, and #Pharmacokinetics and Drug Metabolism. Amgen,
Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Neuroscience, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jiali Hu</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Medicinal Chemistry, ‡Neuroscience, §Molecular Engineering, ∥Discovery Attribute
Sciences, ⊥Biologics, and #Pharmacokinetics and Drug Metabolism. Amgen,
Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Neuroscience, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Liyue Huang</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Medicinal Chemistry, ‡Neuroscience, §Molecular Engineering, ∥Discovery Attribute
Sciences, ⊥Biologics, and #Pharmacokinetics and Drug Metabolism. Amgen,
Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Neuroscience, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xin Huang</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Medicinal Chemistry, ‡Neuroscience, §Molecular Engineering, ∥Discovery Attribute
Sciences, ⊥Biologics, and #Pharmacokinetics and Drug Metabolism. Amgen,
Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Neuroscience, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul H. Krolikowski</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Medicinal Chemistry, ‡Neuroscience, §Molecular Engineering, ∥Discovery Attribute
Sciences, ⊥Biologics, and #Pharmacokinetics and Drug Metabolism. Amgen,
Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Neuroscience, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sonya G. Lehto</span> - <span class="hlFld-Affiliation affiliation">Department
of Neuroscience, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Richard T. Lewis</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Medicinal Chemistry, ‡Neuroscience, §Molecular Engineering, ∥Discovery Attribute
Sciences, ⊥Biologics, and #Pharmacokinetics and Drug Metabolism. Amgen,
Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Neuroscience, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Klaus Michelsen</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Medicinal Chemistry, ‡Neuroscience, §Molecular Engineering, ∥Discovery Attribute
Sciences, ⊥Biologics, and #Pharmacokinetics and Drug Metabolism. Amgen,
Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Neuroscience, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pamela Pegman</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Medicinal Chemistry, ‡Neuroscience, §Molecular Engineering, ∥Discovery Attribute
Sciences, ⊥Biologics, and #Pharmacokinetics and Drug Metabolism. Amgen,
Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Neuroscience, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthew H. Plant</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Medicinal Chemistry, ‡Neuroscience, §Molecular Engineering, ∥Discovery Attribute
Sciences, ⊥Biologics, and #Pharmacokinetics and Drug Metabolism. Amgen,
Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Neuroscience, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul L. Shaffer</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Medicinal Chemistry, ‡Neuroscience, §Molecular Engineering, ∥Discovery Attribute
Sciences, ⊥Biologics, and #Pharmacokinetics and Drug Metabolism. Amgen,
Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Neuroscience, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yohannes Teffera</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Medicinal Chemistry, ‡Neuroscience, §Molecular Engineering, ∥Discovery Attribute
Sciences, ⊥Biologics, and #Pharmacokinetics and Drug Metabolism. Amgen,
Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Neuroscience, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shuyan Yi</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Medicinal Chemistry, ‡Neuroscience, §Molecular Engineering, ∥Discovery Attribute
Sciences, ⊥Biologics, and #Pharmacokinetics and Drug Metabolism. Amgen,
Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Neuroscience, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maosheng Zhang</span> - <span class="hlFld-Affiliation affiliation">Department
of Neuroscience, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jacinthe Gingras</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Medicinal Chemistry, ‡Neuroscience, §Molecular Engineering, ∥Discovery Attribute
Sciences, ⊥Biologics, and #Pharmacokinetics and Drug Metabolism. Amgen,
Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Neuroscience, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Erin F. DiMauro</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Medicinal Chemistry, ‡Neuroscience, §Molecular Engineering, ∥Discovery Attribute
Sciences, ⊥Biologics, and #Pharmacokinetics and Drug Metabolism. Amgen,
Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Neuroscience, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>All authors have contributed and have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d104e7386-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i125">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14061" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14061" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank the following people for their contributions: Grace Bi and Larry Miller for chiral resolution and compound purification support, Iain Campuzano for the generation of high-resolution mass spectroscopy data, Stephen Altmann for cell line validation work, Virginia Berry, Loren Berry, and Brett Janosky for PKDM support, Dr. Benjamin C. Milgram for useful chemistry discussions, and Dr. Margaret Chu-Moyer for critical review of the manuscript.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i126" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i126"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i127" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i127"> Abbreviations Used</h2><tr><td class="NLM_term">μW</td><td class="NLM_def"><p class="first last">microwave</p></td></tr><tr><td class="NLM_term">CL</td><td class="NLM_def"><p class="first last">clearance</p></td></tr><tr><td class="NLM_term">CL<sub>int</sub></td><td class="NLM_def"><p class="first last">intrinsic clearance</p></td></tr><tr><td class="NLM_term">PPB</td><td class="NLM_def"><p class="first last">plasma protein binding</p></td></tr><tr><td class="NLM_term">DRG</td><td class="NLM_def"><p class="first last">dorsal root ganglion neuron</p></td></tr><tr><td class="NLM_term">HLM</td><td class="NLM_def"><p class="first last">human liver microsomes</p></td></tr><tr><td class="NLM_term">RLM</td><td class="NLM_def"><p class="first last">rat liver microsomes</p></td></tr><tr><td class="NLM_term">MLM</td><td class="NLM_def"><p class="first last">mouse liver microsomes</p></td></tr><tr><td class="NLM_term">MDR1</td><td class="NLM_def"><p class="first last">multidrug resistance protein 1</p></td></tr><tr><td class="NLM_term">MDCK</td><td class="NLM_def"><p class="first last">Madin–Darby canine kidney</p></td></tr><tr><td class="NLM_term">BCRP</td><td class="NLM_def"><p class="first last">breast cancer resistance protein</p></td></tr><tr><td class="NLM_term"><i>P</i><sub>app</sub></td><td class="NLM_def"><p class="first last">apparent passive permeability</p></td></tr><tr><td class="NLM_term">LE</td><td class="NLM_def"><p class="first last">ligand efficiency</p></td></tr><tr><td class="NLM_term">LipE</td><td class="NLM_def"><p class="first last">lipophilic efficiency</p></td></tr><tr><td class="NLM_term"><i>V</i><sub>d</sub></td><td class="NLM_def"><p class="first last">volume of distribution</p></td></tr><tr><td class="NLM_term">TTX</td><td class="NLM_def"><p class="first last">tetrodotoxin</p></td></tr><tr><td class="NLM_term">CNQX</td><td class="NLM_def"><p class="first last">6-cyano-7-nitroquinoxaline-2,3-dione)</p></td></tr><tr><td class="NLM_term">APV</td><td class="NLM_def"><p class="first last">(2<i>R</i>)-amino-5-phosphonovaleric acid</p></td></tr><tr><td class="NLM_term">AMPA</td><td class="NLM_def"><p class="first last">α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid</p></td></tr><tr><td class="NLM_term">NMDA</td><td class="NLM_def"><p class="first last"><i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartic acid</p></td></tr><tr><td class="NLM_term">GABA</td><td class="NLM_def"><p class="first last">γ-aminobutyric acid</p></td></tr><tr><td class="NLM_term">S<sub>N</sub>Ar</td><td class="NLM_def"><p class="first last">nucleophilic aromatic substitution</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i128">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34001" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34001" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 40 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Dworkin, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audette, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baron, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gourlay, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haanpaa, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kent, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krane, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebel, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levy, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackey, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miaskowski, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raja, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmader, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stacey, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanos, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treede, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turk, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walco, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, C. D.</span><span> </span><span class="NLM_article-title">Recommendations for the pharmacological management of neuropathic pain: an overview and literature update</span> <span class="citation_source-journal">Mayo Clin. Proc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">S3</span><span class="NLM_x">–</span> <span class="NLM_lpage">14</span><span class="refDoi"> DOI: 10.4065/mcp.2009.0649</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=10.4065%2Fmcp.2009.0649" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=20194146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkt1Sjsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2010&pages=S3-14&author=R.+H.+Dworkinauthor=A.+B.+O%E2%80%99Connorauthor=J.+Audetteauthor=R.+Baronauthor=G.+K.+Gourlayauthor=M.+L.+Haanpaaauthor=J.+L.+Kentauthor=E.+J.+Kraneauthor=A.+A.+Lebelauthor=R.+M.+Levyauthor=S.+C.+Mackeyauthor=J.+Mayerauthor=C.+Miaskowskiauthor=S.+N.+Rajaauthor=A.+S.+Riceauthor=K.+E.+Schmaderauthor=B.+Staceyauthor=S.+Stanosauthor=R.+D.+Treedeauthor=D.+C.+Turkauthor=G.+A.+Walcoauthor=C.+D.+Wells&title=Recommendations+for+the+pharmacological+management+of+neuropathic+pain%3A+an+overview+and+literature+update&doi=10.4065%2Fmcp.2009.0649"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Recommendations for the pharmacological management of neuropathic pain: an overview and literature update</span></div><div class="casAuthors">Dworkin, Robert H.; O'Connor, Alec B.; Audette, Joseph; Baron, Ralf; Gourlay, Geoffrey K.; Haanpaa, Maija L.; Kent, Joel L.; Krane, Elliot J.; Lebel, Alyssa A.; Levy, Robert M.; Mackey, Sean C.; Mayer, John; Miaskowski, Christine; Raja, Srinivasa N.; Rice, Andrew S. C.; Schmader, Kenneth E.; Stacey, Brett; Stanos, Steven; Treede, Rolf-Detlef; Turk, Dennis C.; Walco, Gary A.; Wells, Christopher D.</div><div class="citationInfo"><span class="NLM_cas:title">Mayo Clinic Proceedings</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">3, Suppl.</span>),
    <span class="NLM_cas:pages">S3-S14</span>CODEN:
                <span class="NLM_cas:coden">MACPAJ</span>;
        ISSN:<span class="NLM_cas:issn">0025-6196</span>.
    
            (<span class="NLM_cas:orgname">Dowden Health Media, Inc.</span>)
        </div><div class="casAbstract">A review.  The Neuropathic Pain Special Interest Group of the International Assocn. for the Study of Pain recently sponsored the development of evidence-based guidelines for the pharmacol. treatment of neuropathic pain.  Tricyclic antidepressants, dual reuptake inhibitors of serotonin and norepinephrine, calcium channel α2-δ ligands (le, gabapentin and pregabalin), and topical lidocaine were recommended as first-line treatment options on the basis of the results of randomized clin. trials.  Opioid analgesics and tramadol were recommended as second-line treatments that can be considered for first-line use in certain clin. circumstances.  Results of several recent clin. trials have become available since the development of these guidelines.  These studies have examd. botulinum toxin, high-concn. capsaicin patch, lacosamide, selective serotonin reuptake inhibitors, and combination therapies in various neuropathic pain conditions.  The increasing no. of neg. clin. trials of pharmacol. treatments for neuropathic pain and ambiguities in the interpretation of these neg. trials must also be considered in developing treatment guidelines.  The objectives of the current article are to review the Neuropathic Pain Special Interest Group guidelines for the pharmacol. management of neuropathic pain and to provide a brief overview of these recent studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9_qlufOfrkLVg90H21EOLACvtfcHk0lgT7EWLlALACQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkt1Sjsb0%253D&md5=749b581e00c2be99ae45dbf54de0bca3</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.4065%2Fmcp.2009.0649&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4065%252Fmcp.2009.0649%26sid%3Dliteratum%253Aachs%26aulast%3DDworkin%26aufirst%3DR.%2BH.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DA.%2BB.%26aulast%3DAudette%26aufirst%3DJ.%26aulast%3DBaron%26aufirst%3DR.%26aulast%3DGourlay%26aufirst%3DG.%2BK.%26aulast%3DHaanpaa%26aufirst%3DM.%2BL.%26aulast%3DKent%26aufirst%3DJ.%2BL.%26aulast%3DKrane%26aufirst%3DE.%2BJ.%26aulast%3DLebel%26aufirst%3DA.%2BA.%26aulast%3DLevy%26aufirst%3DR.%2BM.%26aulast%3DMackey%26aufirst%3DS.%2BC.%26aulast%3DMayer%26aufirst%3DJ.%26aulast%3DMiaskowski%26aufirst%3DC.%26aulast%3DRaja%26aufirst%3DS.%2BN.%26aulast%3DRice%26aufirst%3DA.%2BS.%26aulast%3DSchmader%26aufirst%3DK.%2BE.%26aulast%3DStacey%26aufirst%3DB.%26aulast%3DStanos%26aufirst%3DS.%26aulast%3DTreede%26aufirst%3DR.%2BD.%26aulast%3DTurk%26aufirst%3DD.%2BC.%26aulast%3DWalco%26aufirst%3DG.%2BA.%26aulast%3DWells%26aufirst%3DC.%2BD.%26atitle%3DRecommendations%2520for%2520the%2520pharmacological%2520management%2520of%2520neuropathic%2520pain%253A%2520an%2520overview%2520and%2520literature%2520update%26jtitle%3DMayo%2520Clin.%2520Proc.%26date%3D2010%26volume%3D85%26spage%3DS3%26epage%3D14%26doi%3D10.4065%2Fmcp.2009.0649" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Mendell, L. M.</span><span> </span><span class="NLM_article-title">Constructing and deconstructing the gate theory of pain</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">155</span><span class="NLM_x">, </span> <span class="NLM_fpage">210</span><span class="NLM_x">–</span> <span class="NLM_lpage">216</span><span class="refDoi"> DOI: 10.1016/j.pain.2013.12.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=10.1016%2Fj.pain.2013.12.010" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=155&publication_year=2014&pages=210-216&author=L.+M.+Mendell&title=Constructing+and+deconstructing+the+gate+theory+of+pain&doi=10.1016%2Fj.pain.2013.12.010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.pain.2013.12.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pain.2013.12.010%26sid%3Dliteratum%253Aachs%26aulast%3DMendell%26aufirst%3DL.%2BM.%26atitle%3DConstructing%2520and%2520deconstructing%2520the%2520gate%2520theory%2520of%2520pain%26jtitle%3DPain%26date%3D2014%26volume%3D155%26spage%3D210%26epage%3D216%26doi%3D10.1016%2Fj.pain.2013.12.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Melzack, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wall, P. D.</span><span> </span><span class="NLM_article-title">Pain mechanisms: a new theory</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1965</span><span class="NLM_x">, </span> <span class="NLM_volume">150</span><span class="NLM_x">, </span> <span class="NLM_fpage">971</span><span class="NLM_x">–</span> <span class="NLM_lpage">979</span><span class="refDoi"> DOI: 10.1126/science.150.3699.971</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=10.1126%2Fscience.150.3699.971" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=150&publication_year=1965&pages=971-979&author=R.+Melzackauthor=P.+D.+Wall&title=Pain+mechanisms%3A+a+new+theory&doi=10.1126%2Fscience.150.3699.971"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1126%2Fscience.150.3699.971&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.150.3699.971%26sid%3Dliteratum%253Aachs%26aulast%3DMelzack%26aufirst%3DR.%26aulast%3DWall%26aufirst%3DP.%2BD.%26atitle%3DPain%2520mechanisms%253A%2520a%2520new%2520theory%26jtitle%3DScience%26date%3D1965%26volume%3D150%26spage%3D971%26epage%3D979%26doi%3D10.1126%2Fscience.150.3699.971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Harvey, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Depner, U. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wassle, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmadi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heindl, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinold, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smart, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvey, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schutz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abo-Salem, O. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poisbeau, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welzl, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfer, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Betz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeilhofer, H. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, U.</span><span> </span><span class="NLM_article-title">GlyR alpha3: an essential target for spinal PGE2-mediated inflammatory pain sensitization</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">304</span><span class="NLM_x">, </span> <span class="NLM_fpage">884</span><span class="NLM_x">–</span> <span class="NLM_lpage">887</span><span class="refDoi"> DOI: 10.1126/science.1094925</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=10.1126%2Fscience.1094925" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=304&publication_year=2004&pages=884-887&author=R.+J.+Harveyauthor=U.+B.+Depnerauthor=H.+Wassleauthor=S.+Ahmadiauthor=C.+Heindlauthor=H.+Reinoldauthor=T.+G.+Smartauthor=K.+Harveyauthor=B.+Schutzauthor=O.+M.+Abo-Salemauthor=A.+Zimmerauthor=P.+Poisbeauauthor=H.+Welzlauthor=D.+P.+Wolferauthor=H.+Betzauthor=H.+U.+Zeilhoferauthor=U.+Muller&title=GlyR+alpha3%3A+an+essential+target+for+spinal+PGE2-mediated+inflammatory+pain+sensitization&doi=10.1126%2Fscience.1094925"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1126%2Fscience.1094925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1094925%26sid%3Dliteratum%253Aachs%26aulast%3DHarvey%26aufirst%3DR.%2BJ.%26aulast%3DDepner%26aufirst%3DU.%2BB.%26aulast%3DWassle%26aufirst%3DH.%26aulast%3DAhmadi%26aufirst%3DS.%26aulast%3DHeindl%26aufirst%3DC.%26aulast%3DReinold%26aufirst%3DH.%26aulast%3DSmart%26aufirst%3DT.%2BG.%26aulast%3DHarvey%26aufirst%3DK.%26aulast%3DSchutz%26aufirst%3DB.%26aulast%3DAbo-Salem%26aufirst%3DO.%2BM.%26aulast%3DZimmer%26aufirst%3DA.%26aulast%3DPoisbeau%26aufirst%3DP.%26aulast%3DWelzl%26aufirst%3DH.%26aulast%3DWolfer%26aufirst%3DD.%2BP.%26aulast%3DBetz%26aufirst%3DH.%26aulast%3DZeilhofer%26aufirst%3DH.%2BU.%26aulast%3DMuller%26aufirst%3DU.%26atitle%3DGlyR%2520alpha3%253A%2520an%2520essential%2520target%2520for%2520spinal%2520PGE2-mediated%2520inflammatory%2520pain%2520sensitization%26jtitle%3DScience%26date%3D2004%26volume%3D304%26spage%3D884%26epage%3D887%26doi%3D10.1126%2Fscience.1094925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Acuna, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yevenes, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ralvenius, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benke, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Lio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lara, C. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgos, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moraga-Cid, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corringer, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeilhofer, H. U.</span><span> </span><span class="NLM_article-title">Phosphorylation state-dependent modulation of spinal glycine receptors alleviates inflammatory pain</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">126</span><span class="NLM_x">, </span> <span class="NLM_fpage">2547</span><span class="NLM_x">–</span> <span class="NLM_lpage">2560</span><span class="refDoi"> DOI: 10.1172/JCI83817</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=10.1172%2FJCI83817" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2016&pages=2547-2560&author=M.+A.+Acunaauthor=G.+E.+Yevenesauthor=W.+T.+Ralveniusauthor=D.+Benkeauthor=A.+Di+Lioauthor=C.+O.+Laraauthor=B.+Munozauthor=C.+F.+Burgosauthor=G.+Moraga-Cidauthor=P.+J.+Corringerauthor=H.+U.+Zeilhofer&title=Phosphorylation+state-dependent+modulation+of+spinal+glycine+receptors+alleviates+inflammatory+pain&doi=10.1172%2FJCI83817"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1172%2FJCI83817&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI83817%26sid%3Dliteratum%253Aachs%26aulast%3DAcuna%26aufirst%3DM.%2BA.%26aulast%3DYevenes%26aufirst%3DG.%2BE.%26aulast%3DRalvenius%26aufirst%3DW.%2BT.%26aulast%3DBenke%26aufirst%3DD.%26aulast%3DDi%2BLio%26aufirst%3DA.%26aulast%3DLara%26aufirst%3DC.%2BO.%26aulast%3DMunoz%26aufirst%3DB.%26aulast%3DBurgos%26aufirst%3DC.%2BF.%26aulast%3DMoraga-Cid%26aufirst%3DG.%26aulast%3DCorringer%26aufirst%3DP.%2BJ.%26aulast%3DZeilhofer%26aufirst%3DH.%2BU.%26atitle%3DPhosphorylation%2520state-dependent%2520modulation%2520of%2520spinal%2520glycine%2520receptors%2520alleviates%2520inflammatory%2520pain%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2016%26volume%3D126%26spage%3D2547%26epage%3D2560%26doi%3D10.1172%2FJCI83817" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Baba, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doubell, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woolf, C. J.</span><span> </span><span class="NLM_article-title">Peripheral inflammation facilitates Abeta fiber-mediated synaptic input to the substantia gelatinosa of the adult rat spinal cord</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">859</span><span class="NLM_x">–</span> <span class="NLM_lpage">867</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=10.1523%2FJNEUROSCI.19-02-00859.1999" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=9880605" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=1%3ACAS%3A528%3ADyaK1MXltlaltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1999&pages=859-867&author=H.+Babaauthor=T.+P.+Doubellauthor=C.+J.+Woolf&title=Peripheral+inflammation+facilitates+Abeta+fiber-mediated+synaptic+input+to+the+substantia+gelatinosa+of+the+adult+rat+spinal+cord"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Peripheral inflammation facilitates Aβ fiber-mediated synaptic input to the substantia gelatinosa of the adult rat spinal cord</span></div><div class="casAuthors">Baba, Hiroshi; Doubell, Timothy P.; Woolf, Clifford J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">859-867</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Whole-cell patch-clamp recordings were made from substantia gelatinosa (SG) neurons in thick adult rat transverse spinal cord slices with attached dorsal roots to study changes in fast synaptic transmission induced by peripheral inflammation.  In slices from naive rats, primary afferent stimulation at Aβ fiber intensity elicited polysynaptic EPSCs in only 14 of 57 (25%) SG neurons.  In contrast, Aβ fiber stimulation evoked polysynaptic EPSCs in 39 of 62 (63%) SG neurons recorded in slices from rats inflamed by an intraplantar injection of complete Freund's adjuvant (CFA) 48 h earlier (p < 0.001).  Although the peripheral inflammation had no significant effect on the threshold and conduction velocities of Aβ, Aδ, and C fibers recorded in dorsal roots, the mean threshold intensity for eliciting EPSCs was significantly lower in cells recorded from rats with inflammation (naive: 33.2 ± 15.1 μA, n = 57; inflamed: 22.8 ± 11.3 μA, n = 62, p < 0.001), and the mean latency of EPSCs elicited by Aβ fiber stimulation in CFA-treated rats was significantly shorter than that recorded from naive rats (3.3 ± 1.8 ms, n = 36 vs 6.0 ± 3.5 ms, n = 12; p = 0.010).  Aβ fiber stimulation evoked polysynaptic IPSCs in 4 of 25 (16%) cells recorded from naive rat prepns. and 14 of 26 (54%) SG neurons from CFA-treated rats (p < 0.001).  The mean threshold intensity for IPSCs was also significantly lower in CFA-treated rats (naive: 32.5 ± 15.7 μA, n = 25; inflamed: 21.9 ± 9.9 μA, n = 26, p = 0.013).  The facilitation of Aβ fiber-mediated input into the substantia gelatinosa after peripheral inflammation may contribute to altered sensory processing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrK6Y7ZjY5FarVg90H21EOLACvtfcHk0lgkzXlEMBPfMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXltlaltw%253D%253D&md5=8345437edc407e9bb800b39eba332cc4</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.19-02-00859.1999&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.19-02-00859.1999%26sid%3Dliteratum%253Aachs%26aulast%3DBaba%26aufirst%3DH.%26aulast%3DDoubell%26aufirst%3DT.%2BP.%26aulast%3DWoolf%26aufirst%3DC.%2BJ.%26atitle%3DPeripheral%2520inflammation%2520facilitates%2520Abeta%2520fiber-mediated%2520synaptic%2520input%2520to%2520the%2520substantia%2520gelatinosa%2520of%2520the%2520adult%2520rat%2520spinal%2520cord%26jtitle%3DJ.%2520Neurosci.%26date%3D1999%26volume%3D19%26spage%3D859%26epage%3D867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Ahmadi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippross, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neuhuber, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeilhofer, H. U.</span><span> </span><span class="NLM_article-title">PGE(2) selectively blocks inhibitory glycinergic neurotransmission onto rat superficial dorsal horn neurons</span> <span class="citation_source-journal">Nat. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">34</span><span class="NLM_x">–</span> <span class="NLM_lpage">40</span><span class="refDoi"> DOI: 10.1038/nn778</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=10.1038%2Fnn778" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=11740501" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=1%3ACAS%3A528%3ADC%252BD38XjtlCquw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2002&pages=34-40&author=S.+Ahmadiauthor=S.+Lipprossauthor=W.+L.+Neuhuberauthor=H.+U.+Zeilhofer&title=PGE%282%29+selectively+blocks+inhibitory+glycinergic+neurotransmission+onto+rat+superficial+dorsal+horn+neurons&doi=10.1038%2Fnn778"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">PGE2 selectively blocks inhibitory glycinergic neurotransmission onto rat superficial dorsal horn neurons</span></div><div class="casAuthors">Ahmadi, Seifollah; Lippross, Sebastian; Neuhuber, Winfried L.; Zeilhofer, Hanns Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">34-40</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">Despite the crucial role that prostaglandins (PGs) have in the sensitization of the central nervous system to pain, their cellular and mol. targets leading to increased pain perception have remained elusive.  Here the authors investigated the effects of PGE2 on fast synaptic transmission onto neurons in the rat spinal cord dorsal horn, the first site of synaptic integration in the pain pathway.  The authors identified the inhibitory (strychnine-sensitive) glycine receptor as a specific target of PGE2.  PGE2, but not PGF2α, PGD2 or PGI2, reduced inhibitory glycinergic synaptic transmission in low nanomolar concns., whereas GABAA, AMPA and NMDA receptor-mediated transmission remained unaffected.  Inhibition of glycine receptors occurred via a postsynaptic mechanism involving the activation of EP2 receptors, cholera-toxin-sensitive G-proteins and cAMP-dependent protein kinase.  Via this mechanism, PGE2 may facilitate the transmission of nociceptive input through the spinal cord dorsal horn to higher brain areas where pain becomes conscious.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTxxP_OKhkq7Vg90H21EOLACvtfcHk0lhBqn7VT5pSEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjtlCquw%253D%253D&md5=f69dfe113f56412ace02511f8949187a</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnn778&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn778%26sid%3Dliteratum%253Aachs%26aulast%3DAhmadi%26aufirst%3DS.%26aulast%3DLippross%26aufirst%3DS.%26aulast%3DNeuhuber%26aufirst%3DW.%2BL.%26aulast%3DZeilhofer%26aufirst%3DH.%2BU.%26atitle%3DPGE%25282%2529%2520selectively%2520blocks%2520inhibitory%2520glycinergic%2520neurotransmission%2520onto%2520rat%2520superficial%2520dorsal%2520horn%2520neurons%26jtitle%3DNat.%2520Neurosci.%26date%3D2002%26volume%3D5%26spage%3D34%26epage%3D40%26doi%3D10.1038%2Fnn778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Yevenes, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeilhofer, H. U.</span><span> </span><span class="NLM_article-title">Allosteric modulation of glycine receptors</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">164</span><span class="NLM_x">, </span> <span class="NLM_fpage">224</span><span class="NLM_x">–</span> <span class="NLM_lpage">236</span><span class="refDoi"> DOI: 10.1111/j.1476-5381.2011.01471.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=10.1111%2Fj.1476-5381.2011.01471.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=21557733" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFWqsLnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=164&publication_year=2011&pages=224-236&author=G.+E.+Yevenesauthor=H.+U.+Zeilhofer&title=Allosteric+modulation+of+glycine+receptors&doi=10.1111%2Fj.1476-5381.2011.01471.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric modulation of glycine receptors</span></div><div class="casAuthors">Yevenes, Gonzalo E.; Zeilhofer, Hanns Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">164</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">224-236</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Inhibitory (or strychnine sensitive) glycine receptors (GlyRs) are anion-selective transmitter-gated ion channels of the cys-loop superfamily, which includes among others also the inhibitory γ-aminobutyric acid receptors (GABAA receptors).  While GABA mediates fast inhibitory neurotransmission throughout the CNS, the action of glycine as a fast inhibitory neurotransmitter is more restricted.  This probably explains why GABAA receptors constitute a group of extremely successful drug targets in the treatment of a wide variety of CNS diseases, including anxiety, sleep disorders and epilepsy, while drugs specifically targeting GlyRs are virtually lacking.  However, the spatially more restricted distribution of glycinergic inhibition may be advantageous in situations when a more localized enhancement of inhibition is sought.  Inhibitory GlyRs are particularly relevant for the control of excitability in the mammalian spinal cord, brain stem and a few selected brain areas, such as the cerebellum and the retina.  At these sites, GlyRs regulate important physiol. functions, including respiratory rhythms, motor control, muscle tone and sensory as well as pain processing.  In the hippocampus, RNA-edited high affinity extrasynaptic GlyRs may contribute to the pathol. of temporal lobe epilepsy.  Although specific modulators have not yet been identified, GlyRs still possess sites for allosteric modulation by a no. of structurally diverse mols., including alcs., neurosteroids, cannabinoids, tropeines, general anesthetics, certain neurotransmitters and cations.  This review summarizes the present knowledge about this modulation and the mol. bases of the interactions involved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6eJFQAejcz7Vg90H21EOLACvtfcHk0lhBqn7VT5pSEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFWqsLnI&md5=914d17340c9b2db2306f100e57374654</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2011.01471.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2011.01471.x%26sid%3Dliteratum%253Aachs%26aulast%3DYevenes%26aufirst%3DG.%2BE.%26aulast%3DZeilhofer%26aufirst%3DH.%2BU.%26atitle%3DAllosteric%2520modulation%2520of%2520glycine%2520receptors%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2011%26volume%3D164%26spage%3D224%26epage%3D236%26doi%3D10.1111%2Fj.1476-5381.2011.01471.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Xiong, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godlewski, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span> </span><span class="NLM_article-title">Cannabinoid potentiation of glycine receptors contributes to cannabis-induced analgesia</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">296</span><span class="NLM_x">–</span> <span class="NLM_lpage">303</span><span class="refDoi"> DOI: 10.1038/nchembio.552</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=10.1038%2Fnchembio.552" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=21460829" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFahsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=296-303&author=W.+Xiongauthor=K.+Chengauthor=T.+Cuiauthor=G.+Godlewskiauthor=K.+C.+Riceauthor=Y.+Xuauthor=L.+Zhang&title=Cannabinoid+potentiation+of+glycine+receptors+contributes+to+cannabis-induced+analgesia&doi=10.1038%2Fnchembio.552"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Cannabinoid potentiation of glycine receptors contributes to cannabis-induced analgesia</span></div><div class="casAuthors">Xiong, Wei; Cheng, Ke-Jun; Cui, Tan-Xing; Godlewski, Grzegorz; Rice, Kenner C.; Xu, Yan; Zhang, Li</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">296-303</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Cannabinoids enhance the function of glycine receptors (GlyRs).  However, little is known about the mechanisms and behavioral implication of cannabinoid-GlyR interaction.  Using mutagenesis and NMR anal., we have identified a serine at 296 in the GlyR protein crit. for the potentiation of IGly by Δ9-tetrahydrocannabinol (THC), a major psychoactive component of marijuana.  The polarity of the amino acid residue at 296 and the hydroxyl groups of THC are crit. for THC potentiation.  Removal of the hydroxyl groups of THC results in a compd. that does not affect IGly when applied alone but selectively antagonizes cannabinoid-induced potentiating effect on IGly and analgesic effect in a tail-flick test in mice.  The cannabinoid-induced analgesia is absent in mice lacking α3GlyRs but not in those lacking CB1 and CB2 receptors.  These findings reveal a new mechanism underlying cannabinoid potentiation of GlyRs, which could contribute to some of the cannabis-induced analgesic and therapeutic effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXXYUIGOW5aLVg90H21EOLACvtfcHk0lhBqn7VT5pSEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFahsb8%253D&md5=d876adbbb4cf5b88302b7a15b430a30c</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.552&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.552%26sid%3Dliteratum%253Aachs%26aulast%3DXiong%26aufirst%3DW.%26aulast%3DCheng%26aufirst%3DK.%26aulast%3DCui%26aufirst%3DT.%26aulast%3DGodlewski%26aufirst%3DG.%26aulast%3DRice%26aufirst%3DK.%2BC.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DL.%26atitle%3DCannabinoid%2520potentiation%2520of%2520glycine%2520receptors%2520contributes%2520to%2520cannabis-induced%2520analgesia%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2011%26volume%3D7%26spage%3D296%26epage%3D303%26doi%3D10.1038%2Fnchembio.552" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Xiong, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willenbring, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span> </span><span class="NLM_article-title">Cannabinoids suppress inflammatory and neuropathic pain by targeting alpha3 glycine receptors</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">209</span><span class="NLM_x">, </span> <span class="NLM_fpage">1121</span><span class="NLM_x">–</span> <span class="NLM_lpage">1134</span><span class="refDoi"> DOI: 10.1084/jem.20120242</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=10.1084%2Fjem.20120242" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=22585736" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=1%3ACAS%3A528%3ADC%252BC38XoslSiu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=209&publication_year=2012&pages=1121-1134&author=W.+Xiongauthor=T.+Cuiauthor=K.+Chengauthor=F.+Yangauthor=S.+R.+Chenauthor=D.+Willenbringauthor=Y.+Guanauthor=H.+L.+Panauthor=K.+Renauthor=Y.+Xuauthor=L.+Zhang&title=Cannabinoids+suppress+inflammatory+and+neuropathic+pain+by+targeting+alpha3+glycine+receptors&doi=10.1084%2Fjem.20120242"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors</span></div><div class="casAuthors">Xiong, Wei; Cui, Tanxing; Cheng, Kejun; Yang, Fei; Chen, Shao-Rui; Willenbring, Dan; Guan, Yun; Pan, Hui-Lin; Ren, Ke; Xu, Yan; Zhang, Li</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">209</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1121-1134</span>CODEN:
                <span class="NLM_cas:coden">JEMEAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-1007</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Certain types of nonpsychoactive cannabinoids can potentiate glycine receptors (GlyRs), an important target for nociceptive regulation at the spinal level.  However, little is known about the potential and mechanism of glycinergic cannabinoids for chronic pain treatment.  We report that systemic and intrathecal administration of cannabidiol (CBD), a major nonpsychoactive component of marijuana, and its modified derivs. significantly suppress chronic inflammatory and neuropathic pain without causing apparent analgesic tolerance in rodents.  The cannabinoids significantly potentiate glycine currents in dorsal horn neurons in rat spinal cord slices.  The analgesic potency of 11 structurally similar cannabinoids is pos. correlated with cannabinoid potentiation of the α3 GlyRs.  In contrast, the cannabinoid analgesia is neither correlated with their binding affinity for CB1 and CB2 receptors nor with their psychoactive side effects.  NMR anal. reveals a direct interaction between CBD and S296 in the third transmembrane domain of purified α3 GlyR.  The cannabinoid-induced analgesic effect is absent in mice lacking the α3 GlyRs.  Our findings suggest that the α3 GlyRs mediate glycinergic cannabinoid-induced suppression of chronic pain.  These cannabinoids may represent a novel class of therapeutic agents for the treatment of chronic pain and other diseases involving GlyR dysfunction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEOC_gcxFbX7Vg90H21EOLACvtfcHk0lguVgF1BQLgbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XoslSiu7s%253D&md5=5544bf3edd1c484c04a1ae0c8980ec4a</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1084%2Fjem.20120242&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20120242%26sid%3Dliteratum%253Aachs%26aulast%3DXiong%26aufirst%3DW.%26aulast%3DCui%26aufirst%3DT.%26aulast%3DCheng%26aufirst%3DK.%26aulast%3DYang%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DS.%2BR.%26aulast%3DWillenbring%26aufirst%3DD.%26aulast%3DGuan%26aufirst%3DY.%26aulast%3DPan%26aufirst%3DH.%2BL.%26aulast%3DRen%26aufirst%3DK.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DL.%26atitle%3DCannabinoids%2520suppress%2520inflammatory%2520and%2520neuropathic%2520pain%2520by%2520targeting%2520alpha3%2520glycine%2520receptors%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2012%26volume%3D209%26spage%3D1121%26epage%3D1134%26doi%3D10.1084%2Fjem.20120242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Yevenes, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeilhofer, H. U.</span><span> </span><span class="NLM_article-title">Molecular sites for the positive allosteric modulation of glycine receptors by endocannabinoids</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">e23886</span><span class="refDoi"> DOI: 10.1371/journal.pone.0023886</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=10.1371%2Fjournal.pone.0023886" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=e23886&author=G.+E.+Yevenesauthor=H.+U.+Zeilhofer&title=Molecular+sites+for+the+positive+allosteric+modulation+of+glycine+receptors+by+endocannabinoids&doi=10.1371%2Fjournal.pone.0023886"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0023886&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0023886%26sid%3Dliteratum%253Aachs%26aulast%3DYevenes%26aufirst%3DG.%2BE.%26aulast%3DZeilhofer%26aufirst%3DH.%2BU.%26atitle%3DMolecular%2520sites%2520for%2520the%2520positive%2520allosteric%2520modulation%2520of%2520glycine%2520receptors%2520by%2520endocannabinoids%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26spage%3De23886%26doi%3D10.1371%2Fjournal.pone.0023886" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Zhang, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y. X.</span><span> </span><span class="NLM_article-title">Gelsemine, a principal alkaloid from Gelsemium sempervirens Ait., exhibits potent and specific antinociception in chronic pain by acting at spinal alpha3 glycine receptors</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">154</span><span class="NLM_x">, </span> <span class="NLM_fpage">2452</span><span class="NLM_x">–</span> <span class="NLM_lpage">2462</span><span class="refDoi"> DOI: 10.1016/j.pain.2013.07.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=10.1016%2Fj.pain.2013.07.027" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=154&publication_year=2013&pages=2452-2462&author=J.+Y.+Zhangauthor=N.+Gongauthor=J.+L.+Huangauthor=L.+C.+Guoauthor=Y.+X.+Wang&title=Gelsemine%2C+a+principal+alkaloid+from+Gelsemium+sempervirens+Ait.%2C+exhibits+potent+and+specific+antinociception+in+chronic+pain+by+acting+at+spinal+alpha3+glycine+receptors&doi=10.1016%2Fj.pain.2013.07.027"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.pain.2013.07.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pain.2013.07.027%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%2BY.%26aulast%3DGong%26aufirst%3DN.%26aulast%3DHuang%26aufirst%3DJ.%2BL.%26aulast%3DGuo%26aufirst%3DL.%2BC.%26aulast%3DWang%26aufirst%3DY.%2BX.%26atitle%3DGelsemine%252C%2520a%2520principal%2520alkaloid%2520from%2520Gelsemium%2520sempervirens%2520Ait.%252C%2520exhibits%2520potent%2520and%2520specific%2520antinociception%2520in%2520chronic%2520pain%2520by%2520acting%2520at%2520spinal%2520alpha3%2520glycine%2520receptors%26jtitle%3DPain%26date%3D2013%26volume%3D154%26spage%3D2452%26epage%3D2462%26doi%3D10.1016%2Fj.pain.2013.07.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Lara, C. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murath, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marileo, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">San Martin, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgos, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mariqueo, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguayo, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuentealba, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godoy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yevenes, G. E.</span><span> </span><span class="NLM_article-title">Functional modulation of glycine receptors by the alkaloid gelsemine</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">173</span><span class="NLM_x">, </span> <span class="NLM_fpage">2263</span><span class="NLM_x">–</span> <span class="NLM_lpage">2277</span><span class="refDoi"> DOI: 10.1111/bph.13507</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=10.1111%2Fbph.13507" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=27128379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=1%3ACAS%3A528%3ADC%252BC28XptFWgtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=173&publication_year=2016&pages=2263-2277&author=C.+O.+Laraauthor=P.+Murathauthor=B.+Munozauthor=A.+M.+Marileoauthor=L.+S.+Martinauthor=V.+P.+San+Martinauthor=C.+F.+Burgosauthor=T.+A.+Mariqueoauthor=L.+G.+Aguayoauthor=J.+Fuentealbaauthor=P.+Godoyauthor=L.+Guzmanauthor=G.+E.+Yevenes&title=Functional+modulation+of+glycine+receptors+by+the+alkaloid+gelsemine&doi=10.1111%2Fbph.13507"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Functional modulation of glycine receptors by the alkaloid gelsemine</span></div><div class="casAuthors">Lara, Cesar O.; Murath, Pablo; Munoz, Braulio; Marileo, Ana M.; San Martin, Loreto; San Martin, Victoria P.; Burgos, Carlos F.; Mariqueo, Trinidad A.; Aguayo, Luis G.; Fuentealba, Jorge; Godoy, Patricio; Guzman, Leonardo; Yevenes, Gonzalo E.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">173</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2263-2277</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose : Gelsemine is one of the principal alkaloids produced by the Gelsemium genus of plants belonging to the Loganiaceae family.  The exts. of these plants have been used for many years, for a variety of medicinal purposes.  Coincidentally, recent studies have shown that gelsemine exerts anxiolytic and analgesic effects on behavioral models.  Several lines of evidence have suggested that these beneficial actions were dependent on glycine receptors, which are inhibitory neurotransmitter-gated ion channels of the CNS.  However, it is currently unknown whether gelsemine can directly modulate the function of glycine receptors.  Exptl. Approach : We examd. the functional effects of gelsemine on glycine receptors expressed in transfected HEK293 cells and in cultured spinal neurons by electrophysiol. techniques.  Key Results : Gelsemine directly modulated recombinant and native glycine receptors and exerted conformation-specific and subunit-selective effects.  Gelsemine modulation was voltage-independent and was assocd. with differential changes in the apparent affinity for glycine and in the open probability of the ion channel.  In addn., the alkaloid preferentially targeted glycine receptors in spinal neurons and showed only minor effects on GABAA and AMPA receptors.  Furthermore, gelsemine significantly diminished the frequency of glycinergic and glutamatergic synaptic events without altering the amplitude.  Conclusions and Implications : Our results provide a pharmacol. basis to explain, at least in part, the glycine receptor-dependent, beneficial and toxic effects of gelsemine in animals and humans.  In addn., the pharmacol. profile of gelsemine may open new approaches to the development of subunit-selective modulators of glycine receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYJ1piJL_OibVg90H21EOLACvtfcHk0lguVgF1BQLgbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XptFWgtbY%253D&md5=89c5e3b2346ee99b92565cc129dd24be</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1111%2Fbph.13507&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.13507%26sid%3Dliteratum%253Aachs%26aulast%3DLara%26aufirst%3DC.%2BO.%26aulast%3DMurath%26aufirst%3DP.%26aulast%3DMunoz%26aufirst%3DB.%26aulast%3DMarileo%26aufirst%3DA.%2BM.%26aulast%3DMartin%26aufirst%3DL.%2BS.%26aulast%3DSan%2BMartin%26aufirst%3DV.%2BP.%26aulast%3DBurgos%26aufirst%3DC.%2BF.%26aulast%3DMariqueo%26aufirst%3DT.%2BA.%26aulast%3DAguayo%26aufirst%3DL.%2BG.%26aulast%3DFuentealba%26aufirst%3DJ.%26aulast%3DGodoy%26aufirst%3DP.%26aulast%3DGuzman%26aufirst%3DL.%26aulast%3DYevenes%26aufirst%3DG.%2BE.%26atitle%3DFunctional%2520modulation%2520of%2520glycine%2520receptors%2520by%2520the%2520alkaloid%2520gelsemine%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2016%26volume%3D173%26spage%3D2263%26epage%3D2277%26doi%3D10.1111%2Fbph.13507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Breitinger, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sticht, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breitinger, H. G.</span><span> </span><span class="NLM_article-title">Modulation of recombinant human alpha1 glycine receptors by mono- and disaccharides: a kinetic study</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1077</span><span class="NLM_x">–</span> <span class="NLM_lpage">1087</span><span class="refDoi"> DOI: 10.1021/acschemneuro.6b00044</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.6b00044" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=1%3ACAS%3A528%3ADC%252BC28XosFyksb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=1077-1087&author=U.+Breitingerauthor=H.+Stichtauthor=H.+G.+Breitinger&title=Modulation+of+recombinant+human+alpha1+glycine+receptors+by+mono-+and+disaccharides%3A+a+kinetic+study&doi=10.1021%2Facschemneuro.6b00044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of Recombinant Human α1 Glycine Receptors by Mono- and Disaccharides: A Kinetic Study</span></div><div class="casAuthors">Breitinger, Ulrike; Sticht, Heinrich; Breitinger, Hans-Georg</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1077-1087</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Glycine receptors (GlyRs) mediate fast synaptic inhibition in spinal cord, brainstem, and higher brain centers.  Recently, glucose was identified as a pos. modulator of GlyR-mediated currents.  Here, we investigated extent and kinetics of the pos. modulation of recombinant human α1 glycine receptors by different mono- and disaccharides and sorbitol using patch-clamp recording techniques.  Glucose and fructose augmented glycine-mediated whole-cell currents with an EC50 of 6-7 mM.  At concns. > 10 mM, the max. of current enhancement was reached within ∼30 min.  Kinetics of GlyR modulation resemble those of protein glycation.  On-rates were <0.5 h for satg. concns. of monosaccharides and ∼1.5 h for disaccharides.  Off-rates were considerably slower (>24 h).  Galactose, the C4-epimer of glucose, and the sugar alc. sorbitol had no effect on GlyR currents.  Recent cryoelectron microscopy structures were used to identify a potential binding site for saccharides near the ivermectin binding pocket with lysine 143 as possible attachment site.  The GlyR mutant α1(K143A) was not potentiated by glucose, suggesting an involvement of this residue in glycine receptor modulation by saccharides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0uDD48vAjrbVg90H21EOLACvtfcHk0lijtb7zJIMiJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XosFyksb0%253D&md5=dd2525255bcf13de4e5a25b0a1cd4e77</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.6b00044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.6b00044%26sid%3Dliteratum%253Aachs%26aulast%3DBreitinger%26aufirst%3DU.%26aulast%3DSticht%26aufirst%3DH.%26aulast%3DBreitinger%26aufirst%3DH.%2BG.%26atitle%3DModulation%2520of%2520recombinant%2520human%2520alpha1%2520glycine%2520receptors%2520by%2520mono-%2520and%2520disaccharides%253A%2520a%2520kinetic%2520study%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2016%26volume%3D7%26spage%3D1077%26epage%3D1087%26doi%3D10.1021%2Facschemneuro.6b00044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Maleeva, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buldakova, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bregestovski, P.</span><span> </span><span class="NLM_article-title">Selective potentiation of alpha 1 glycine receptors by ginkgolic acid</span> <span class="citation_source-journal">Front. Mol. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">64</span><span class="refDoi"> DOI: 10.3389/fnmol.2015.00064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=10.3389%2Ffnmol.2015.00064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=26578878" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=1%3ACAS%3A528%3ADC%252BC1cXlvVCrsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2015&pages=64&author=G.+Maleevaauthor=S.+Buldakovaauthor=P.+Bregestovski&title=Selective+potentiation+of+alpha+1+glycine+receptors+by+ginkgolic+acid&doi=10.3389%2Ffnmol.2015.00064"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Selective potentiation of alpha 1 glycine receptors by ginkgolic acid</span></div><div class="casAuthors">Maleeva, Galyna; Buldakova, Svetlana; Bregestovski, Piotr</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Molecular Neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">64/1-64/11</span>CODEN:
                <span class="NLM_cas:coden">FMNRAJ</span>;
        ISSN:<span class="NLM_cas:issn">1662-5099</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Glycine receptors (GlyRs) belong to the superfamily of pentameric cys-loop receptor-operated channels and are involved in numerous physiol. functions, including movement, vision, and pain.  In search for compds. performing subunit-specific modulation of GlyRs we studied action of ginkgolic acid, an abundant Ginkgo biloba product.  Using patch-clamp recordings, we analyzed the effects of ginkgolic acid in concns. from 30 nM to 25 μM on α1-α3 and α1/β, α2/β configurations of GlyR and on GABAARs expressed in cultured CHO-K1 cells and mouse neuroblastoma (N2a) cells.  Ginkgolic acid caused an increase in the amplitude of currents mediated by homomeric α1 and heteromeric α1/β GlyRs and provoked a left-shift of the concn.-dependent curves for glycine.  Even at high concns. (10-25 μM) ginkgolic acid was not able to augment ionic currents mediated by α2, α2/β, and α3 GlyRs, or by GABAAR consisting of α1/β2/γ2 subunits.  Mutation of three residues (T59A/A261G/A303S) in the α2 GlyR subunit to the corresponding ones from the α1 converted the action of ginkgolic acid to potentiation with a distinct decrease in EC50 for glycine, suggesting an important role for these residues in modulation by ginkgolic acid.  Our results suggest that ginkgolic acid is a novel selective enhancer of α1 GlyRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1m_PGwOzR0rVg90H21EOLACvtfcHk0lijtb7zJIMiJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXlvVCrsrc%253D&md5=b8880c5344c55676e05516e338762d05</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.3389%2Ffnmol.2015.00064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnmol.2015.00064%26sid%3Dliteratum%253Aachs%26aulast%3DMaleeva%26aufirst%3DG.%26aulast%3DBuldakova%26aufirst%3DS.%26aulast%3DBregestovski%26aufirst%3DP.%26atitle%3DSelective%2520potentiation%2520of%2520alpha%25201%2520glycine%2520receptors%2520by%2520ginkgolic%2520acid%26jtitle%3DFront.%2520Mol.%2520Neurosci.%26date%3D2015%26volume%3D8%26spage%3D64%26doi%3D10.3389%2Ffnmol.2015.00064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Stead, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nickolls, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kammonen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pryde, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cawkill, D.</span><span> </span><span class="NLM_article-title">Identification of positive allosteric modulators of glycine receptors from a high-throughput screen using a fluorescent membrane potential assay</span> <span class="citation_source-journal">J. Biomol. Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1042</span><span class="NLM_x">–</span> <span class="NLM_lpage">1053</span><span class="refDoi"> DOI: 10.1177/1087057116657779</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=10.1177%2F1087057116657779" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=27412533" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=1%3ACAS%3A280%3ADC%252BC2s3gsFGjtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=1042-1053&author=C.+Steadauthor=A.+Brownauthor=C.+Adamsauthor=S.+J.+Nickollsauthor=G.+Youngauthor=J.+Kammonenauthor=D.+Prydeauthor=D.+Cawkill&title=Identification+of+positive+allosteric+modulators+of+glycine+receptors+from+a+high-throughput+screen+using+a+fluorescent+membrane+potential+assay&doi=10.1177%2F1087057116657779"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Positive Allosteric Modulators of Glycine Receptors from a High-Throughput Screen Using a Fluorescent Membrane Potential Assay</span></div><div class="casAuthors">Stead Clara; Brown Adam; Adams Cathryn; Nickolls Sarah J; Young Gareth; Kammonen Juha; Pryde David; Cawkill Darren</div><div class="citationInfo"><span class="NLM_cas:title">Journal of biomolecular screening</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1042-1053</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Glycine receptor 3 (GlyRα3) is a ligand-gated ion channel of the cys-loop family that plays a key role in mediating inhibitory neurotransmission and regulation of pain signaling in the dorsal horn.  Potentiation of GlyRα3 function is therefore of interest as a putative analgesic mechanism with which to target new therapeutics.  However, to date, positive allosteric modulators (PAMs) of this receptor with sufficient selectivity to enable target validation studies have not been described.  To address this lack of pharmacological tools, we developed a suite of in vitro assays comprising a high-throughput fluorescent membrane potential screen and a medium-throughput electrophysiology assay using IonFlux HT together with conventional manual patch clamp.  Using these assays, we conducted a primary screening campaign and report the structures of hit compounds identified as GlyR PAMs.  Our functional characterization data reveal a hit compound with high efficacy relative to current known potentiators and selectivity over GABAAR, another major class of inhibitory neurotransmission receptors of importance to pain.  These small-molecule GlyR PAMs have high potential both as early tool compounds to enable pharmacological studies of GlyR inhibitory neurotransmission and as a starting point for the development of potent, selective GlyRα3 PAMs as novel analgesics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS_9S5PmMQ5VD0O18WR3iAofW6udTcc2eaYZgCzEJK2vrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s3gsFGjtg%253D%253D&md5=4cd7f034e2cdb59bb4d156c92e5b9ed0</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1177%2F1087057116657779&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057116657779%26sid%3Dliteratum%253Aachs%26aulast%3DStead%26aufirst%3DC.%26aulast%3DBrown%26aufirst%3DA.%26aulast%3DAdams%26aufirst%3DC.%26aulast%3DNickolls%26aufirst%3DS.%2BJ.%26aulast%3DYoung%26aufirst%3DG.%26aulast%3DKammonen%26aufirst%3DJ.%26aulast%3DPryde%26aufirst%3DD.%26aulast%3DCawkill%26aufirst%3DD.%26atitle%3DIdentification%2520of%2520positive%2520allosteric%2520modulators%2520of%2520glycine%2520receptors%2520from%2520a%2520high-throughput%2520screen%2520using%2520a%2520fluorescent%2520membrane%2520potential%2520assay%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2016%26volume%3D21%26spage%3D1042%26epage%3D1053%26doi%3D10.1177%2F1087057116657779" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Rajendra, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schofield, P. R.</span><span> </span><span class="NLM_article-title">The glycine receptor</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">121</span><span class="NLM_x">–</span> <span class="NLM_lpage">146</span><span class="refDoi"> DOI: 10.1016/S0163-7258(96)00163-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=10.1016%2FS0163-7258%2896%2900163-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=9131721" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=1%3ACAS%3A528%3ADyaK2sXisFKiu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=1997&pages=121-146&author=S.+Rajendraauthor=J.+W.+Lynchauthor=P.+R.+Schofield&title=The+glycine+receptor&doi=10.1016%2FS0163-7258%2896%2900163-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">The glycine receptor</span></div><div class="casAuthors">Rajendra, Sundran; Lynch, Joseph W.; Schofield, Peter R.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">121-146</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review, with ∼250 refs.  The inhibitory glycine receptor (GlyR) is a member of the ligand-gated ion channel receptor superfamily.  The GlyR comprises a pentameric complex that forms a Cl--selective transmembrane channel, which is predominantly expressed in the spinal cord and brain stem.  We review the pharmacol. and physiol. properties of the GlyR and relate this information to more recent insights that have been obtained through the cloning and recombinant expression of the GlyR subunits.  We also discuss insights into our understanding of GlyR structure and function that have been obtained by the genetic characterization of various heritable disorders of glycinergic neurotransmission.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcw9zCDlj2_7Vg90H21EOLACvtfcHk0lhktGNvhvJnwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXisFKiu7k%253D&md5=575fc82e5852206bf96a44bcf93e4a76</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2FS0163-7258%2896%2900163-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0163-7258%252896%252900163-5%26sid%3Dliteratum%253Aachs%26aulast%3DRajendra%26aufirst%3DS.%26aulast%3DLynch%26aufirst%3DJ.%2BW.%26aulast%3DSchofield%26aufirst%3DP.%2BR.%26atitle%3DThe%2520glycine%2520receptor%26jtitle%3DPharmacol.%2520Ther.%26date%3D1997%26volume%3D73%26spage%3D121%26epage%3D146%26doi%3D10.1016%2FS0163-7258%2896%2900163-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Lynch, J. W.</span><span> </span><span class="NLM_article-title">Molecular structure and function of the glycine receptor chloride channel</span> <span class="citation_source-journal">Physiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">1051</span><span class="NLM_x">–</span> <span class="NLM_lpage">1095</span><span class="refDoi"> DOI: 10.1152/physrev.00042.2003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=10.1152%2Fphysrev.00042.2003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=15383648" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=1%3ACAS%3A528%3ADC%252BD2cXovVyltLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2004&pages=1051-1095&author=J.+W.+Lynch&title=Molecular+structure+and+function+of+the+glycine+receptor+chloride+channel&doi=10.1152%2Fphysrev.00042.2003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular structure and function of the glycine receptor chloride channel</span></div><div class="casAuthors">Lynch, Joseph W.</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1051-1095</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">0031-9333</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review.  The glycine receptor chloride channel (GlyR) is a member of the nicotinic acetylcholine receptor family of ligand-gated ion channels.  Functional receptors of this family comprise five subunits and are important targets for neuroactive drugs.  The GlyR is best known for mediating inhibitory neurotransmission in the spinal cord and brain stem, although recent evidence suggests it may also have other physiol. roles, including excitatory neurotransmission in embryonic neurons.  To date, four α-subunits (α1 to α4) and one β-subunit have been identified.  The differential expression of subunits underlies a diversity in GlyR pharmacol.  A developmental switch from α2 to α1β is completed by around postnatal day 20 in the rat.  The β-subunit is responsible for anchoring GlyRs to the subsynaptic cytoskeleton via the cytoplasmic protein gephyrin.  The last few years have seen a surge in interest in these receptors.  Consequently, a wealth of information has recently emerged concerning GlyR mol. structure and function.  Most of the information has been obtained from homomeric α1 GlyRs, with the roles of the other subunits receiving relatively little attention.  Heritable mutations to human GlyR genes give rise to a rare neurol. disorder, hyperekplexia (or startle disease).  Similar syndromes also occur in other species.  A rapidly growing list of compds. has been shown to exert potent modulatory effects on this receptor.  Since GlyRs are involved in motor reflex circuits of the spinal cord and provide inhibitory synapses onto pain sensory neurons, these agents may provide lead compds. for the development of muscle relaxant and peripheral analgesic drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGommVKKf8XFtrVg90H21EOLACvtfcHk0lhktGNvhvJnwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXovVyltLk%253D&md5=d7da2a4c450699500456989990d91226</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.00042.2003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.00042.2003%26sid%3Dliteratum%253Aachs%26aulast%3DLynch%26aufirst%3DJ.%2BW.%26atitle%3DMolecular%2520structure%2520and%2520function%2520of%2520the%2520glycine%2520receptor%2520chloride%2520channel%26jtitle%3DPhysiol.%2520Rev.%26date%3D2004%26volume%3D84%26spage%3D1051%26epage%3D1095%26doi%3D10.1152%2Fphysrev.00042.2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Laube, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maksay, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schemm, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Betz, H.</span><span> </span><span class="NLM_article-title">Modulation of glycine receptor function: a novel approach for therapeutic intervention at inhibitory synapses?</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">519</span><span class="NLM_x">–</span> <span class="NLM_lpage">527</span><span class="refDoi"> DOI: 10.1016/S0165-6147(02)02138-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=10.1016%2FS0165-6147%2802%2902138-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=12413807" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=1%3ACAS%3A528%3ADC%252BD38XotF2js70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2002&pages=519-527&author=B.+Laubeauthor=G.+Maksayauthor=R.+Schemmauthor=H.+Betz&title=Modulation+of+glycine+receptor+function%3A+a+novel+approach+for+therapeutic+intervention+at+inhibitory+synapses%3F&doi=10.1016%2FS0165-6147%2802%2902138-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of glycine receptor function: a novel approach for therapeutic intervention at inhibitory synapses?</span></div><div class="casAuthors">Laube, Bodo; Maksay, Gabor; Schemm, Rudolf; Betz, Heinrich</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">519-527</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Transmitter-gated ion channels mediate rapid synaptic transmission in the central nervous system and constitute important targets for many neuroactive drugs.  Inhibitory glycine receptors (GlyRs) are members of the nicotinic acetylcholine receptor superfamily and inhibit neuronal firing by opening Cl- channels following agonist binding.  In this article, we discuss recent developments in GlyR pharmacol., delineate the receptor domains that are involved in binding of agonists and allosteric modulators, and present a mol. model of the extracellular architecture of the receptor.  The recent discovery of compds. that act preferentially on specific GlyR isoforms and the differential expression of these isoforms in distinct regions of the developing and adult CNS show considerable promise towards the development of drugs that act in defined glycine-mediated pathways.  In particular, compds. that can potentiate GlyR function should provide leads for novel muscle relaxants in addn. to sedative and analgesic agents.  The recent discovery of compds. that act preferentially on specific glycine receptor (GlyR) isoforms and the differential expression of these isoforms in distinct regions of the developing and adult CNS show considerable promise towards the development of novel muscle relaxant and analgesic drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovwKNawCH4G7Vg90H21EOLACvtfcHk0lhktGNvhvJnwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XotF2js70%253D&md5=ca83d48169c390fd7c0f6e9b46eb3376</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2FS0165-6147%2802%2902138-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0165-6147%252802%252902138-7%26sid%3Dliteratum%253Aachs%26aulast%3DLaube%26aufirst%3DB.%26aulast%3DMaksay%26aufirst%3DG.%26aulast%3DSchemm%26aufirst%3DR.%26aulast%3DBetz%26aufirst%3DH.%26atitle%3DModulation%2520of%2520glycine%2520receptor%2520function%253A%2520a%2520novel%2520approach%2520for%2520therapeutic%2520intervention%2520at%2520inhibitory%2520synapses%253F%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2002%26volume%3D23%26spage%3D519%26epage%3D527%26doi%3D10.1016%2FS0165-6147%2802%2902138-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">May, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sexton, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, A.</span><span> </span><span class="NLM_article-title">Allosteric modulation of G protein-coupled receptors</span> <span class="citation_source-journal">Annu. Rev. Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span><span class="refDoi"> DOI: 10.1146/annurev.pharmtox.47.120505.105159</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=10.1146%2Fannurev.pharmtox.47.120505.105159" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=17009927" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=1%3ACAS%3A528%3ADC%252BD2sXit1altr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2007&pages=1-51&author=L.+T.+Mayauthor=K.+Leachauthor=P.+M.+Sextonauthor=A.+Christopoulos&title=Allosteric+modulation+of+G+protein-coupled+receptors&doi=10.1146%2Fannurev.pharmtox.47.120505.105159"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric modulation of G protein-coupled receptors</span></div><div class="casAuthors">May, Lauren T.; Leach, Katie; Sexton, Patrick M.; Christopoulos, Arthur</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Pharmacology and Toxicology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-51</span>CODEN:
                <span class="NLM_cas:coden">ARPTDI</span>;
        ISSN:<span class="NLM_cas:issn">0362-1642</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  The past decade has witnessed a significant growth in the identification of allosteric modulators of G protein-coupled receptors (GPCRs), i.e., ligands that interact with binding sites that are topog. distinct from the orthosteric site recognized by the receptor's endogenous agonist.  Because of their ability to modulate receptor conformations in the presence of orthosteric ligand, allosteric modulators can "fine-tune" classical pharmacol. responses.  This is advantageous in terms of a potential for engendering greater GPCR subtype-selectivity, but represents a significant challenge for detecting and validating allosteric behaviors.  Although allosteric sites need not have evolved to accommodate endogenous ligands, there are a no. of examples of where such modulators have been shown to contribute to physiol. or pathophysiol. processes.  Studies are also beginning to unravel the structural basis of allosteric modulation of GPCRs.  It remains to be detd. whether such modulation represents interactions within monomers vs. across dimers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6rgFXhej3ibVg90H21EOLACvtfcHk0ljV-I9MYkDAiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXit1altr0%253D&md5=848fa85abdfb3b40834887416479edec</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1146%2Fannurev.pharmtox.47.120505.105159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.pharmtox.47.120505.105159%26sid%3Dliteratum%253Aachs%26aulast%3DMay%26aufirst%3DL.%2BT.%26aulast%3DLeach%26aufirst%3DK.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DChristopoulos%26aufirst%3DA.%26atitle%3DAllosteric%2520modulation%2520of%2520G%2520protein-coupled%2520receptors%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D2007%26volume%3D47%26spage%3D1%26epage%3D51%26doi%3D10.1146%2Fannurev.pharmtox.47.120505.105159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="note"><p class="first last">See <a href="/doi/suppl/10.1021/acs.jmedchem.6b01496/suppl_file/jm6b01496_si_001.pdf" class="ext-link">Supporting Information</a> for platform, subtype and mouse cell line activities for <b>9</b>, <b>20</b>, and <b>32</b>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Pajouhesh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenz, G. R.</span><span> </span><span class="NLM_article-title">Medicinal chemical properties of successful central nervous system drugs</span> <span class="citation_source-journal">NeuroRx</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">541</span><span class="NLM_x">–</span> <span class="NLM_lpage">553</span><span class="refDoi"> DOI: 10.1602/neurorx.2.4.541</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=10.1602%2Fneurorx.2.4.541" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=16489364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=1%3ACAS%3A280%3ADC%252BD28%252FpvVKqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=541-553&author=H.+Pajouheshauthor=G.+R.+Lenz&title=Medicinal+chemical+properties+of+successful+central+nervous+system+drugs&doi=10.1602%2Fneurorx.2.4.541"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemical properties of successful central nervous system drugs</span></div><div class="casAuthors">Pajouhesh Hassan; Lenz George R</div><div class="citationInfo"><span class="NLM_cas:title">NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">541-53</span>
        ISSN:<span class="NLM_cas:issn">1545-5343</span>.
    </div><div class="casAbstract">Fundamental physiochemical features of CNS drugs are related to their ability to penetrate the blood-brain barrier affinity and exhibit CNS activity.  Factors relevant to the success of CNS drugs are reviewed.  CNS drugs show values of molecular weight, lipophilicity, and hydrogen bond donor and acceptor that in general have a smaller range than general therapeutics.  Pharmacokinetic properties can be manipulated by the medicinal chemist to a significant extent.  The solubility, permeability, metabolic stability, protein binding, and human ether-ago-go-related gene inhibition of CNS compounds need to be optimized simultaneously with potency, selectivity, and other biological parameters.  The balance between optimizing the physiochemical and pharmacokinetic properties to make the best compromises in properties is critical for designing new drugs likely to penetrate the blood brain barrier and affect relevant biological systems.  This review is intended as a guide to designing CNS therapeutic agents with better drug-like properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT_ncsy3yuEinl8icjszYl0fW6udTcc2eb-alOHX_NBFbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28%252FpvVKqsg%253D%253D&md5=0815084e2d107b9243b785d0782dfc3a</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1602%2Fneurorx.2.4.541&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1602%252Fneurorx.2.4.541%26sid%3Dliteratum%253Aachs%26aulast%3DPajouhesh%26aufirst%3DH.%26aulast%3DLenz%26aufirst%3DG.%2BR.%26atitle%3DMedicinal%2520chemical%2520properties%2520of%2520successful%2520central%2520nervous%2520system%2520drugs%26jtitle%3DNeuroRx%26date%3D2005%26volume%3D2%26spage%3D541%26epage%3D553%26doi%3D10.1602%2Fneurorx.2.4.541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="note"><p class="first last">Mouse GlyRα3β protein was not available. A strong correlation exists between human channel subtypes and human and mouse channels (see <a href="/doi/suppl/10.1021/acs.jmedchem.6b01496/suppl_file/jm6b01496_si_001.pdf" class="ext-link">Supporting Information</a> for data table of top leads).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="note"><p class="first last">ACD v10 values are provided.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Orr, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ripp, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballard, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henderson, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obach, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span> </span><span class="NLM_article-title">Mechanism-based inactivation (MBI) of cytochrome P450 enzymes: structure-activity relationships and discovery strategies to mitigate drug-drug interaction risks</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">4896</span><span class="NLM_x">–</span> <span class="NLM_lpage">4933</span><span class="refDoi"> DOI: 10.1021/jm300065h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300065h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjs1Wlur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4896-4933&author=S.+T.+Orrauthor=S.+L.+Rippauthor=T.+E.+Ballardauthor=J.+L.+Hendersonauthor=D.+O.+Scottauthor=R.+S.+Obachauthor=H.+Sunauthor=A.+S.+Kalgutkar&title=Mechanism-based+inactivation+%28MBI%29+of+cytochrome+P450+enzymes%3A+structure-activity+relationships+and+discovery+strategies+to+mitigate+drug-drug+interaction+risks&doi=10.1021%2Fjm300065h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism-Based Inactivation (MBI) of Cytochrome P450 Enzymes: Structure-Activity Relationships and Discovery Strategies To Mitigate Drug-Drug Interaction Risks</span></div><div class="casAuthors">Orr, Suvi T. M.; Ripp, Sharon L.; Ballard, T. Eric; Henderson, Jaclyn L.; Scott, Dennis O.; Obach, R. Scott; Sun, Hao; Kalgutkar, Amit S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4896-4933</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The importance of mitigating drug-drug interaction (DDI) risks, which arise from inhibition of major human cytochrome P 450 enzymes is a well-established component of the lead optimization process in drug discovery.  More recently, there has been much interest in clin. DDIs potentially arising via time- and concn.-dependent cytochrome P 450 inhibition, a phenomenon consistent with mechanism-based inactivation.  Inactivated P 450 is catalytically incompetent and must be replenished by newly synthesized protein.  Consequently, time-dependent inhibition of P450s presents a greater safety concern compared to reversible inhibition because of the increased propensity for pharmacokinetic interactions upon multiple dosing and the sustained duration of these interactions after discontinuation of the mechanism-based inactivator.  Mechanism-based or time-dependent P 450 inhibitors pose an addnl. risk of idiosyncratic drug toxicity since the mechanism of time-dependency often involves the formation of reactive metabolites, which can react with proteins other than the P 450 isoenzyme responsible for catalysis. in vitro time-dependent inhibition (TDI) of P 450 enzymes is now routinely assessed as part of lead optimization efforts in preclin. drug discovery.  However, identification of an in vitro TDI liability can raise several questions such as: What is the mechanism of TDI.  Does it involve the formation of reactive metabolites.  Is there a 1:1 correlation between P 450 TDI and RM formation (as measured from reactive metabolite trapping studies).  What is the likelihood that a P 450 time-dependent inhibitor will also cause toxicity.  What are the DDI risk mitigation options when dealing with P 450 inactivators in drug discovery - compd. progression or termination.  Several drugs exhibit in vitro TDI of P 450 enzymes, but only a fraction thereof causes clin. DDIs.  Hence, when do we initiate labor-intensive medicinal chem. efforts to design compds. devoid of P 450 TDI liability.  What are the best methods to precisely predict the likelihood of occurrence of clin. DDIs with drug candidates that inactivate P 450 enzymes.  What are (if any) the qualifying considerations for clin. progression of a P 450 time-dependent inactivator with projected clin. DDI risks.  In an effort to address these questions and hopefully provide answers to some of them, we embarked on the present venture wherein we highlight the current state-of-the-art knowledge in this field with a special emphasis on (a) available biochem. and mechanistic approaches in drug discovery to examine TDI of P 450 isoenzymes with new chem. entities, (b) structure-activity relationship studies with marketed drugs assocd. with DDIs via P 450 inactivation, (c) case studies of medicinal chem. tactics to abrogate P 450 inactivation liability, (d) strategies for progression of P 450 TDI-pos. drug candidates, and (e) the utility of in silico methodol., including the use of physiol.-based pharmacokinetic simulators, in drug discovery to predict the magnitude of clin. DDIs risks anticipated with new clin. candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDO60qqRvpS7Vg90H21EOLACvtfcHk0ljV-I9MYkDAiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjs1Wlur8%253D&md5=aa4aa4f633b3b4f73b3d79917327b0de</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm300065h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300065h%26sid%3Dliteratum%253Aachs%26aulast%3DOrr%26aufirst%3DS.%2BT.%26aulast%3DRipp%26aufirst%3DS.%2BL.%26aulast%3DBallard%26aufirst%3DT.%2BE.%26aulast%3DHenderson%26aufirst%3DJ.%2BL.%26aulast%3DScott%26aufirst%3DD.%2BO.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26atitle%3DMechanism-based%2520inactivation%2520%2528MBI%2529%2520of%2520cytochrome%2520P450%2520enzymes%253A%2520structure-activity%2520relationships%2520and%2520discovery%2520strategies%2520to%2520mitigate%2520drug-drug%2520interaction%2520risks%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4896%26epage%3D4933%26doi%3D10.1021%2Fjm300065h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="note"><p class="first last">Compound <b>14</b> was found to be unstable in neutral buffer (50% decomposition after 1 h at 37 °C), acidic buffer (pH = 2, immediate decomposition at room temperature), and basic buffer (pH = 11, 30% decomposition observed at 20 h at room temperature).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Huang, X.; Shaffer, P. L.; Ayube, S.; Bregman, H.; Chen, H.; Lehto, S. G.; Luther, J. A.; Matson, D. J.; McDonough, S. I.; Michelsen, K.; Plant, M. M.; Schneider, S.; Simard, J. R.; Teffera, Y.; Yi, S.; Zhang, M.; DiMauro, E. F.; Gingras, J.</span><span> </span><span class="NLM_article-title">Crystal structures of human GlyRα3 bound to a novel class of potentiators with efficacy in a mouse model of neuropathic pain</span>.  <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="refDoi"> DOI: 10.1038/nsmb.3329</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=10.1038%2Fnsmb.3329" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Huang%2C+X.%3B+Shaffer%2C+P.+L.%3B+Ayube%2C+S.%3B+Bregman%2C+H.%3B+Chen%2C+H.%3B+Lehto%2C+S.+G.%3B+Luther%2C+J.+A.%3B+Matson%2C+D.+J.%3B+McDonough%2C+S.+I.%3B+Michelsen%2C+K.%3B+Plant%2C+M.+M.%3B+Schneider%2C+S.%3B+Simard%2C+J.+R.%3B+Teffera%2C+Y.%3B+Yi%2C+S.%3B+Zhang%2C+M.%3B+DiMauro%2C+E.+F.%3B+Gingras%2C+J.+Crystal+structures+of+human+GlyR%CE%B13+bound+to+a+novel+class+of+potentiators+with+efficacy+in+a+mouse+model+of+neuropathic+pain.+Nat.+Struct.+Mol.+Biol.+10.1038%2Fnsmb.3329."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.3329&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.3329%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DX.%26atitle%3DCrystal%2520structures%2520of%2520human%2520GlyR%25CE%25B13%2520bound%2520to%2520a%2520novel%2520class%2520of%2520potentiators%2520with%2520efficacy%2520in%2520a%2520mouse%2520model%2520of%2520neuropathic%2520pain%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26doi%3D10.1038%2Fnsmb.3329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Berry, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Be, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, M. H.</span><span> </span><span class="NLM_article-title">Prediction of V(ss) from in vitro tissue-binding studies</span> <span class="citation_source-journal">Drug. Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">115</span><span class="NLM_x">–</span> <span class="NLM_lpage">121</span><span class="refDoi"> DOI: 10.1124/dmd.109.029629</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=10.1124%2Fdmd.109.029629" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2010&pages=115-121&author=L.+M.+Berryauthor=J.+Robertsauthor=X.+Beauthor=Z.+Zhaoauthor=M.+H.+Lin&title=Prediction+of+V%28ss%29+from+in+vitro+tissue-binding+studies&doi=10.1124%2Fdmd.109.029629"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1124%2Fdmd.109.029629&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.109.029629%26sid%3Dliteratum%253Aachs%26aulast%3DBerry%26aufirst%3DL.%2BM.%26aulast%3DRoberts%26aufirst%3DJ.%26aulast%3DBe%26aufirst%3DX.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DLin%26aufirst%3DM.%2BH.%26atitle%3DPrediction%2520of%2520V%2528ss%2529%2520from%2520in%2520vitro%2520tissue-binding%2520studies%26jtitle%3DDrug.%2520Metab.%2520Dispos.%26date%3D2010%26volume%3D38%26spage%3D115%26epage%3D121%26doi%3D10.1124%2Fdmd.109.029629" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Huang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janosky, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, M.-H. J.</span><span> </span><span class="NLM_article-title">Differential role of P-glycoprotein and breast cancer resistance protein in drug distribution into brain, CSF and peripheral nerve tissues in rats</span> <span class="citation_source-journal">Xenobiotica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">547</span><span class="NLM_x">–</span> <span class="NLM_lpage">555</span><span class="refDoi"> DOI: 10.3109/00498254.2014.997324</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=10.3109%2F00498254.2014.997324" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2015&pages=547-555&author=L.+Huangauthor=X.+Liauthor=J.+Robertsauthor=B.+Janoskyauthor=M.-H.+J.+Lin&title=Differential+role+of+P-glycoprotein+and+breast+cancer+resistance+protein+in+drug+distribution+into+brain%2C+CSF+and+peripheral+nerve+tissues+in+rats&doi=10.3109%2F00498254.2014.997324"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.3109%2F00498254.2014.997324&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F00498254.2014.997324%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DRoberts%26aufirst%3DJ.%26aulast%3DJanosky%26aufirst%3DB.%26aulast%3DLin%26aufirst%3DM.-H.%2BJ.%26atitle%3DDifferential%2520role%2520of%2520P-glycoprotein%2520and%2520breast%2520cancer%2520resistance%2520protein%2520in%2520drug%2520distribution%2520into%2520brain%252C%2520CSF%2520and%2520peripheral%2520nerve%2520tissues%2520in%2520rats%26jtitle%3DXenobiotica%26date%3D2015%26volume%3D45%26spage%3D547%26epage%3D555%26doi%3D10.3109%2F00498254.2014.997324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Jaggi, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, N.</span><span> </span><span class="NLM_article-title">Animal models of neuropathic pain</span> <span class="citation_source-journal">Fundam. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">28</span><span class="refDoi"> DOI: 10.1111/j.1472-8206.2009.00801.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=10.1111%2Fj.1472-8206.2009.00801.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=20030738" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhslKrsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=1-28&author=A.+S.+Jaggiauthor=V.+Jainauthor=N.+Singh&title=Animal+models+of+neuropathic+pain&doi=10.1111%2Fj.1472-8206.2009.00801.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Animal models of neuropathic pain</span></div><div class="casAuthors">Jaggi, Amteshwar Singh; Jain, Vivek; Singh, Nirmal</div><div class="citationInfo"><span class="NLM_cas:title">Fundamental & Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-28</span>CODEN:
                <span class="NLM_cas:coden">FCPHEZ</span>;
        ISSN:<span class="NLM_cas:issn">0767-3981</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Animal models are pivotal for understanding the mechanism of neuropathic pain and development of effective therapy for its optimal management.  A battery of neuropathic pain models has been developed to simulate the clin. pain conditions with diverse etiol.  The present review exhaustively discusses the methodol., behavioral alterations, limitations, and advantages of about 40 different animal models of neuropathic pain along with their modifications.  Development of these models has contributed immensely in understanding the chronic pain and underlying peripheral as well as central pathogenic mechanisms.  Furthermore, research has resulted in the development of new therapeutic agents for neuropathic pain management, and the preclin. data obtained using these animal models have been successively translated to effective pain management in clin. setup also.  As each animal model has been created with specific methodol. and results tend to vary largely with the slight changes related to methodol., therefore, it is essential that data from different models should be reported and interpreted in the context of the specific pain model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-2tLxHzZ1ubVg90H21EOLACvtfcHk0liZ40xcwHYY7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhslKrsb4%253D&md5=85f8149349f673e11ecba18d4e94a599</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1111%2Fj.1472-8206.2009.00801.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1472-8206.2009.00801.x%26sid%3Dliteratum%253Aachs%26aulast%3DJaggi%26aufirst%3DA.%2BS.%26aulast%3DJain%26aufirst%3DV.%26aulast%3DSingh%26aufirst%3DN.%26atitle%3DAnimal%2520models%2520of%2520neuropathic%2520pain%26jtitle%3DFundam.%2520Clin.%2520Pharmacol.%26date%3D2011%26volume%3D25%26spage%3D1%26epage%3D28%26doi%3D10.1111%2Fj.1472-8206.2009.00801.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="note"><p class="first last">See <a href="/doi/suppl/10.1021/acs.jmedchem.6b01496/suppl_file/jm6b01496_si_001.pdf" class="ext-link">Supporting Information</a> for 2D NMR data.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="note"><p class="first last">To evaluate the conformational distribution of <b>32</b> and <b>9</b> in solution, a stochastic conformational search for each molecule was performed using the program <i>Molecular Operating Environment</i> (MOE), 2014.09; Chemical Computing Group Inc., 1010 Sherbooke St. West, Suite 910, Montreal, QC, Canada, H3A 2R7, 2015. MMFF94x force field, Generalized Born implicit solvation, RMSD limit 0.1 A, energy window 7 kcal, and the resulting conformations optimized on the quantum mechanics potential surface with Gaussian 09 (B3LYP/6-31G*) followed by a single point calculation using the IEFPCM aqueous solvation model and UFF cavity model. The global minima of <b>32</b> was assumed to be the bioactive conformation, and differed substantially from the global minima of <b>9</b>. The conformation of <b>9</b> which most closely matched the bioactive conformation was ∼3.08 kcal higher in energy as compared to the global minima of <b>9</b>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Frisch, M. J.; Trucks, G. W.; Schlegel, H. B.; Scuseria, G. E.; Robb, M. A.; Cheeseman, J. R.; Scalmani, G.; Barone, V.; Mennucci, B.; Petersson, G. A.; Nakatsuji, H.; Caricato, M.; Li, X.; Hratchian, H. P.; Izmaylov, A. F.; Bloino, J.; Zheng, G.; Sonnenberg, J. L.; Hada, M.; Ehara, M.; Toyota, K.; Fukuda, R.; Hasegawa, J.; Ishida, M.; Nakajima, T.; Honda, Y.; Kitao, O.; Nakai, H.; Vreven, T.; Montgomery, J. A.,  Jr.; Peralta, J. E.; Ogliaro, F.; Bearpark, M.; Heyd, J. J.; Brothers, E.; Kudin, K. N.; Staroverov, V. N.; Kobayashi, R.; Normand, J.; Raghavachari, K.; Rendell, A.; Burant, J. C.; Iyengar, S. S.; Tomasi, J.; Cossi, M.; Rega, N.; Millam, J. M.; Klene, M.; Knox, J. E.; Cross, J. B.; Bakken, V.; Adamo, C.; Jaramillo, J.; Gomperts, R.; Stratmann, R. E.; Yazyev, O.; Austin, A. J.; Cammi, R.; Pomelli, C.; Ochterski, J. W.; Martin, R. L.; Morokuma, K.; Zakrzewski, V. G.; Voth, G. A.; Salvador, P.; Dannenberg, J. J.; Dapprich, S.; Daniels, A. D.; Farkas, Ö.; Foresman, J. B.; Ortiz, J. V.; Cioslowski, J.; Fox, D. J.</span>,  <span class="citation_source-book">Gaussian 09</span>, <span class="NLM_edition">revision D.01</span>; <span class="NLM_publisher-name">Gaussian, Inc.</span>: <span class="NLM_publisher-loc">Wallingford CT</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=M.+J.+Frisch&author=G.+W.+Trucks&author=H.+B.+Schlegel&author=G.+E.+Scuseria&author=M.+A.+Robb&author=J.+R.+Cheeseman&author=G.+Scalmani&author=V.+Barone&author=B.+Mennucci&author=G.+A.+Petersson&author=H.+Nakatsuji&author=M.+Caricato&author=X.+Li&author=H.+P.+Hratchian&author=A.+F.+Izmaylov&author=J.+Bloino&author=G.+Zheng&author=J.+L.+Sonnenberg&author=M.+Hada&author=M.+Ehara&author=K.+Toyota&author=R.+Fukuda&author=J.+Hasegawa&author=M.+Ishida&author=T.+Nakajima&author=Y.+Honda&author=O.+Kitao&author=H.+Nakai&author=T.+Vreven&author=J.+A.+Montgomery&author=J.+E.+Peralta&author=F.+Ogliaro&author=M.+Bearpark&author=J.+J.+Heyd&author=E.+Brothers&author=K.+N.+Kudin&author=V.+N.+Staroverov&author=R.+Kobayashi&author=J.+Normand&author=K.+Raghavachari&author=A.+Rendell&author=J.+C.+Burant&author=S.+S.+Iyengar&author=J.+Tomasi&author=M.+Cossi&author=N.+Rega&author=J.+M.+Millam&author=M.+Klene&author=J.+E.+Knox&author=J.+B.+Cross&author=V.+Bakken&author=C.+Adamo&author=J.+Jaramillo&author=R.+Gomperts&author=R.+E.+Stratmann&author=O.+Yazyev&author=A.+J.+Austin&author=R.+Cammi&author=C.+Pomelli&author=J.+W.+Ochterski&author=R.+L.+Martin&author=K.+Morokuma&author=V.+G.+Zakrzewski&author=G.+A.+Voth&author=P.+Salvador&author=J.+J.+Dannenberg&author=S.+Dapprich&author=A.+D.+Daniels&author=%C3%96.+Farkas&author=J.+B.+Foresman&author=J.+V.+Ortiz&author=J.+Cioslowski&author=D.+J.+Fox&title=Gaussian+09"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DFrisch%26aufirst%3DM.%2BJ.%26btitle%3DGaussian%252009%26pub%3DGaussian%252C%2520Inc%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michelsen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaffer, P. L.</span><span> </span><span class="NLM_article-title">Crystal structure of human glycine receptor-alpha3 bound to antagonist strychnine</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">526</span><span class="NLM_x">, </span> <span class="NLM_fpage">277</span><span class="NLM_x">–</span> <span class="NLM_lpage">280</span><span class="refDoi"> DOI: 10.1038/nature14972</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=10.1038%2Fnature14972" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=26416729" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1Chu7jJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=526&publication_year=2015&pages=277-280&author=X.+Huangauthor=H.+Chenauthor=K.+Michelsenauthor=S.+Schneiderauthor=P.+L.+Shaffer&title=Crystal+structure+of+human+glycine+receptor-alpha3+bound+to+antagonist+strychnine&doi=10.1038%2Fnature14972"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of human glycine receptor-α3 bound to antagonist strychnine</span></div><div class="casAuthors">Huang, Xin; Chen, Hao; Michelsen, Klaus; Schneider, Stephen; Shaffer, Paul L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">526</span>
        (<span class="NLM_cas:issue">7572</span>),
    <span class="NLM_cas:pages">277-280</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Neurotransmitter-gated ion channels of the Cys-loop receptor family are essential mediators of fast neurotransmission throughout the nervous system and are implicated in many neurol. disorders.  Available X-ray structures of prokaryotic and eukaryotic Cys-loop receptors provide tremendous insights into the binding of agonists, the subsequent opening of the ion channel, and the mechanism of channel activation.  Yet the mechanism of inactivation by antagonists remains unknown.  Here we present a 3.0 Å X-ray structure of the human glycine receptor-α3 homopentamer in complex with a high affinity, high-specificity antagonist, strychnine.  Our structure allows us to explore in detail the mol. recognition of antagonists.  Comparisons with previous structures reveal a mechanism for antagonist-induced inactivation of Cys-loop receptors, involving an expansion of the orthosteric binding site in the extracellular domain (ECD) that is coupled to closure of the ion pore in the transmembrane domain (TMD).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVeTttGF4v77Vg90H21EOLACvtfcHk0liZ40xcwHYY7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1Chu7jJ&md5=85f4a34b4d2dd7860e7c7683a13394f7</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1038%2Fnature14972&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature14972%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DMichelsen%26aufirst%3DK.%26aulast%3DSchneider%26aufirst%3DS.%26aulast%3DShaffer%26aufirst%3DP.%2BL.%26atitle%3DCrystal%2520structure%2520of%2520human%2520glycine%2520receptor-alpha3%2520bound%2520to%2520antagonist%2520strychnine%26jtitle%3DNature%26date%3D2015%26volume%3D526%26spage%3D277%26epage%3D280%26doi%3D10.1038%2Fnature14972" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="note"><p class="first last">The ligand conformation from the <b>32</b> complex crystal structure was optimized on the gas-phase quantum mechanics potential energy surface using Gaussian 09 (B3LYP/6-31G*) followed by a single-point calculation using the IEFPCM aqueous solvation model and UFF cavity model. The resulting conformation was identical to a conformation 0.05 kcal above the global minima of <b>32</b>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Cheng, C.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, S.-J.</span><span> </span><span class="NLM_article-title">The Friedlander synthesis of quinolines</span> <span class="citation_source-journal">Org. React.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">2</span><span class="refDoi"> DOI: 10.1002/0471264180.or028.02</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=10.1002%2F0471264180.or028.02" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1982&pages=2&author=C.-C.+Chengauthor=S.-J.+Yan&title=The+Friedlander+synthesis+of+quinolines&doi=10.1002%2F0471264180.or028.02"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1002%2F0471264180.or028.02&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F0471264180.or028.02%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DC.-C.%26aulast%3DYan%26aufirst%3DS.-J.%26atitle%3DThe%2520Friedlander%2520synthesis%2520of%2520quinolines%26jtitle%3DOrg.%2520React.%26date%3D1982%26volume%3D28%26spage%3D2%26doi%3D10.1002%2F0471264180.or028.02" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Fevig, J. M. F.; Jianxin; Ahmad; Saleem</span>. <span> </span><span class="NLM_article-title">Pyrrolo(oxo)isoquinolines as 5-HT ligands and their preparation, pharmaceutical compositions, pharmacological analysis and binding assay of 5-HT2 receptors for treatment of metabolic and central nervous system disorders</span>. US 20060014777,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=J.+M.+F.+Fevig&author=+Jianxin&author=+Ahmad&author=+Saleem&title=Pyrrolo%28oxo%29isoquinolines+as+5-HT+ligands+and+their+preparation%2C+pharmaceutical+compositions%2C+pharmacological+analysis+and+binding+assay+of+5-HT2+receptors+for+treatment+of+metabolic+and+central+nervous+system+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DFevig%26aufirst%3DJ.%2BM.%2BF.%26atitle%3DPyrrolo%2528oxo%2529isoquinolines%2520as%25205-HT%2520ligands%2520and%2520their%2520preparation%252C%2520pharmaceutical%2520compositions%252C%2520pharmacological%2520analysis%2520and%2520binding%2520assay%2520of%25205-HT2%2520receptors%2520for%2520treatment%2520of%2520metabolic%2520and%2520central%2520nervous%2520system%2520disorders%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Chen, Y.; Ren, W.; Meng, Q.; Ning, Z.; Rui, T.; Sun, B.; Wang, Q.; Yuan, X.; Yu, L.</span><span> </span><span class="NLM_article-title">Method for synthesis of (3a<i>S</i>,9b<i>R</i>)-<i>tert</i>-butyl-3,3a,4,5-tetrahydropyrrol[3,4-<i>c</i>]quinoline-2(9b<i>H</i>) ester</span>. CN 103073547,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=Y.+Chen&author=W.+Ren&author=Q.+Meng&author=Z.+Ning&author=T.+Rui&author=B.+Sun&author=Q.+Wang&author=X.+Yuan&author=L.+Yu&title=Method+for+synthesis+of+%283aS%2C9bR%29-tert-butyl-3%2C3a%2C4%2C5-tetrahydropyrrol%5B3%2C4-c%5Dquinoline-2%289bH%29+ester"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%26atitle%3DMethod%2520for%2520synthesis%2520of%2520%25283aS%252C9bR%2529-tert-butyl-3%252C3a%252C4%252C5-tetrahydropyrrol%255B3%252C4-c%255Dquinoline-2%25289bH%2529%2520ester%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Manzano, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rominger, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashmi, S. K.</span><span> </span><span class="NLM_article-title">Saturated abnormal NHC-gold(I) complexes: synthesis and catalytic activity</span> <span class="citation_source-journal">Organometallics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">2199</span><span class="NLM_x">–</span> <span class="NLM_lpage">2203</span><span class="refDoi"> DOI: 10.1021/om4000659</span> </span><div class="citationLinks">[<a href="/doi/10.1021/om4000659" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktFKnsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2013&pages=2199-2203&author=R.+Manzanoauthor=F.+Romingerauthor=S.+K.+Hashmi&title=Saturated+abnormal+NHC-gold%28I%29+complexes%3A+synthesis+and+catalytic+activity&doi=10.1021%2Fom4000659"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Saturated abnormal NHC-gold(I) complexes: synthesis and catalytic activity</span></div><div class="casAuthors">Manzano, Ruben; Rominger, Frank; Hashmi, A. Stephen K.</div><div class="citationInfo"><span class="NLM_cas:title">Organometallics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2199-2203</span>CODEN:
                <span class="NLM_cas:coden">ORGND7</span>;
        ISSN:<span class="NLM_cas:issn">0276-7333</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">New satd. abnormal N-heterocyclic carbene complexes of gold(I) [(1-R1-3-R2-4-R3-Im)AuX] (Im = 1,2-dihydro-4H-imidazol-5-yl; R1, R2 = tBu, CH2CH:CH2, iPr, CHMePh, CH2Ph, 2,6-iPr2C6H3; X = Cl, I) have been prepd. by a 1,3-dipolar cycloaddn. of an in situ generated azomethine ylides Me3SiCHR3NR2CH2OMe with an isocyanogold(I) halides R1NCAuX.  A series of different substituents on the nitrogen atom of the 1,3-dipole are tolerated without problem.  Substituents on a carbon atom of the 1,3-dipole are problematic in the case of the isocyanogold(I) chlorides; only low yields are obtained.  However, the corresponding isocyanogold(I) iodide shows good reactivity, and these abnormal N-heterocyclic carbenes bear the substituents R3 in a position α to the carbene carbon, as proven by a crystal structure anal. of one of the products.  Some of the new satd. abnormal N-heterocyclic carbene complexes were then tested in the gold-catalyzed phenol synthesis by recyclization of 2-furanmethyl propargyl ethers; moderate turnover nos. of 252-380 could be reached.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9GAvGgXq9l7Vg90H21EOLACvtfcHk0lh27m3DzPsgLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktFKnsrs%253D&md5=f04200b42f0f4146bf28e333a53da190</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fom4000659&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fom4000659%26sid%3Dliteratum%253Aachs%26aulast%3DManzano%26aufirst%3DR.%26aulast%3DRominger%26aufirst%3DF.%26aulast%3DHashmi%26aufirst%3DS.%2BK.%26atitle%3DSaturated%2520abnormal%2520NHC-gold%2528I%2529%2520complexes%253A%2520synthesis%2520and%2520catalytic%2520activity%26jtitle%3DOrganometallics%26date%3D2013%26volume%3D32%26spage%3D2199%26epage%3D2203%26doi%3D10.1021%2Fom4000659" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Corey, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaykovsky, M.</span><span> </span><span class="NLM_article-title">Dimethyloxosulfonium methylide and dimethylsulfonium methylide. Formation and application to organic synthesis</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1965</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">1353</span><span class="NLM_x">–</span> <span class="NLM_lpage">1364</span><span class="refDoi"> DOI: 10.1021/ja01084a034</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja01084a034" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=1965&pages=1353-1364&author=E.+J.+Coreyauthor=M.+Chaykovsky&title=Dimethyloxosulfonium+methylide+and+dimethylsulfonium+methylide.+Formation+and+application+to+organic+synthesis&doi=10.1021%2Fja01084a034"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fja01084a034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01084a034%26sid%3Dliteratum%253Aachs%26aulast%3DCorey%26aufirst%3DE.%2BJ.%26aulast%3DChaykovsky%26aufirst%3DM.%26atitle%3DDimethyloxosulfonium%2520methylide%2520and%2520dimethylsulfonium%2520methylide.%2520Formation%2520and%2520application%2520to%2520organic%2520synthesis%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1965%26volume%3D87%26spage%3D1353%26epage%3D1364%26doi%3D10.1021%2Fja01084a034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':[],'ref22':['cit22'],'ref23':[],'ref24':[],'ref25':['cit25'],'ref26':[],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':[],'ref32':[],'ref33':['cit33'],'ref34':['cit34'],'ref35':[],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 21 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Qian-Kun Zhao, Xiong Wu, Fan Yang, Pu-Cha Yan, Jian-Hua Xie, <span class="NLM_string-name hlFld-ContribAuthor">Qi-Lin Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Catalytic Asymmetric Hydrogenation of 3-Ethoxycarbonyl Quinolin-2-ones and Coumarins. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2021,</strong> <em>23 </em>
                                    (9)
                                     , 3593-3598. <a href="https://doi.org/10.1021/acs.orglett.1c00993" title="DOI URL">https://doi.org/10.1021/acs.orglett.1c00993</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.1c00993&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.1c00993%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DCatalytic%252BAsymmetric%252BHydrogenation%252Bof%252B3-Ethoxycarbonyl%252BQuinolin-2-ones%252Band%252BCoumarins%26aulast%3DZhao%26aufirst%3DQian-Kun%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D23032021%26date%3D19042021%26volume%3D23%26issue%3D9%26spage%3D3593%26epage%3D3598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Bingsong Han, Francesco G. Salituro, <span class="NLM_string-name hlFld-ContribAuthor">Maria-Jesus Blanco</span>. </span><span class="cited-content_cbyCitation_article-title">Impact of Allosteric Modulation in Drug Discovery: Innovation in Emerging Chemical Modalities. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (10)
                                     , 1810-1819. <a href="https://doi.org/10.1021/acsmedchemlett.9b00655" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00655</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00655&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00655%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DImpact%252Bof%252BAllosteric%252BModulation%252Bin%252BDrug%252BDiscovery%25253A%252BInnovation%252Bin%252BEmerging%252BChemical%252BModalities%26aulast%3DHan%26aufirst%3DBingsong%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D26122019%26date%3D10032020%26date%3D20032020%26date%3D10032020%26volume%3D11%26issue%3D10%26spage%3D1810%26epage%3D1819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ulrike Breitinger, <span class="NLM_string-name hlFld-ContribAuthor">Hans-Georg Breitinger</span>. </span><span class="cited-content_cbyCitation_article-title">Modulators of the Inhibitory Glycine Receptor. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2020,</strong> <em>11 </em>
                                    (12)
                                     , 1706-1725. <a href="https://doi.org/10.1021/acschemneuro.0c00054" title="DOI URL">https://doi.org/10.1021/acschemneuro.0c00054</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.0c00054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.0c00054%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DModulators%252Bof%252Bthe%252BInhibitory%252BGlycine%252BReceptor%26aulast%3DBreitinger%26aufirst%3DUlrike%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D30012020%26date%3D11052020%26date%3D03062020%26date%3D11052020%26volume%3D11%26issue%3D12%26spage%3D1706%26epage%3D1725" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Zhuqing Jia, Xiaoyi Hu, Yunlong Zhao, Fayang G. Qiu, Albert S. C. Chan, <span class="NLM_string-name hlFld-ContribAuthor">Junling Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">One-Pot Enantioselective Synthesis of 2-Pyrrolidinone Derivatives Bearing a Trifluoromethylated All-Carbon Quaternary Stereocenter. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2019,</strong> <em>21 </em>
                                    (23)
                                     , 9584-9588. <a href="https://doi.org/10.1021/acs.orglett.9b03758" title="DOI URL">https://doi.org/10.1021/acs.orglett.9b03758</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.9b03758&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.9b03758%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DOne-Pot%252BEnantioselective%252BSynthesis%252Bof%252B2-Pyrrolidinone%252BDerivatives%252BBearing%252Ba%252BTrifluoromethylated%252BAll-Carbon%252BQuaternary%252BStereocenter%26aulast%3DJia%26aufirst%3DZhuqing%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D23102019%26date%3D20112019%26volume%3D21%26issue%3D23%26spage%3D9584%26epage%3D9588" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Adam A. H. Elmehriki, <span class="NLM_string-name hlFld-ContribAuthor">James L. Gleason</span>. </span><span class="cited-content_cbyCitation_article-title">A Spiroalkylation Method for the Stereoselective Construction of α-Quaternary Carbons and Its Application to the Total Synthesis of (R)-Puraquinonic Acid. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2019,</strong> <em>21 </em>
                                    (23)
                                     , 9729-9733. <a href="https://doi.org/10.1021/acs.orglett.9b03887" title="DOI URL">https://doi.org/10.1021/acs.orglett.9b03887</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.9b03887&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.9b03887%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DA%252BSpiroalkylation%252BMethod%252Bfor%252Bthe%252BStereoselective%252BConstruction%252Bof%252B%2525CE%2525B1-Quaternary%252BCarbons%252Band%252BIts%252BApplication%252Bto%252Bthe%252BTotal%252BSynthesis%252Bof%252B%252528R%252529-Puraquinonic%252BAcid%26aulast%3DElmehriki%26aufirst%3DAdam%2BA.%2BH.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D30102019%26date%3D22112019%26volume%3D21%26issue%3D23%26spage%3D9729%26epage%3D9733" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Robert
K. Bressin, Julia L. Driscoll, Yanping Wang, <span class="NLM_string-name hlFld-ContribAuthor">Kazunori Koide</span>. </span><span class="cited-content_cbyCitation_article-title">Scalable Preparation of Methylated Ando-Type Horner–Wadsworth–Emmons Reagent. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2019,</strong> <em>23 </em>
                                    (2)
                                     , 274-277. <a href="https://doi.org/10.1021/acs.oprd.8b00423" title="DOI URL">https://doi.org/10.1021/acs.oprd.8b00423</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.oprd.8b00423&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.oprd.8b00423%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DScalable%252BPreparation%252Bof%252BMethylated%252BAndo-Type%252BHorner%2525E2%252580%252593Wadsworth%2525E2%252580%252593Emmons%252BReagent%26aulast%3DBressin%26aufirst%3DRobert%2BK.%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D04122018%26date%3D29012019%26volume%3D23%26issue%3D2%26spage%3D274%26epage%3D277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="NLM_string-name hlFld-ContribAuthor">Christopher L. Cioffi</span>. </span><span class="cited-content_cbyCitation_article-title">Modulation of Glycine-Mediated Spinal Neurotransmission for the Treatment of Chronic Pain. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (7)
                                     , 2652-2679. <a href="https://doi.org/10.1021/acs.jmedchem.7b00956" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00956</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00956&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00956%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DModulation%252Bof%252BGlycine-Mediated%252BSpinal%252BNeurotransmission%252Bfor%252Bthe%252BTreatment%252Bof%252BChronic%252BPain%26aulast%3DCioffi%26aufirst%3DChristopher%2BL.%26date%3D2018%26date%3D2017%26date%3D2017%26date%3D29062017%26date%3D22092017%26date%3D06092017%26volume%3D61%26issue%3D7%26spage%3D2652%26epage%3D2679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexios  Chatzigoulas</span>, <span class="hlFld-ContribAuthor ">Zoe  Cournia</span>. </span><span class="cited-content_cbyCitation_article-title">Rational design of allosteric modulators: Challenges and successes. </span><span class="cited-content_cbyCitation_journal-name">WIREs Computational Molecular Science</span><span> <strong>2021,</strong> <em>17 </em><a href="https://doi.org/10.1002/wcms.1529" title="DOI URL">https://doi.org/10.1002/wcms.1529</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/wcms.1529&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fwcms.1529%26sid%3Dliteratum%253Aachs%26jtitle%3DWIREs%2520Computational%2520Molecular%2520Science%26atitle%3DRational%252Bdesign%252Bof%252Ballosteric%252Bmodulators%25253A%252BChallenges%252Band%252Bsuccesses%26aulast%3DChatzigoulas%26aufirst%3DAlexios%26date%3D2021%26date%3D2021%26volume%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hanns Ulrich  Zeilhofer</span>, <span class="hlFld-ContribAuthor ">Karolina  Werynska</span>, <span class="hlFld-ContribAuthor ">Jacinthe  Gingras</span>, <span class="hlFld-ContribAuthor ">Gonzalo E.  Yévenes</span>. </span><span class="cited-content_cbyCitation_article-title">Glycine Receptors in Spinal Nociceptive Control—An Update. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules</span><span> <strong>2021,</strong> <em>11 </em>
                                    (6)
                                     , 846. <a href="https://doi.org/10.3390/biom11060846" title="DOI URL">https://doi.org/10.3390/biom11060846</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biom11060846&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiom11060846%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%26atitle%3DGlycine%252BReceptors%252Bin%252BSpinal%252BNociceptive%252BControl%2525E2%252580%252594An%252BUpdate%26aulast%3DZeilhofer%26aufirst%3DHanns%2BUlrich%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D6%26spage%3D846" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sami  Ben Salah</span>, <span class="hlFld-ContribAuthor ">Morgane  Sanselme</span>, <span class="hlFld-ContribAuthor ">Yves  Champavier</span>, <span class="hlFld-ContribAuthor ">Mohamed  Othman</span>, <span class="hlFld-ContribAuthor ">Adam  Daïch</span>, <span class="hlFld-ContribAuthor ">Isabelle  Chataigner</span>, <span class="hlFld-ContribAuthor ">Ata  Martin Lawson</span>. </span><span class="cited-content_cbyCitation_article-title">Five‐Membered Nitrogen Heterocycles Synthesis through 1,3‐Dipolar Cycloaddition of Non‐Stabilized Azomethine Ylides with 2‐Pyridone Heteroaromatic Systems as Dipolarophiles. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2021,</strong> <em>2021 </em>
                                    (1)
                                     , 102-116. <a href="https://doi.org/10.1002/ejoc.202001404" title="DOI URL">https://doi.org/10.1002/ejoc.202001404</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.202001404&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.202001404%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DFive%2525E2%252580%252590Membered%252BNitrogen%252BHeterocycles%252BSynthesis%252Bthrough%252B1%25252C3%2525E2%252580%252590Dipolar%252BCycloaddition%252Bof%252BNon%2525E2%252580%252590Stabilized%252BAzomethine%252BYlides%252Bwith%252B2%2525E2%252580%252590Pyridone%252BHeteroaromatic%252BSystems%252Bas%252BDipolarophiles%26aulast%3DBen%2BSalah%26aufirst%3DSami%26date%3D2021%26date%3D2020%26volume%3D2021%26issue%3D1%26spage%3D102%26epage%3D116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Steven O.  Devenish</span>, <span class="hlFld-ContribAuthor ">Bryony L.  Winters</span>, <span class="hlFld-ContribAuthor ">Lyndsey L.  Anderson</span>, <span class="hlFld-ContribAuthor ">Jonathon C.  Arnold</span>, <span class="hlFld-ContribAuthor ">Iain S.  McGregor</span>, <span class="hlFld-ContribAuthor ">Christopher W.  Vaughan</span>, <span class="hlFld-ContribAuthor ">Mary  Chebib</span>, <span class="hlFld-ContribAuthor ">Nathan L.  Absalom</span>. </span><span class="cited-content_cbyCitation_article-title">The anticonvulsant zonisamide positively modulates recombinant and native glycine receptors at clinically relevant concentrations. </span><span class="cited-content_cbyCitation_journal-name">Neuropharmacology</span><span> <strong>2021,</strong> <em>182 </em>, 108371. <a href="https://doi.org/10.1016/j.neuropharm.2020.108371" title="DOI URL">https://doi.org/10.1016/j.neuropharm.2020.108371</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuropharm.2020.108371&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuropharm.2020.108371%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropharmacology%26atitle%3DThe%252Banticonvulsant%252Bzonisamide%252Bpositively%252Bmodulates%252Brecombinant%252Band%252Bnative%252Bglycine%252Breceptors%252Bat%252Bclinically%252Brelevant%252Bconcentrations%26aulast%3DDevenish%26aufirst%3DSteven%2BO.%26date%3D2021%26volume%3D182%26spage%3D108371" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fei  Li</span>, <span class="hlFld-ContribAuthor ">Pascal F.  Egea</span>, <span class="hlFld-ContribAuthor ">Alex J.  Vecchio</span>, <span class="hlFld-ContribAuthor ">Ignacio  Asial</span>, <span class="hlFld-ContribAuthor ">Meghna  Gupta</span>, <span class="hlFld-ContribAuthor ">Joana  Paulino</span>, <span class="hlFld-ContribAuthor ">Ruchika  Bajaj</span>, <span class="hlFld-ContribAuthor ">Miles Sasha  Dickinson</span>, <span class="hlFld-ContribAuthor ">Shelagh  Ferguson-Miller</span>, <span class="hlFld-ContribAuthor ">Brian C.  Monk</span>, <span class="hlFld-ContribAuthor ">Robert M.  Stroud</span>. </span><span class="cited-content_cbyCitation_article-title">Highlighting membrane protein structure and function: A celebration of the Protein Data Bank. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biological Chemistry</span><span> <strong>2021,</strong> <em>296 </em>, 100557. <a href="https://doi.org/10.1016/j.jbc.2021.100557" title="DOI URL">https://doi.org/10.1016/j.jbc.2021.100557</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jbc.2021.100557&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jbc.2021.100557%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biological%2520Chemistry%26atitle%3DHighlighting%252Bmembrane%252Bprotein%252Bstructure%252Band%252Bfunction%25253A%252BA%2525C2%2525A0celebration%252Bof%252Bthe%252BProtein%252BData%252BBank%26aulast%3DLi%26aufirst%3DFei%26date%3D2021%26volume%3D296%26spage%3D100557" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shovan  Mondal</span>, <span class="hlFld-ContribAuthor ">Suniti  Malakar</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of sulfonamide and their synthetic and therapeutic applications: Recent advances. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2020,</strong> <em>76 </em>
                                    (48)
                                     , 131662. <a href="https://doi.org/10.1016/j.tet.2020.131662" title="DOI URL">https://doi.org/10.1016/j.tet.2020.131662</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2020.131662&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2020.131662%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DSynthesis%252Bof%252Bsulfonamide%252Band%252Btheir%252Bsynthetic%252Band%252Btherapeutic%252Bapplications%25253A%252BRecent%252Badvances%26aulast%3DMondal%26aufirst%3DShovan%26date%3D2020%26volume%3D76%26issue%3D48%26spage%3D131662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Valeria A.  Litvinova</span>, <span class="hlFld-ContribAuthor ">Alexander S.  Tikhomirov</span>, <span class="hlFld-ContribAuthor ">Ivan V.  Ivanov</span>, <span class="hlFld-ContribAuthor ">Svetlana E.  Solovieva</span>, <span class="hlFld-ContribAuthor ">Andrey E.  Shchekotikhin</span>. </span><span class="cited-content_cbyCitation_article-title">A facile access to 2-substituted naphtho[2,3-g]quinoline-3-carboxylic acid esters via intramolecular cyclization and PyBOP-promoted functionalization. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2020,</strong> <em>76 </em>
                                    (36)
                                     , 131418. <a href="https://doi.org/10.1016/j.tet.2020.131418" title="DOI URL">https://doi.org/10.1016/j.tet.2020.131418</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2020.131418&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2020.131418%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DA%252Bfacile%252Baccess%252Bto%252B2-substituted%252Bnaphtho%25255B2%25252C3-g%25255Dquinoline-3-carboxylic%252Bacid%252Besters%252Bvia%252Bintramolecular%252Bcyclization%252Band%252BPyBOP-promoted%252Bfunctionalization%26aulast%3DLitvinova%26aufirst%3DValeria%2BA.%26date%3D2020%26volume%3D76%26issue%3D36%26spage%3D131418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">César O.  Lara</span>, <span class="hlFld-ContribAuthor ">Carlos F.  Burgos</span>, <span class="hlFld-ContribAuthor ">Gustavo  Moraga-Cid</span>, <span class="hlFld-ContribAuthor ">Mónica A.  Carrasco</span>, <span class="hlFld-ContribAuthor ">Gonzalo E.  Yévenes</span>. </span><span class="cited-content_cbyCitation_article-title">Pentameric Ligand-Gated Ion Channels as Pharmacological Targets Against Chronic Pain. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Pharmacology</span><span> <strong>2020,</strong> <em>11 </em><a href="https://doi.org/10.3389/fphar.2020.00167" title="DOI URL">https://doi.org/10.3389/fphar.2020.00167</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphar.2020.00167&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphar.2020.00167%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Pharmacology%26atitle%3DPentameric%252BLigand-Gated%252BIon%252BChannels%252Bas%252BPharmacological%252BTargets%252BAgainst%252BChronic%252BPain%26aulast%3DLara%26aufirst%3DC%25C3%25A9sar%2BO.%26date%3D2020%26date%3D2020%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Volodymyr L.  Mykhalchuk</span>, <span class="hlFld-ContribAuthor ">Vladimir S.  Yarmolchuk</span>, <span class="hlFld-ContribAuthor ">Roman O.  Doroschuk</span>, <span class="hlFld-ContribAuthor ">Andrey A.  Tolmachev</span>, <span class="hlFld-ContribAuthor ">Oleksandr O.  Grygorenko</span>. </span><span class="cited-content_cbyCitation_article-title">[3+2] Cycloaddition of an Azomethyne Ylide and Vinyl Sulfonyl Fluorides ― an Approach to Pyrrolidine-3-sulfonyl Fluorides. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>2018 </em>
                                    (22)
                                     , 2870-2876. <a href="https://doi.org/10.1002/ejoc.201800521" title="DOI URL">https://doi.org/10.1002/ejoc.201800521</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201800521&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201800521%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3D%25255B3%25252B2%25255D%252BCycloaddition%252Bof%252Ban%252BAzomethyne%252BYlide%252Band%252BVinyl%252BSulfonyl%252BFluorides%252B%2525E2%252580%252595%252Ban%252BApproach%252Bto%252BPyrrolidine-3-sulfonyl%252BFluorides%26aulast%3DMykhalchuk%26aufirst%3DVolodymyr%2BL.%26date%3D2018%26date%3D2018%26volume%3D2018%26issue%3D22%26spage%3D2870%26epage%3D2876" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hanns Ulrich  Zeilhofer</span>, <span class="hlFld-ContribAuthor ">Mario A.  Acuña</span>, <span class="hlFld-ContribAuthor ">Jacinthe  Gingras</span>, <span class="hlFld-ContribAuthor ">Gonzalo E.  Yévenes</span>. </span><span class="cited-content_cbyCitation_article-title">Glycine receptors and glycine transporters: targets for novel analgesics?. </span><span class="cited-content_cbyCitation_journal-name">Cellular and Molecular Life Sciences</span><span> <strong>2018,</strong> <em>75 </em>
                                    (3)
                                     , 447-465. <a href="https://doi.org/10.1007/s00018-017-2622-x" title="DOI URL">https://doi.org/10.1007/s00018-017-2622-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00018-017-2622-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00018-017-2622-x%26sid%3Dliteratum%253Aachs%26jtitle%3DCellular%2520and%2520Molecular%2520Life%2520Sciences%26atitle%3DGlycine%252Breceptors%252Band%252Bglycine%252Btransporters%25253A%252Btargets%252Bfor%252Bnovel%252Banalgesics%25253F%26aulast%3DZeilhofer%26aufirst%3DHanns%2BUlrich%26date%3D2018%26date%3D2017%26volume%3D75%26issue%3D3%26spage%3D447%26epage%3D465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nagasree  Chakka</span>, <span class="hlFld-ContribAuthor ">Kristin L.  Andrews</span>, <span class="hlFld-ContribAuthor ">Loren M.  Berry</span>, <span class="hlFld-ContribAuthor ">Howard  Bregman</span>, <span class="hlFld-ContribAuthor ">Hakan  Gunaydin</span>, <span class="hlFld-ContribAuthor ">Liyue  Huang</span>, <span class="hlFld-ContribAuthor ">Angel  Guzman-Perez</span>, <span class="hlFld-ContribAuthor ">Matthew H.  Plant</span>, <span class="hlFld-ContribAuthor ">Jeffrey R.  Simard</span>, <span class="hlFld-ContribAuthor ">Jacinthe  Gingras</span>, <span class="hlFld-ContribAuthor ">Erin F.  DiMauro</span>. </span><span class="cited-content_cbyCitation_article-title">Applications of parallel synthetic lead hopping and pharmacophore-based virtual screening in the discovery of efficient glycine receptor potentiators. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>137 </em>, 63-75. <a href="https://doi.org/10.1016/j.ejmech.2017.05.036" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.05.036</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.05.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.05.036%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DApplications%252Bof%252Bparallel%252Bsynthetic%252Blead%252Bhopping%252Band%252Bpharmacophore-based%252Bvirtual%252Bscreening%252Bin%252Bthe%252Bdiscovery%252Bof%252Befficient%252Bglycine%252Breceptor%252Bpotentiators%26aulast%3DChakka%26aufirst%3DNagasree%26date%3D2017%26volume%3D137%26spage%3D63%26epage%3D75" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brian A.  Sparling</span>, <span class="hlFld-ContribAuthor ">Erin F.  DiMauro</span>. </span><span class="cited-content_cbyCitation_article-title">Progress in the discovery of small molecule modulators of the Cys-loop superfamily receptors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (15)
                                     , 3207-3218. <a href="https://doi.org/10.1016/j.bmcl.2017.04.073" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.04.073</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.04.073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.04.073%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DProgress%252Bin%252Bthe%252Bdiscovery%252Bof%252Bsmall%252Bmolecule%252Bmodulators%252Bof%252Bthe%252BCys-loop%252Bsuperfamily%252Breceptors%26aulast%3DSparling%26aufirst%3DBrian%2BA.%26date%3D2017%26volume%3D27%26issue%3D15%26spage%3D3207%26epage%3D3218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shawn  Johnstone</span>, <span class="hlFld-ContribAuthor ">Jeffrey S.  Albert</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacological property optimization for allosteric ligands: A medicinal chemistry perspective. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (11)
                                     , 2239-2258. <a href="https://doi.org/10.1016/j.bmcl.2017.03.084" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.03.084</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.03.084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.03.084%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DPharmacological%252Bproperty%252Boptimization%252Bfor%252Ballosteric%252Bligands%25253A%252BA%252Bmedicinal%252Bchemistry%252Bperspective%26aulast%3DJohnstone%26aufirst%3DShawn%26date%3D2017%26volume%3D27%26issue%3D11%26spage%3D2239%26epage%3D2258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joseph W.  Lynch</span>, <span class="hlFld-ContribAuthor ">Yan  Zhang</span>, <span class="hlFld-ContribAuthor ">Sahil  Talwar</span>, <span class="hlFld-ContribAuthor ">Argel  Estrada-Mondragon</span>. </span><span class="cited-content_cbyCitation_article-title">Glycine Receptor Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 225-253. <a href="https://doi.org/10.1016/bs.apha.2017.01.003" title="DOI URL">https://doi.org/10.1016/bs.apha.2017.01.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.apha.2017.01.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.apha.2017.01.003%26sid%3Dliteratum%253Aachs%26atitle%3DGlycine%252BReceptor%252BDrug%252BDiscovery%26aulast%3DLynch%26aufirst%3DJoseph%2BW.%26date%3D2017%26spage%3D225%26epage%3D253%26pub%3DElsevier%26atitle%3DIon%252BChannels%252BDownUnder%26date%3D2017%26volume%3D79" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/medium/jm-2016-01496d_0018.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/large/jm-2016-01496d_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01496&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/medium/jm-2016-01496d_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/large/jm-2016-01496d_0001.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Representative glycine Schild shift plot. In this example, the mEC<sub>3</sub> (or minimum tested compound concentration to elicit a leftward shift in the Gly EC<sub>50</sub> value ≥3×) corresponds to a compound concentration [cpd] of 6.3 μM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/large/jm-2016-01496d_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01496&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/medium/jm-2016-01496d_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/large/jm-2016-01496d_0002.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Potentiation of glycine evoked current in adult mouse spinal neurons. Representative postsynaptic current (PSC) amplitude (pA) modulation recorded from glycinergic neurons in an isolated adult mouse spinal cord slice: (a) glycine (20 μM), (b) glycine (20 μM) + <b>9</b> (0.5 μM) on the top and (ent)-<b>9</b> (0.5 μM) on the bottom, (c) glycine (20 μM) + <b>9</b> (0.5 μM) + strychnine (10 μM). On average, application of 0.5 μM of <b>9</b> led to a 4.9-fold increase of the PSC amplitude. This response was fully reversed in the presence of strychnine (<i>n</i> = 5 neurons, scale bars apply to all electrophysiological traces).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/large/jm-2016-01496d_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01496&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/medium/jm-2016-01496d_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/large/jm-2016-01496d_0003.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Physicochemical properties and in vitro PK trends. Pink, compounds described herein; gray, structurally related tricyclic sulfonamides (compounds not disclosed herein); green squares, analogues containing an H-bond donor. (A) MLM CL<sub>int</sub> vs Log <i>D</i> (pH = 7.4). (B) MDCK human Pgp efflux ratio vs binned PSA. (C) MDCK human BCRP efflux ratio vs binned PSA.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/large/jm-2016-01496d_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01496&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/medium/jm-2016-01496d_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/large/jm-2016-01496d_0004.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Reversal of SNI-induced tactile allodynia by <b>20</b> when dosed at 20 mg/kg (po). At 60 min post oral dosing, <b>20</b> dosed at 20 mg/kg (po) produced a significant increase in von Frey threshold (1.53 ± 0.31 g) relative to vehicle (0.82 ± 0.19 g) by ANOVA with Dunnett’s Multiple Comparisons; <i>F</i><sub>2,35</sub> = 4.7, <i>p</i> < 0.05. The less active enantiomer (<i>ent</i>)-<b>20</b> also dosed at 20 mg/kg (po) did not reverse tactile allodynia. The positive control, pregabalin, dosed at 30 mg/kg (po), was not included in the statistical analysis because of low <i>n</i> but appeared effective. Exposure values were generated at 90 min post dose.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/large/jm-2016-01496d_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01496&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/medium/jm-2016-01496d_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/large/jm-2016-01496d_0005.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Overlay of global minima conformations of <b>32</b> (magenta) and <b>9</b> (cyan). Figures generated using PyMOL (The PyMOL Molecular Graphics System, version 1.7.05, Schrödinger, LLC).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/large/jm-2016-01496d_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01496&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/medium/jm-2016-01496d_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/large/jm-2016-01496d_0006.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (A) Potentiator binding pocket in human GlyRα3. The bound conformation of <b>32</b> (green) is overlaid with the calculated minimum energy conformation (magenta). (B) X-ray of potentiator <b>32</b> and glycine bound to GlyRα3 (PDB codes: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5TIO">5TIO</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5TIN">5TIN</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/large/jm-2016-01496d_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01496&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/medium/jm-2016-01496d_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/large/jm-2016-01496d_0007.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Preparation of Quinolinone and Naphthyridone Intermediates<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/large/jm-2016-01496d_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01496&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) piperidine, EtOH, reflux, 50–98%; (b) NH<sub>3</sub>Me (40% in H<sub>2</sub>O), MeOH–EtOH, 120 °C, sealed tube, 48%; (c) (i) NaH, ethyl 2-(diethoxyphosphoryl)-2-fluoroacetate, THF, (ii) aldehyde <b>36</b>, 21%.</p></p></figure><figure data-id="sch2" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/medium/jm-2016-01496d_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/large/jm-2016-01496d_0008.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Preparation of Tricyclic Pyrrolidine Cores<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/large/jm-2016-01496d_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01496&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) Cs<sub>2</sub>CO<sub>3</sub>, MeI, DMF, 36–100%; (b) TFA, CH<sub>2</sub>Cl<sub>2</sub>, 52–100%, 18% for <b>39e</b>; (c) HCl (aq), 100 °C, 78–100%; (d) Pd(OH)<sub>2</sub>, H<sub>2</sub>, EtOH:H<sub>2</sub>O (5 or 10:1), 40 psi, 40–60 °C, 83–100%; (e) (i) vinyl carbonochloridate, DCM, 0 °C–rt, (ii) EtOH, 6 N HCl, 100 °C, 70%.</p></p></figure><figure data-id="sch3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/medium/jm-2016-01496d_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/large/jm-2016-01496d_0009.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Preparation of α-Methyl Ring Fusion and 4-Cyano and 4-Hydroxyl Tricyclic Pyrrolidine Cores<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/large/jm-2016-01496d_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01496&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) Pd/C (10%), Pd(OH)<sub>2</sub>, (Boc)<sub>2</sub>O, H<sub>2</sub>, EtOH, 50 psi, 96%; (b) (i) NaH, MeI, DCE, 59%, (ii) NBS, DCM, 92%; (c) (i) NaH, MeI, (ii) HCl in MeOH; (d) (i) Pd(PPh<sub>3</sub>)<sub>4</sub>, Zn(CN)<sub>2</sub>, DMF, 100 °C, (ii) HCl/dioxane, 100%; (e) (Bpin)<sub>2</sub>, PdCl<sub>2</sub>(dppf), KOAc, dioxane, 90 °C, 100%; (f) (i) H<sub>2</sub>O<sub>2</sub>, NaOH, THF/H<sub>2</sub>O, (ii) HCl/dioxane, 60%.</p></p></figure><figure data-id="sch4" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/medium/jm-2016-01496d_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/large/jm-2016-01496d_0010.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Preparation of 4-Fluoro Tricyclic Core and 5-Aza Tricyclic Core Analogue <b>10</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/large/jm-2016-01496d_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01496&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) K<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, 93% for <b>48a</b>, 24% for <b>48b</b>; (b) TFA, DCM, 87% for <b>49a</b>, 100% for <b>49b</b>; (c) (i) Pd(OH)<sub>2</sub> or Pd/C, H<sub>2</sub>, EtOH, 60 °C, 55 psi, 100%, (ii) AcOH, 80 °C (for <b>49b</b> only), 99% (d) (i) (Boc)<sub>2</sub>O, Et<sub>3</sub>N, EtOH, (ii) NaH, MeI, DMF, (iii) HCl/dioxane, 56%; (e) (i) benzo[<i>d</i>][1,3]dioxole-5-sulfonyl chloride, Et<sub>3</sub>N, DCM, (ii) NaH, MeI, DMF, 2%.</p></p></figure><figure data-id="sch5" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/medium/jm-2016-01496d_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/large/jm-2016-01496d_0011.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Initial Route Towards Isomeric Mixture of α-Methyl Pyrrolidine Tricyclic Core<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/large/jm-2016-01496d_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01496&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) Neat, 180 °C; (b) CH<sub>2</sub>O (aq), K<sub>2</sub>CO<sub>3</sub>, MeOH; (c) (i) <b>38g</b>, TFA, DCM, 33%, (ii) 3 N HCl:dioxane (2:3), 90 °C, (iii) Pd(OH)<sub>2</sub>, H<sub>2</sub>, EtOH:H<sub>2</sub>O (10:1), 40 °C, 40 psi, 96%, (over 2 steps).</p></p></figure><figure data-id="sch6" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/medium/jm-2016-01496d_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/large/jm-2016-01496d_0012.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Improved Route Towards Isomeric Mixture of α-Methyl Pyrrolidine Tricyclic Core<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/large/jm-2016-01496d_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01496&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) (i) MeI, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 51%, (ii) NaH, trimethylsulfoxonium iodide, THF, DMSO; (b) NaN<sub>3</sub>, Et<sub>3</sub>N, AcOH, DMF, 70 °C; (c) PPh<sub>3</sub>, acetone, 60 °C; (d) NaBH<sub>4</sub>, MeOH/DCE, (30% over 4 steps).</p></p></figure><figure data-id="sch7" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/medium/jm-2016-01496d_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/large/jm-2016-01496d_0013.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis of Sulfonamides<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01496/20170203/images/large/jm-2016-01496d_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01496&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) Sulfonyl chloride, triethylamine, CH<sub>3</sub>CN; (b) triethylamine, CH<sub>3</sub>CN, 54%; (c) (i) triethylamine, CH<sub>3</sub>CN, 75%, (ii) chiral SFC purification.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i128">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72268" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72268" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 40 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Dworkin, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audette, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baron, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gourlay, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haanpaa, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kent, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krane, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebel, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levy, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackey, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miaskowski, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raja, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmader, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stacey, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanos, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treede, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turk, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walco, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, C. D.</span><span> </span><span class="NLM_article-title">Recommendations for the pharmacological management of neuropathic pain: an overview and literature update</span> <span class="citation_source-journal">Mayo Clin. Proc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">S3</span><span class="NLM_x">–</span> <span class="NLM_lpage">14</span><span class="refDoi"> DOI: 10.4065/mcp.2009.0649</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=10.4065%2Fmcp.2009.0649" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=20194146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkt1Sjsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2010&pages=S3-14&author=R.+H.+Dworkinauthor=A.+B.+O%E2%80%99Connorauthor=J.+Audetteauthor=R.+Baronauthor=G.+K.+Gourlayauthor=M.+L.+Haanpaaauthor=J.+L.+Kentauthor=E.+J.+Kraneauthor=A.+A.+Lebelauthor=R.+M.+Levyauthor=S.+C.+Mackeyauthor=J.+Mayerauthor=C.+Miaskowskiauthor=S.+N.+Rajaauthor=A.+S.+Riceauthor=K.+E.+Schmaderauthor=B.+Staceyauthor=S.+Stanosauthor=R.+D.+Treedeauthor=D.+C.+Turkauthor=G.+A.+Walcoauthor=C.+D.+Wells&title=Recommendations+for+the+pharmacological+management+of+neuropathic+pain%3A+an+overview+and+literature+update&doi=10.4065%2Fmcp.2009.0649"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Recommendations for the pharmacological management of neuropathic pain: an overview and literature update</span></div><div class="casAuthors">Dworkin, Robert H.; O'Connor, Alec B.; Audette, Joseph; Baron, Ralf; Gourlay, Geoffrey K.; Haanpaa, Maija L.; Kent, Joel L.; Krane, Elliot J.; Lebel, Alyssa A.; Levy, Robert M.; Mackey, Sean C.; Mayer, John; Miaskowski, Christine; Raja, Srinivasa N.; Rice, Andrew S. C.; Schmader, Kenneth E.; Stacey, Brett; Stanos, Steven; Treede, Rolf-Detlef; Turk, Dennis C.; Walco, Gary A.; Wells, Christopher D.</div><div class="citationInfo"><span class="NLM_cas:title">Mayo Clinic Proceedings</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">3, Suppl.</span>),
    <span class="NLM_cas:pages">S3-S14</span>CODEN:
                <span class="NLM_cas:coden">MACPAJ</span>;
        ISSN:<span class="NLM_cas:issn">0025-6196</span>.
    
            (<span class="NLM_cas:orgname">Dowden Health Media, Inc.</span>)
        </div><div class="casAbstract">A review.  The Neuropathic Pain Special Interest Group of the International Assocn. for the Study of Pain recently sponsored the development of evidence-based guidelines for the pharmacol. treatment of neuropathic pain.  Tricyclic antidepressants, dual reuptake inhibitors of serotonin and norepinephrine, calcium channel α2-δ ligands (le, gabapentin and pregabalin), and topical lidocaine were recommended as first-line treatment options on the basis of the results of randomized clin. trials.  Opioid analgesics and tramadol were recommended as second-line treatments that can be considered for first-line use in certain clin. circumstances.  Results of several recent clin. trials have become available since the development of these guidelines.  These studies have examd. botulinum toxin, high-concn. capsaicin patch, lacosamide, selective serotonin reuptake inhibitors, and combination therapies in various neuropathic pain conditions.  The increasing no. of neg. clin. trials of pharmacol. treatments for neuropathic pain and ambiguities in the interpretation of these neg. trials must also be considered in developing treatment guidelines.  The objectives of the current article are to review the Neuropathic Pain Special Interest Group guidelines for the pharmacol. management of neuropathic pain and to provide a brief overview of these recent studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9_qlufOfrkLVg90H21EOLACvtfcHk0lhqmVZOJTW6HQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkt1Sjsb0%253D&md5=749b581e00c2be99ae45dbf54de0bca3</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.4065%2Fmcp.2009.0649&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4065%252Fmcp.2009.0649%26sid%3Dliteratum%253Aachs%26aulast%3DDworkin%26aufirst%3DR.%2BH.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DA.%2BB.%26aulast%3DAudette%26aufirst%3DJ.%26aulast%3DBaron%26aufirst%3DR.%26aulast%3DGourlay%26aufirst%3DG.%2BK.%26aulast%3DHaanpaa%26aufirst%3DM.%2BL.%26aulast%3DKent%26aufirst%3DJ.%2BL.%26aulast%3DKrane%26aufirst%3DE.%2BJ.%26aulast%3DLebel%26aufirst%3DA.%2BA.%26aulast%3DLevy%26aufirst%3DR.%2BM.%26aulast%3DMackey%26aufirst%3DS.%2BC.%26aulast%3DMayer%26aufirst%3DJ.%26aulast%3DMiaskowski%26aufirst%3DC.%26aulast%3DRaja%26aufirst%3DS.%2BN.%26aulast%3DRice%26aufirst%3DA.%2BS.%26aulast%3DSchmader%26aufirst%3DK.%2BE.%26aulast%3DStacey%26aufirst%3DB.%26aulast%3DStanos%26aufirst%3DS.%26aulast%3DTreede%26aufirst%3DR.%2BD.%26aulast%3DTurk%26aufirst%3DD.%2BC.%26aulast%3DWalco%26aufirst%3DG.%2BA.%26aulast%3DWells%26aufirst%3DC.%2BD.%26atitle%3DRecommendations%2520for%2520the%2520pharmacological%2520management%2520of%2520neuropathic%2520pain%253A%2520an%2520overview%2520and%2520literature%2520update%26jtitle%3DMayo%2520Clin.%2520Proc.%26date%3D2010%26volume%3D85%26spage%3DS3%26epage%3D14%26doi%3D10.4065%2Fmcp.2009.0649" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Mendell, L. M.</span><span> </span><span class="NLM_article-title">Constructing and deconstructing the gate theory of pain</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">155</span><span class="NLM_x">, </span> <span class="NLM_fpage">210</span><span class="NLM_x">–</span> <span class="NLM_lpage">216</span><span class="refDoi"> DOI: 10.1016/j.pain.2013.12.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=10.1016%2Fj.pain.2013.12.010" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=155&publication_year=2014&pages=210-216&author=L.+M.+Mendell&title=Constructing+and+deconstructing+the+gate+theory+of+pain&doi=10.1016%2Fj.pain.2013.12.010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.pain.2013.12.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pain.2013.12.010%26sid%3Dliteratum%253Aachs%26aulast%3DMendell%26aufirst%3DL.%2BM.%26atitle%3DConstructing%2520and%2520deconstructing%2520the%2520gate%2520theory%2520of%2520pain%26jtitle%3DPain%26date%3D2014%26volume%3D155%26spage%3D210%26epage%3D216%26doi%3D10.1016%2Fj.pain.2013.12.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Melzack, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wall, P. D.</span><span> </span><span class="NLM_article-title">Pain mechanisms: a new theory</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1965</span><span class="NLM_x">, </span> <span class="NLM_volume">150</span><span class="NLM_x">, </span> <span class="NLM_fpage">971</span><span class="NLM_x">–</span> <span class="NLM_lpage">979</span><span class="refDoi"> DOI: 10.1126/science.150.3699.971</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=10.1126%2Fscience.150.3699.971" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=150&publication_year=1965&pages=971-979&author=R.+Melzackauthor=P.+D.+Wall&title=Pain+mechanisms%3A+a+new+theory&doi=10.1126%2Fscience.150.3699.971"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1126%2Fscience.150.3699.971&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.150.3699.971%26sid%3Dliteratum%253Aachs%26aulast%3DMelzack%26aufirst%3DR.%26aulast%3DWall%26aufirst%3DP.%2BD.%26atitle%3DPain%2520mechanisms%253A%2520a%2520new%2520theory%26jtitle%3DScience%26date%3D1965%26volume%3D150%26spage%3D971%26epage%3D979%26doi%3D10.1126%2Fscience.150.3699.971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Harvey, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Depner, U. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wassle, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmadi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heindl, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinold, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smart, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvey, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schutz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abo-Salem, O. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poisbeau, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welzl, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfer, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Betz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeilhofer, H. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, U.</span><span> </span><span class="NLM_article-title">GlyR alpha3: an essential target for spinal PGE2-mediated inflammatory pain sensitization</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">304</span><span class="NLM_x">, </span> <span class="NLM_fpage">884</span><span class="NLM_x">–</span> <span class="NLM_lpage">887</span><span class="refDoi"> DOI: 10.1126/science.1094925</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=10.1126%2Fscience.1094925" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=304&publication_year=2004&pages=884-887&author=R.+J.+Harveyauthor=U.+B.+Depnerauthor=H.+Wassleauthor=S.+Ahmadiauthor=C.+Heindlauthor=H.+Reinoldauthor=T.+G.+Smartauthor=K.+Harveyauthor=B.+Schutzauthor=O.+M.+Abo-Salemauthor=A.+Zimmerauthor=P.+Poisbeauauthor=H.+Welzlauthor=D.+P.+Wolferauthor=H.+Betzauthor=H.+U.+Zeilhoferauthor=U.+Muller&title=GlyR+alpha3%3A+an+essential+target+for+spinal+PGE2-mediated+inflammatory+pain+sensitization&doi=10.1126%2Fscience.1094925"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1126%2Fscience.1094925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1094925%26sid%3Dliteratum%253Aachs%26aulast%3DHarvey%26aufirst%3DR.%2BJ.%26aulast%3DDepner%26aufirst%3DU.%2BB.%26aulast%3DWassle%26aufirst%3DH.%26aulast%3DAhmadi%26aufirst%3DS.%26aulast%3DHeindl%26aufirst%3DC.%26aulast%3DReinold%26aufirst%3DH.%26aulast%3DSmart%26aufirst%3DT.%2BG.%26aulast%3DHarvey%26aufirst%3DK.%26aulast%3DSchutz%26aufirst%3DB.%26aulast%3DAbo-Salem%26aufirst%3DO.%2BM.%26aulast%3DZimmer%26aufirst%3DA.%26aulast%3DPoisbeau%26aufirst%3DP.%26aulast%3DWelzl%26aufirst%3DH.%26aulast%3DWolfer%26aufirst%3DD.%2BP.%26aulast%3DBetz%26aufirst%3DH.%26aulast%3DZeilhofer%26aufirst%3DH.%2BU.%26aulast%3DMuller%26aufirst%3DU.%26atitle%3DGlyR%2520alpha3%253A%2520an%2520essential%2520target%2520for%2520spinal%2520PGE2-mediated%2520inflammatory%2520pain%2520sensitization%26jtitle%3DScience%26date%3D2004%26volume%3D304%26spage%3D884%26epage%3D887%26doi%3D10.1126%2Fscience.1094925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Acuna, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yevenes, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ralvenius, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benke, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Lio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lara, C. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgos, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moraga-Cid, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corringer, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeilhofer, H. U.</span><span> </span><span class="NLM_article-title">Phosphorylation state-dependent modulation of spinal glycine receptors alleviates inflammatory pain</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">126</span><span class="NLM_x">, </span> <span class="NLM_fpage">2547</span><span class="NLM_x">–</span> <span class="NLM_lpage">2560</span><span class="refDoi"> DOI: 10.1172/JCI83817</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=10.1172%2FJCI83817" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2016&pages=2547-2560&author=M.+A.+Acunaauthor=G.+E.+Yevenesauthor=W.+T.+Ralveniusauthor=D.+Benkeauthor=A.+Di+Lioauthor=C.+O.+Laraauthor=B.+Munozauthor=C.+F.+Burgosauthor=G.+Moraga-Cidauthor=P.+J.+Corringerauthor=H.+U.+Zeilhofer&title=Phosphorylation+state-dependent+modulation+of+spinal+glycine+receptors+alleviates+inflammatory+pain&doi=10.1172%2FJCI83817"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1172%2FJCI83817&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI83817%26sid%3Dliteratum%253Aachs%26aulast%3DAcuna%26aufirst%3DM.%2BA.%26aulast%3DYevenes%26aufirst%3DG.%2BE.%26aulast%3DRalvenius%26aufirst%3DW.%2BT.%26aulast%3DBenke%26aufirst%3DD.%26aulast%3DDi%2BLio%26aufirst%3DA.%26aulast%3DLara%26aufirst%3DC.%2BO.%26aulast%3DMunoz%26aufirst%3DB.%26aulast%3DBurgos%26aufirst%3DC.%2BF.%26aulast%3DMoraga-Cid%26aufirst%3DG.%26aulast%3DCorringer%26aufirst%3DP.%2BJ.%26aulast%3DZeilhofer%26aufirst%3DH.%2BU.%26atitle%3DPhosphorylation%2520state-dependent%2520modulation%2520of%2520spinal%2520glycine%2520receptors%2520alleviates%2520inflammatory%2520pain%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2016%26volume%3D126%26spage%3D2547%26epage%3D2560%26doi%3D10.1172%2FJCI83817" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Baba, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doubell, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woolf, C. J.</span><span> </span><span class="NLM_article-title">Peripheral inflammation facilitates Abeta fiber-mediated synaptic input to the substantia gelatinosa of the adult rat spinal cord</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">859</span><span class="NLM_x">–</span> <span class="NLM_lpage">867</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=10.1523%2FJNEUROSCI.19-02-00859.1999" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=9880605" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=1%3ACAS%3A528%3ADyaK1MXltlaltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1999&pages=859-867&author=H.+Babaauthor=T.+P.+Doubellauthor=C.+J.+Woolf&title=Peripheral+inflammation+facilitates+Abeta+fiber-mediated+synaptic+input+to+the+substantia+gelatinosa+of+the+adult+rat+spinal+cord"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Peripheral inflammation facilitates Aβ fiber-mediated synaptic input to the substantia gelatinosa of the adult rat spinal cord</span></div><div class="casAuthors">Baba, Hiroshi; Doubell, Timothy P.; Woolf, Clifford J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">859-867</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Whole-cell patch-clamp recordings were made from substantia gelatinosa (SG) neurons in thick adult rat transverse spinal cord slices with attached dorsal roots to study changes in fast synaptic transmission induced by peripheral inflammation.  In slices from naive rats, primary afferent stimulation at Aβ fiber intensity elicited polysynaptic EPSCs in only 14 of 57 (25%) SG neurons.  In contrast, Aβ fiber stimulation evoked polysynaptic EPSCs in 39 of 62 (63%) SG neurons recorded in slices from rats inflamed by an intraplantar injection of complete Freund's adjuvant (CFA) 48 h earlier (p < 0.001).  Although the peripheral inflammation had no significant effect on the threshold and conduction velocities of Aβ, Aδ, and C fibers recorded in dorsal roots, the mean threshold intensity for eliciting EPSCs was significantly lower in cells recorded from rats with inflammation (naive: 33.2 ± 15.1 μA, n = 57; inflamed: 22.8 ± 11.3 μA, n = 62, p < 0.001), and the mean latency of EPSCs elicited by Aβ fiber stimulation in CFA-treated rats was significantly shorter than that recorded from naive rats (3.3 ± 1.8 ms, n = 36 vs 6.0 ± 3.5 ms, n = 12; p = 0.010).  Aβ fiber stimulation evoked polysynaptic IPSCs in 4 of 25 (16%) cells recorded from naive rat prepns. and 14 of 26 (54%) SG neurons from CFA-treated rats (p < 0.001).  The mean threshold intensity for IPSCs was also significantly lower in CFA-treated rats (naive: 32.5 ± 15.7 μA, n = 25; inflamed: 21.9 ± 9.9 μA, n = 26, p = 0.013).  The facilitation of Aβ fiber-mediated input into the substantia gelatinosa after peripheral inflammation may contribute to altered sensory processing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrK6Y7ZjY5FarVg90H21EOLACvtfcHk0lipDNCRRt3-rA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXltlaltw%253D%253D&md5=8345437edc407e9bb800b39eba332cc4</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.19-02-00859.1999&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.19-02-00859.1999%26sid%3Dliteratum%253Aachs%26aulast%3DBaba%26aufirst%3DH.%26aulast%3DDoubell%26aufirst%3DT.%2BP.%26aulast%3DWoolf%26aufirst%3DC.%2BJ.%26atitle%3DPeripheral%2520inflammation%2520facilitates%2520Abeta%2520fiber-mediated%2520synaptic%2520input%2520to%2520the%2520substantia%2520gelatinosa%2520of%2520the%2520adult%2520rat%2520spinal%2520cord%26jtitle%3DJ.%2520Neurosci.%26date%3D1999%26volume%3D19%26spage%3D859%26epage%3D867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Ahmadi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippross, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neuhuber, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeilhofer, H. U.</span><span> </span><span class="NLM_article-title">PGE(2) selectively blocks inhibitory glycinergic neurotransmission onto rat superficial dorsal horn neurons</span> <span class="citation_source-journal">Nat. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">34</span><span class="NLM_x">–</span> <span class="NLM_lpage">40</span><span class="refDoi"> DOI: 10.1038/nn778</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=10.1038%2Fnn778" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=11740501" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=1%3ACAS%3A528%3ADC%252BD38XjtlCquw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2002&pages=34-40&author=S.+Ahmadiauthor=S.+Lipprossauthor=W.+L.+Neuhuberauthor=H.+U.+Zeilhofer&title=PGE%282%29+selectively+blocks+inhibitory+glycinergic+neurotransmission+onto+rat+superficial+dorsal+horn+neurons&doi=10.1038%2Fnn778"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">PGE2 selectively blocks inhibitory glycinergic neurotransmission onto rat superficial dorsal horn neurons</span></div><div class="casAuthors">Ahmadi, Seifollah; Lippross, Sebastian; Neuhuber, Winfried L.; Zeilhofer, Hanns Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">34-40</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">Despite the crucial role that prostaglandins (PGs) have in the sensitization of the central nervous system to pain, their cellular and mol. targets leading to increased pain perception have remained elusive.  Here the authors investigated the effects of PGE2 on fast synaptic transmission onto neurons in the rat spinal cord dorsal horn, the first site of synaptic integration in the pain pathway.  The authors identified the inhibitory (strychnine-sensitive) glycine receptor as a specific target of PGE2.  PGE2, but not PGF2α, PGD2 or PGI2, reduced inhibitory glycinergic synaptic transmission in low nanomolar concns., whereas GABAA, AMPA and NMDA receptor-mediated transmission remained unaffected.  Inhibition of glycine receptors occurred via a postsynaptic mechanism involving the activation of EP2 receptors, cholera-toxin-sensitive G-proteins and cAMP-dependent protein kinase.  Via this mechanism, PGE2 may facilitate the transmission of nociceptive input through the spinal cord dorsal horn to higher brain areas where pain becomes conscious.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTxxP_OKhkq7Vg90H21EOLACvtfcHk0lipDNCRRt3-rA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjtlCquw%253D%253D&md5=f69dfe113f56412ace02511f8949187a</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnn778&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn778%26sid%3Dliteratum%253Aachs%26aulast%3DAhmadi%26aufirst%3DS.%26aulast%3DLippross%26aufirst%3DS.%26aulast%3DNeuhuber%26aufirst%3DW.%2BL.%26aulast%3DZeilhofer%26aufirst%3DH.%2BU.%26atitle%3DPGE%25282%2529%2520selectively%2520blocks%2520inhibitory%2520glycinergic%2520neurotransmission%2520onto%2520rat%2520superficial%2520dorsal%2520horn%2520neurons%26jtitle%3DNat.%2520Neurosci.%26date%3D2002%26volume%3D5%26spage%3D34%26epage%3D40%26doi%3D10.1038%2Fnn778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Yevenes, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeilhofer, H. U.</span><span> </span><span class="NLM_article-title">Allosteric modulation of glycine receptors</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">164</span><span class="NLM_x">, </span> <span class="NLM_fpage">224</span><span class="NLM_x">–</span> <span class="NLM_lpage">236</span><span class="refDoi"> DOI: 10.1111/j.1476-5381.2011.01471.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=10.1111%2Fj.1476-5381.2011.01471.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=21557733" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFWqsLnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=164&publication_year=2011&pages=224-236&author=G.+E.+Yevenesauthor=H.+U.+Zeilhofer&title=Allosteric+modulation+of+glycine+receptors&doi=10.1111%2Fj.1476-5381.2011.01471.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric modulation of glycine receptors</span></div><div class="casAuthors">Yevenes, Gonzalo E.; Zeilhofer, Hanns Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">164</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">224-236</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Inhibitory (or strychnine sensitive) glycine receptors (GlyRs) are anion-selective transmitter-gated ion channels of the cys-loop superfamily, which includes among others also the inhibitory γ-aminobutyric acid receptors (GABAA receptors).  While GABA mediates fast inhibitory neurotransmission throughout the CNS, the action of glycine as a fast inhibitory neurotransmitter is more restricted.  This probably explains why GABAA receptors constitute a group of extremely successful drug targets in the treatment of a wide variety of CNS diseases, including anxiety, sleep disorders and epilepsy, while drugs specifically targeting GlyRs are virtually lacking.  However, the spatially more restricted distribution of glycinergic inhibition may be advantageous in situations when a more localized enhancement of inhibition is sought.  Inhibitory GlyRs are particularly relevant for the control of excitability in the mammalian spinal cord, brain stem and a few selected brain areas, such as the cerebellum and the retina.  At these sites, GlyRs regulate important physiol. functions, including respiratory rhythms, motor control, muscle tone and sensory as well as pain processing.  In the hippocampus, RNA-edited high affinity extrasynaptic GlyRs may contribute to the pathol. of temporal lobe epilepsy.  Although specific modulators have not yet been identified, GlyRs still possess sites for allosteric modulation by a no. of structurally diverse mols., including alcs., neurosteroids, cannabinoids, tropeines, general anesthetics, certain neurotransmitters and cations.  This review summarizes the present knowledge about this modulation and the mol. bases of the interactions involved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6eJFQAejcz7Vg90H21EOLACvtfcHk0lhlkjMt_MzpEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFWqsLnI&md5=914d17340c9b2db2306f100e57374654</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2011.01471.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2011.01471.x%26sid%3Dliteratum%253Aachs%26aulast%3DYevenes%26aufirst%3DG.%2BE.%26aulast%3DZeilhofer%26aufirst%3DH.%2BU.%26atitle%3DAllosteric%2520modulation%2520of%2520glycine%2520receptors%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2011%26volume%3D164%26spage%3D224%26epage%3D236%26doi%3D10.1111%2Fj.1476-5381.2011.01471.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Xiong, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godlewski, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span> </span><span class="NLM_article-title">Cannabinoid potentiation of glycine receptors contributes to cannabis-induced analgesia</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">296</span><span class="NLM_x">–</span> <span class="NLM_lpage">303</span><span class="refDoi"> DOI: 10.1038/nchembio.552</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=10.1038%2Fnchembio.552" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=21460829" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFahsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=296-303&author=W.+Xiongauthor=K.+Chengauthor=T.+Cuiauthor=G.+Godlewskiauthor=K.+C.+Riceauthor=Y.+Xuauthor=L.+Zhang&title=Cannabinoid+potentiation+of+glycine+receptors+contributes+to+cannabis-induced+analgesia&doi=10.1038%2Fnchembio.552"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Cannabinoid potentiation of glycine receptors contributes to cannabis-induced analgesia</span></div><div class="casAuthors">Xiong, Wei; Cheng, Ke-Jun; Cui, Tan-Xing; Godlewski, Grzegorz; Rice, Kenner C.; Xu, Yan; Zhang, Li</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">296-303</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Cannabinoids enhance the function of glycine receptors (GlyRs).  However, little is known about the mechanisms and behavioral implication of cannabinoid-GlyR interaction.  Using mutagenesis and NMR anal., we have identified a serine at 296 in the GlyR protein crit. for the potentiation of IGly by Δ9-tetrahydrocannabinol (THC), a major psychoactive component of marijuana.  The polarity of the amino acid residue at 296 and the hydroxyl groups of THC are crit. for THC potentiation.  Removal of the hydroxyl groups of THC results in a compd. that does not affect IGly when applied alone but selectively antagonizes cannabinoid-induced potentiating effect on IGly and analgesic effect in a tail-flick test in mice.  The cannabinoid-induced analgesia is absent in mice lacking α3GlyRs but not in those lacking CB1 and CB2 receptors.  These findings reveal a new mechanism underlying cannabinoid potentiation of GlyRs, which could contribute to some of the cannabis-induced analgesic and therapeutic effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXXYUIGOW5aLVg90H21EOLACvtfcHk0lhlkjMt_MzpEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFahsb8%253D&md5=d876adbbb4cf5b88302b7a15b430a30c</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.552&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.552%26sid%3Dliteratum%253Aachs%26aulast%3DXiong%26aufirst%3DW.%26aulast%3DCheng%26aufirst%3DK.%26aulast%3DCui%26aufirst%3DT.%26aulast%3DGodlewski%26aufirst%3DG.%26aulast%3DRice%26aufirst%3DK.%2BC.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DL.%26atitle%3DCannabinoid%2520potentiation%2520of%2520glycine%2520receptors%2520contributes%2520to%2520cannabis-induced%2520analgesia%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2011%26volume%3D7%26spage%3D296%26epage%3D303%26doi%3D10.1038%2Fnchembio.552" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Xiong, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willenbring, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span> </span><span class="NLM_article-title">Cannabinoids suppress inflammatory and neuropathic pain by targeting alpha3 glycine receptors</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">209</span><span class="NLM_x">, </span> <span class="NLM_fpage">1121</span><span class="NLM_x">–</span> <span class="NLM_lpage">1134</span><span class="refDoi"> DOI: 10.1084/jem.20120242</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=10.1084%2Fjem.20120242" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=22585736" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=1%3ACAS%3A528%3ADC%252BC38XoslSiu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=209&publication_year=2012&pages=1121-1134&author=W.+Xiongauthor=T.+Cuiauthor=K.+Chengauthor=F.+Yangauthor=S.+R.+Chenauthor=D.+Willenbringauthor=Y.+Guanauthor=H.+L.+Panauthor=K.+Renauthor=Y.+Xuauthor=L.+Zhang&title=Cannabinoids+suppress+inflammatory+and+neuropathic+pain+by+targeting+alpha3+glycine+receptors&doi=10.1084%2Fjem.20120242"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors</span></div><div class="casAuthors">Xiong, Wei; Cui, Tanxing; Cheng, Kejun; Yang, Fei; Chen, Shao-Rui; Willenbring, Dan; Guan, Yun; Pan, Hui-Lin; Ren, Ke; Xu, Yan; Zhang, Li</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">209</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1121-1134</span>CODEN:
                <span class="NLM_cas:coden">JEMEAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-1007</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Certain types of nonpsychoactive cannabinoids can potentiate glycine receptors (GlyRs), an important target for nociceptive regulation at the spinal level.  However, little is known about the potential and mechanism of glycinergic cannabinoids for chronic pain treatment.  We report that systemic and intrathecal administration of cannabidiol (CBD), a major nonpsychoactive component of marijuana, and its modified derivs. significantly suppress chronic inflammatory and neuropathic pain without causing apparent analgesic tolerance in rodents.  The cannabinoids significantly potentiate glycine currents in dorsal horn neurons in rat spinal cord slices.  The analgesic potency of 11 structurally similar cannabinoids is pos. correlated with cannabinoid potentiation of the α3 GlyRs.  In contrast, the cannabinoid analgesia is neither correlated with their binding affinity for CB1 and CB2 receptors nor with their psychoactive side effects.  NMR anal. reveals a direct interaction between CBD and S296 in the third transmembrane domain of purified α3 GlyR.  The cannabinoid-induced analgesic effect is absent in mice lacking the α3 GlyRs.  Our findings suggest that the α3 GlyRs mediate glycinergic cannabinoid-induced suppression of chronic pain.  These cannabinoids may represent a novel class of therapeutic agents for the treatment of chronic pain and other diseases involving GlyR dysfunction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEOC_gcxFbX7Vg90H21EOLACvtfcHk0lhlkjMt_MzpEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XoslSiu7s%253D&md5=5544bf3edd1c484c04a1ae0c8980ec4a</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1084%2Fjem.20120242&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20120242%26sid%3Dliteratum%253Aachs%26aulast%3DXiong%26aufirst%3DW.%26aulast%3DCui%26aufirst%3DT.%26aulast%3DCheng%26aufirst%3DK.%26aulast%3DYang%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DS.%2BR.%26aulast%3DWillenbring%26aufirst%3DD.%26aulast%3DGuan%26aufirst%3DY.%26aulast%3DPan%26aufirst%3DH.%2BL.%26aulast%3DRen%26aufirst%3DK.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DL.%26atitle%3DCannabinoids%2520suppress%2520inflammatory%2520and%2520neuropathic%2520pain%2520by%2520targeting%2520alpha3%2520glycine%2520receptors%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2012%26volume%3D209%26spage%3D1121%26epage%3D1134%26doi%3D10.1084%2Fjem.20120242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Yevenes, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeilhofer, H. U.</span><span> </span><span class="NLM_article-title">Molecular sites for the positive allosteric modulation of glycine receptors by endocannabinoids</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">e23886</span><span class="refDoi"> DOI: 10.1371/journal.pone.0023886</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=10.1371%2Fjournal.pone.0023886" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=e23886&author=G.+E.+Yevenesauthor=H.+U.+Zeilhofer&title=Molecular+sites+for+the+positive+allosteric+modulation+of+glycine+receptors+by+endocannabinoids&doi=10.1371%2Fjournal.pone.0023886"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0023886&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0023886%26sid%3Dliteratum%253Aachs%26aulast%3DYevenes%26aufirst%3DG.%2BE.%26aulast%3DZeilhofer%26aufirst%3DH.%2BU.%26atitle%3DMolecular%2520sites%2520for%2520the%2520positive%2520allosteric%2520modulation%2520of%2520glycine%2520receptors%2520by%2520endocannabinoids%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26spage%3De23886%26doi%3D10.1371%2Fjournal.pone.0023886" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Zhang, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y. X.</span><span> </span><span class="NLM_article-title">Gelsemine, a principal alkaloid from Gelsemium sempervirens Ait., exhibits potent and specific antinociception in chronic pain by acting at spinal alpha3 glycine receptors</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">154</span><span class="NLM_x">, </span> <span class="NLM_fpage">2452</span><span class="NLM_x">–</span> <span class="NLM_lpage">2462</span><span class="refDoi"> DOI: 10.1016/j.pain.2013.07.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=10.1016%2Fj.pain.2013.07.027" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=154&publication_year=2013&pages=2452-2462&author=J.+Y.+Zhangauthor=N.+Gongauthor=J.+L.+Huangauthor=L.+C.+Guoauthor=Y.+X.+Wang&title=Gelsemine%2C+a+principal+alkaloid+from+Gelsemium+sempervirens+Ait.%2C+exhibits+potent+and+specific+antinociception+in+chronic+pain+by+acting+at+spinal+alpha3+glycine+receptors&doi=10.1016%2Fj.pain.2013.07.027"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.pain.2013.07.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pain.2013.07.027%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%2BY.%26aulast%3DGong%26aufirst%3DN.%26aulast%3DHuang%26aufirst%3DJ.%2BL.%26aulast%3DGuo%26aufirst%3DL.%2BC.%26aulast%3DWang%26aufirst%3DY.%2BX.%26atitle%3DGelsemine%252C%2520a%2520principal%2520alkaloid%2520from%2520Gelsemium%2520sempervirens%2520Ait.%252C%2520exhibits%2520potent%2520and%2520specific%2520antinociception%2520in%2520chronic%2520pain%2520by%2520acting%2520at%2520spinal%2520alpha3%2520glycine%2520receptors%26jtitle%3DPain%26date%3D2013%26volume%3D154%26spage%3D2452%26epage%3D2462%26doi%3D10.1016%2Fj.pain.2013.07.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Lara, C. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murath, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marileo, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">San Martin, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgos, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mariqueo, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguayo, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuentealba, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godoy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yevenes, G. E.</span><span> </span><span class="NLM_article-title">Functional modulation of glycine receptors by the alkaloid gelsemine</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">173</span><span class="NLM_x">, </span> <span class="NLM_fpage">2263</span><span class="NLM_x">–</span> <span class="NLM_lpage">2277</span><span class="refDoi"> DOI: 10.1111/bph.13507</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=10.1111%2Fbph.13507" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=27128379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=1%3ACAS%3A528%3ADC%252BC28XptFWgtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=173&publication_year=2016&pages=2263-2277&author=C.+O.+Laraauthor=P.+Murathauthor=B.+Munozauthor=A.+M.+Marileoauthor=L.+S.+Martinauthor=V.+P.+San+Martinauthor=C.+F.+Burgosauthor=T.+A.+Mariqueoauthor=L.+G.+Aguayoauthor=J.+Fuentealbaauthor=P.+Godoyauthor=L.+Guzmanauthor=G.+E.+Yevenes&title=Functional+modulation+of+glycine+receptors+by+the+alkaloid+gelsemine&doi=10.1111%2Fbph.13507"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Functional modulation of glycine receptors by the alkaloid gelsemine</span></div><div class="casAuthors">Lara, Cesar O.; Murath, Pablo; Munoz, Braulio; Marileo, Ana M.; San Martin, Loreto; San Martin, Victoria P.; Burgos, Carlos F.; Mariqueo, Trinidad A.; Aguayo, Luis G.; Fuentealba, Jorge; Godoy, Patricio; Guzman, Leonardo; Yevenes, Gonzalo E.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">173</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2263-2277</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose : Gelsemine is one of the principal alkaloids produced by the Gelsemium genus of plants belonging to the Loganiaceae family.  The exts. of these plants have been used for many years, for a variety of medicinal purposes.  Coincidentally, recent studies have shown that gelsemine exerts anxiolytic and analgesic effects on behavioral models.  Several lines of evidence have suggested that these beneficial actions were dependent on glycine receptors, which are inhibitory neurotransmitter-gated ion channels of the CNS.  However, it is currently unknown whether gelsemine can directly modulate the function of glycine receptors.  Exptl. Approach : We examd. the functional effects of gelsemine on glycine receptors expressed in transfected HEK293 cells and in cultured spinal neurons by electrophysiol. techniques.  Key Results : Gelsemine directly modulated recombinant and native glycine receptors and exerted conformation-specific and subunit-selective effects.  Gelsemine modulation was voltage-independent and was assocd. with differential changes in the apparent affinity for glycine and in the open probability of the ion channel.  In addn., the alkaloid preferentially targeted glycine receptors in spinal neurons and showed only minor effects on GABAA and AMPA receptors.  Furthermore, gelsemine significantly diminished the frequency of glycinergic and glutamatergic synaptic events without altering the amplitude.  Conclusions and Implications : Our results provide a pharmacol. basis to explain, at least in part, the glycine receptor-dependent, beneficial and toxic effects of gelsemine in animals and humans.  In addn., the pharmacol. profile of gelsemine may open new approaches to the development of subunit-selective modulators of glycine receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYJ1piJL_OibVg90H21EOLACvtfcHk0lioEKPsStWrpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XptFWgtbY%253D&md5=89c5e3b2346ee99b92565cc129dd24be</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1111%2Fbph.13507&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.13507%26sid%3Dliteratum%253Aachs%26aulast%3DLara%26aufirst%3DC.%2BO.%26aulast%3DMurath%26aufirst%3DP.%26aulast%3DMunoz%26aufirst%3DB.%26aulast%3DMarileo%26aufirst%3DA.%2BM.%26aulast%3DMartin%26aufirst%3DL.%2BS.%26aulast%3DSan%2BMartin%26aufirst%3DV.%2BP.%26aulast%3DBurgos%26aufirst%3DC.%2BF.%26aulast%3DMariqueo%26aufirst%3DT.%2BA.%26aulast%3DAguayo%26aufirst%3DL.%2BG.%26aulast%3DFuentealba%26aufirst%3DJ.%26aulast%3DGodoy%26aufirst%3DP.%26aulast%3DGuzman%26aufirst%3DL.%26aulast%3DYevenes%26aufirst%3DG.%2BE.%26atitle%3DFunctional%2520modulation%2520of%2520glycine%2520receptors%2520by%2520the%2520alkaloid%2520gelsemine%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2016%26volume%3D173%26spage%3D2263%26epage%3D2277%26doi%3D10.1111%2Fbph.13507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Breitinger, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sticht, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breitinger, H. G.</span><span> </span><span class="NLM_article-title">Modulation of recombinant human alpha1 glycine receptors by mono- and disaccharides: a kinetic study</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1077</span><span class="NLM_x">–</span> <span class="NLM_lpage">1087</span><span class="refDoi"> DOI: 10.1021/acschemneuro.6b00044</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.6b00044" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=1%3ACAS%3A528%3ADC%252BC28XosFyksb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=1077-1087&author=U.+Breitingerauthor=H.+Stichtauthor=H.+G.+Breitinger&title=Modulation+of+recombinant+human+alpha1+glycine+receptors+by+mono-+and+disaccharides%3A+a+kinetic+study&doi=10.1021%2Facschemneuro.6b00044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of Recombinant Human α1 Glycine Receptors by Mono- and Disaccharides: A Kinetic Study</span></div><div class="casAuthors">Breitinger, Ulrike; Sticht, Heinrich; Breitinger, Hans-Georg</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1077-1087</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Glycine receptors (GlyRs) mediate fast synaptic inhibition in spinal cord, brainstem, and higher brain centers.  Recently, glucose was identified as a pos. modulator of GlyR-mediated currents.  Here, we investigated extent and kinetics of the pos. modulation of recombinant human α1 glycine receptors by different mono- and disaccharides and sorbitol using patch-clamp recording techniques.  Glucose and fructose augmented glycine-mediated whole-cell currents with an EC50 of 6-7 mM.  At concns. > 10 mM, the max. of current enhancement was reached within ∼30 min.  Kinetics of GlyR modulation resemble those of protein glycation.  On-rates were <0.5 h for satg. concns. of monosaccharides and ∼1.5 h for disaccharides.  Off-rates were considerably slower (>24 h).  Galactose, the C4-epimer of glucose, and the sugar alc. sorbitol had no effect on GlyR currents.  Recent cryoelectron microscopy structures were used to identify a potential binding site for saccharides near the ivermectin binding pocket with lysine 143 as possible attachment site.  The GlyR mutant α1(K143A) was not potentiated by glucose, suggesting an involvement of this residue in glycine receptor modulation by saccharides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0uDD48vAjrbVg90H21EOLACvtfcHk0lioEKPsStWrpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XosFyksb0%253D&md5=dd2525255bcf13de4e5a25b0a1cd4e77</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.6b00044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.6b00044%26sid%3Dliteratum%253Aachs%26aulast%3DBreitinger%26aufirst%3DU.%26aulast%3DSticht%26aufirst%3DH.%26aulast%3DBreitinger%26aufirst%3DH.%2BG.%26atitle%3DModulation%2520of%2520recombinant%2520human%2520alpha1%2520glycine%2520receptors%2520by%2520mono-%2520and%2520disaccharides%253A%2520a%2520kinetic%2520study%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2016%26volume%3D7%26spage%3D1077%26epage%3D1087%26doi%3D10.1021%2Facschemneuro.6b00044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Maleeva, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buldakova, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bregestovski, P.</span><span> </span><span class="NLM_article-title">Selective potentiation of alpha 1 glycine receptors by ginkgolic acid</span> <span class="citation_source-journal">Front. Mol. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">64</span><span class="refDoi"> DOI: 10.3389/fnmol.2015.00064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=10.3389%2Ffnmol.2015.00064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=26578878" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=1%3ACAS%3A528%3ADC%252BC1cXlvVCrsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2015&pages=64&author=G.+Maleevaauthor=S.+Buldakovaauthor=P.+Bregestovski&title=Selective+potentiation+of+alpha+1+glycine+receptors+by+ginkgolic+acid&doi=10.3389%2Ffnmol.2015.00064"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Selective potentiation of alpha 1 glycine receptors by ginkgolic acid</span></div><div class="casAuthors">Maleeva, Galyna; Buldakova, Svetlana; Bregestovski, Piotr</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Molecular Neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">64/1-64/11</span>CODEN:
                <span class="NLM_cas:coden">FMNRAJ</span>;
        ISSN:<span class="NLM_cas:issn">1662-5099</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Glycine receptors (GlyRs) belong to the superfamily of pentameric cys-loop receptor-operated channels and are involved in numerous physiol. functions, including movement, vision, and pain.  In search for compds. performing subunit-specific modulation of GlyRs we studied action of ginkgolic acid, an abundant Ginkgo biloba product.  Using patch-clamp recordings, we analyzed the effects of ginkgolic acid in concns. from 30 nM to 25 μM on α1-α3 and α1/β, α2/β configurations of GlyR and on GABAARs expressed in cultured CHO-K1 cells and mouse neuroblastoma (N2a) cells.  Ginkgolic acid caused an increase in the amplitude of currents mediated by homomeric α1 and heteromeric α1/β GlyRs and provoked a left-shift of the concn.-dependent curves for glycine.  Even at high concns. (10-25 μM) ginkgolic acid was not able to augment ionic currents mediated by α2, α2/β, and α3 GlyRs, or by GABAAR consisting of α1/β2/γ2 subunits.  Mutation of three residues (T59A/A261G/A303S) in the α2 GlyR subunit to the corresponding ones from the α1 converted the action of ginkgolic acid to potentiation with a distinct decrease in EC50 for glycine, suggesting an important role for these residues in modulation by ginkgolic acid.  Our results suggest that ginkgolic acid is a novel selective enhancer of α1 GlyRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1m_PGwOzR0rVg90H21EOLACvtfcHk0lioEKPsStWrpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXlvVCrsrc%253D&md5=b8880c5344c55676e05516e338762d05</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.3389%2Ffnmol.2015.00064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnmol.2015.00064%26sid%3Dliteratum%253Aachs%26aulast%3DMaleeva%26aufirst%3DG.%26aulast%3DBuldakova%26aufirst%3DS.%26aulast%3DBregestovski%26aufirst%3DP.%26atitle%3DSelective%2520potentiation%2520of%2520alpha%25201%2520glycine%2520receptors%2520by%2520ginkgolic%2520acid%26jtitle%3DFront.%2520Mol.%2520Neurosci.%26date%3D2015%26volume%3D8%26spage%3D64%26doi%3D10.3389%2Ffnmol.2015.00064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Stead, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nickolls, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kammonen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pryde, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cawkill, D.</span><span> </span><span class="NLM_article-title">Identification of positive allosteric modulators of glycine receptors from a high-throughput screen using a fluorescent membrane potential assay</span> <span class="citation_source-journal">J. Biomol. Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1042</span><span class="NLM_x">–</span> <span class="NLM_lpage">1053</span><span class="refDoi"> DOI: 10.1177/1087057116657779</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=10.1177%2F1087057116657779" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=27412533" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=1%3ACAS%3A280%3ADC%252BC2s3gsFGjtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=1042-1053&author=C.+Steadauthor=A.+Brownauthor=C.+Adamsauthor=S.+J.+Nickollsauthor=G.+Youngauthor=J.+Kammonenauthor=D.+Prydeauthor=D.+Cawkill&title=Identification+of+positive+allosteric+modulators+of+glycine+receptors+from+a+high-throughput+screen+using+a+fluorescent+membrane+potential+assay&doi=10.1177%2F1087057116657779"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Positive Allosteric Modulators of Glycine Receptors from a High-Throughput Screen Using a Fluorescent Membrane Potential Assay</span></div><div class="casAuthors">Stead Clara; Brown Adam; Adams Cathryn; Nickolls Sarah J; Young Gareth; Kammonen Juha; Pryde David; Cawkill Darren</div><div class="citationInfo"><span class="NLM_cas:title">Journal of biomolecular screening</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1042-1053</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Glycine receptor 3 (GlyRα3) is a ligand-gated ion channel of the cys-loop family that plays a key role in mediating inhibitory neurotransmission and regulation of pain signaling in the dorsal horn.  Potentiation of GlyRα3 function is therefore of interest as a putative analgesic mechanism with which to target new therapeutics.  However, to date, positive allosteric modulators (PAMs) of this receptor with sufficient selectivity to enable target validation studies have not been described.  To address this lack of pharmacological tools, we developed a suite of in vitro assays comprising a high-throughput fluorescent membrane potential screen and a medium-throughput electrophysiology assay using IonFlux HT together with conventional manual patch clamp.  Using these assays, we conducted a primary screening campaign and report the structures of hit compounds identified as GlyR PAMs.  Our functional characterization data reveal a hit compound with high efficacy relative to current known potentiators and selectivity over GABAAR, another major class of inhibitory neurotransmission receptors of importance to pain.  These small-molecule GlyR PAMs have high potential both as early tool compounds to enable pharmacological studies of GlyR inhibitory neurotransmission and as a starting point for the development of potent, selective GlyRα3 PAMs as novel analgesics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS_9S5PmMQ5VD0O18WR3iAofW6udTcc2ebAJ4jxGB-qsLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s3gsFGjtg%253D%253D&md5=4cd7f034e2cdb59bb4d156c92e5b9ed0</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1177%2F1087057116657779&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057116657779%26sid%3Dliteratum%253Aachs%26aulast%3DStead%26aufirst%3DC.%26aulast%3DBrown%26aufirst%3DA.%26aulast%3DAdams%26aufirst%3DC.%26aulast%3DNickolls%26aufirst%3DS.%2BJ.%26aulast%3DYoung%26aufirst%3DG.%26aulast%3DKammonen%26aufirst%3DJ.%26aulast%3DPryde%26aufirst%3DD.%26aulast%3DCawkill%26aufirst%3DD.%26atitle%3DIdentification%2520of%2520positive%2520allosteric%2520modulators%2520of%2520glycine%2520receptors%2520from%2520a%2520high-throughput%2520screen%2520using%2520a%2520fluorescent%2520membrane%2520potential%2520assay%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2016%26volume%3D21%26spage%3D1042%26epage%3D1053%26doi%3D10.1177%2F1087057116657779" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Rajendra, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schofield, P. R.</span><span> </span><span class="NLM_article-title">The glycine receptor</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">121</span><span class="NLM_x">–</span> <span class="NLM_lpage">146</span><span class="refDoi"> DOI: 10.1016/S0163-7258(96)00163-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=10.1016%2FS0163-7258%2896%2900163-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=9131721" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=1%3ACAS%3A528%3ADyaK2sXisFKiu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=1997&pages=121-146&author=S.+Rajendraauthor=J.+W.+Lynchauthor=P.+R.+Schofield&title=The+glycine+receptor&doi=10.1016%2FS0163-7258%2896%2900163-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">The glycine receptor</span></div><div class="casAuthors">Rajendra, Sundran; Lynch, Joseph W.; Schofield, Peter R.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">121-146</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review, with ∼250 refs.  The inhibitory glycine receptor (GlyR) is a member of the ligand-gated ion channel receptor superfamily.  The GlyR comprises a pentameric complex that forms a Cl--selective transmembrane channel, which is predominantly expressed in the spinal cord and brain stem.  We review the pharmacol. and physiol. properties of the GlyR and relate this information to more recent insights that have been obtained through the cloning and recombinant expression of the GlyR subunits.  We also discuss insights into our understanding of GlyR structure and function that have been obtained by the genetic characterization of various heritable disorders of glycinergic neurotransmission.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcw9zCDlj2_7Vg90H21EOLACvtfcHk0lhElbcDgPOTew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXisFKiu7k%253D&md5=575fc82e5852206bf96a44bcf93e4a76</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2FS0163-7258%2896%2900163-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0163-7258%252896%252900163-5%26sid%3Dliteratum%253Aachs%26aulast%3DRajendra%26aufirst%3DS.%26aulast%3DLynch%26aufirst%3DJ.%2BW.%26aulast%3DSchofield%26aufirst%3DP.%2BR.%26atitle%3DThe%2520glycine%2520receptor%26jtitle%3DPharmacol.%2520Ther.%26date%3D1997%26volume%3D73%26spage%3D121%26epage%3D146%26doi%3D10.1016%2FS0163-7258%2896%2900163-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Lynch, J. W.</span><span> </span><span class="NLM_article-title">Molecular structure and function of the glycine receptor chloride channel</span> <span class="citation_source-journal">Physiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">1051</span><span class="NLM_x">–</span> <span class="NLM_lpage">1095</span><span class="refDoi"> DOI: 10.1152/physrev.00042.2003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=10.1152%2Fphysrev.00042.2003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=15383648" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=1%3ACAS%3A528%3ADC%252BD2cXovVyltLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2004&pages=1051-1095&author=J.+W.+Lynch&title=Molecular+structure+and+function+of+the+glycine+receptor+chloride+channel&doi=10.1152%2Fphysrev.00042.2003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular structure and function of the glycine receptor chloride channel</span></div><div class="casAuthors">Lynch, Joseph W.</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1051-1095</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">0031-9333</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review.  The glycine receptor chloride channel (GlyR) is a member of the nicotinic acetylcholine receptor family of ligand-gated ion channels.  Functional receptors of this family comprise five subunits and are important targets for neuroactive drugs.  The GlyR is best known for mediating inhibitory neurotransmission in the spinal cord and brain stem, although recent evidence suggests it may also have other physiol. roles, including excitatory neurotransmission in embryonic neurons.  To date, four α-subunits (α1 to α4) and one β-subunit have been identified.  The differential expression of subunits underlies a diversity in GlyR pharmacol.  A developmental switch from α2 to α1β is completed by around postnatal day 20 in the rat.  The β-subunit is responsible for anchoring GlyRs to the subsynaptic cytoskeleton via the cytoplasmic protein gephyrin.  The last few years have seen a surge in interest in these receptors.  Consequently, a wealth of information has recently emerged concerning GlyR mol. structure and function.  Most of the information has been obtained from homomeric α1 GlyRs, with the roles of the other subunits receiving relatively little attention.  Heritable mutations to human GlyR genes give rise to a rare neurol. disorder, hyperekplexia (or startle disease).  Similar syndromes also occur in other species.  A rapidly growing list of compds. has been shown to exert potent modulatory effects on this receptor.  Since GlyRs are involved in motor reflex circuits of the spinal cord and provide inhibitory synapses onto pain sensory neurons, these agents may provide lead compds. for the development of muscle relaxant and peripheral analgesic drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGommVKKf8XFtrVg90H21EOLACvtfcHk0lhElbcDgPOTew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXovVyltLk%253D&md5=d7da2a4c450699500456989990d91226</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.00042.2003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.00042.2003%26sid%3Dliteratum%253Aachs%26aulast%3DLynch%26aufirst%3DJ.%2BW.%26atitle%3DMolecular%2520structure%2520and%2520function%2520of%2520the%2520glycine%2520receptor%2520chloride%2520channel%26jtitle%3DPhysiol.%2520Rev.%26date%3D2004%26volume%3D84%26spage%3D1051%26epage%3D1095%26doi%3D10.1152%2Fphysrev.00042.2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Laube, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maksay, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schemm, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Betz, H.</span><span> </span><span class="NLM_article-title">Modulation of glycine receptor function: a novel approach for therapeutic intervention at inhibitory synapses?</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">519</span><span class="NLM_x">–</span> <span class="NLM_lpage">527</span><span class="refDoi"> DOI: 10.1016/S0165-6147(02)02138-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=10.1016%2FS0165-6147%2802%2902138-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=12413807" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=1%3ACAS%3A528%3ADC%252BD38XotF2js70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2002&pages=519-527&author=B.+Laubeauthor=G.+Maksayauthor=R.+Schemmauthor=H.+Betz&title=Modulation+of+glycine+receptor+function%3A+a+novel+approach+for+therapeutic+intervention+at+inhibitory+synapses%3F&doi=10.1016%2FS0165-6147%2802%2902138-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of glycine receptor function: a novel approach for therapeutic intervention at inhibitory synapses?</span></div><div class="casAuthors">Laube, Bodo; Maksay, Gabor; Schemm, Rudolf; Betz, Heinrich</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">519-527</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Transmitter-gated ion channels mediate rapid synaptic transmission in the central nervous system and constitute important targets for many neuroactive drugs.  Inhibitory glycine receptors (GlyRs) are members of the nicotinic acetylcholine receptor superfamily and inhibit neuronal firing by opening Cl- channels following agonist binding.  In this article, we discuss recent developments in GlyR pharmacol., delineate the receptor domains that are involved in binding of agonists and allosteric modulators, and present a mol. model of the extracellular architecture of the receptor.  The recent discovery of compds. that act preferentially on specific GlyR isoforms and the differential expression of these isoforms in distinct regions of the developing and adult CNS show considerable promise towards the development of drugs that act in defined glycine-mediated pathways.  In particular, compds. that can potentiate GlyR function should provide leads for novel muscle relaxants in addn. to sedative and analgesic agents.  The recent discovery of compds. that act preferentially on specific glycine receptor (GlyR) isoforms and the differential expression of these isoforms in distinct regions of the developing and adult CNS show considerable promise towards the development of novel muscle relaxant and analgesic drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovwKNawCH4G7Vg90H21EOLACvtfcHk0liGmIQKdEys0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XotF2js70%253D&md5=ca83d48169c390fd7c0f6e9b46eb3376</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2FS0165-6147%2802%2902138-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0165-6147%252802%252902138-7%26sid%3Dliteratum%253Aachs%26aulast%3DLaube%26aufirst%3DB.%26aulast%3DMaksay%26aufirst%3DG.%26aulast%3DSchemm%26aufirst%3DR.%26aulast%3DBetz%26aufirst%3DH.%26atitle%3DModulation%2520of%2520glycine%2520receptor%2520function%253A%2520a%2520novel%2520approach%2520for%2520therapeutic%2520intervention%2520at%2520inhibitory%2520synapses%253F%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2002%26volume%3D23%26spage%3D519%26epage%3D527%26doi%3D10.1016%2FS0165-6147%2802%2902138-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">May, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sexton, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, A.</span><span> </span><span class="NLM_article-title">Allosteric modulation of G protein-coupled receptors</span> <span class="citation_source-journal">Annu. Rev. Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span><span class="refDoi"> DOI: 10.1146/annurev.pharmtox.47.120505.105159</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=10.1146%2Fannurev.pharmtox.47.120505.105159" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=17009927" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=1%3ACAS%3A528%3ADC%252BD2sXit1altr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2007&pages=1-51&author=L.+T.+Mayauthor=K.+Leachauthor=P.+M.+Sextonauthor=A.+Christopoulos&title=Allosteric+modulation+of+G+protein-coupled+receptors&doi=10.1146%2Fannurev.pharmtox.47.120505.105159"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric modulation of G protein-coupled receptors</span></div><div class="casAuthors">May, Lauren T.; Leach, Katie; Sexton, Patrick M.; Christopoulos, Arthur</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Pharmacology and Toxicology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-51</span>CODEN:
                <span class="NLM_cas:coden">ARPTDI</span>;
        ISSN:<span class="NLM_cas:issn">0362-1642</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  The past decade has witnessed a significant growth in the identification of allosteric modulators of G protein-coupled receptors (GPCRs), i.e., ligands that interact with binding sites that are topog. distinct from the orthosteric site recognized by the receptor's endogenous agonist.  Because of their ability to modulate receptor conformations in the presence of orthosteric ligand, allosteric modulators can "fine-tune" classical pharmacol. responses.  This is advantageous in terms of a potential for engendering greater GPCR subtype-selectivity, but represents a significant challenge for detecting and validating allosteric behaviors.  Although allosteric sites need not have evolved to accommodate endogenous ligands, there are a no. of examples of where such modulators have been shown to contribute to physiol. or pathophysiol. processes.  Studies are also beginning to unravel the structural basis of allosteric modulation of GPCRs.  It remains to be detd. whether such modulation represents interactions within monomers vs. across dimers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6rgFXhej3ibVg90H21EOLACvtfcHk0liGmIQKdEys0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXit1altr0%253D&md5=848fa85abdfb3b40834887416479edec</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1146%2Fannurev.pharmtox.47.120505.105159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.pharmtox.47.120505.105159%26sid%3Dliteratum%253Aachs%26aulast%3DMay%26aufirst%3DL.%2BT.%26aulast%3DLeach%26aufirst%3DK.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DChristopoulos%26aufirst%3DA.%26atitle%3DAllosteric%2520modulation%2520of%2520G%2520protein-coupled%2520receptors%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D2007%26volume%3D47%26spage%3D1%26epage%3D51%26doi%3D10.1146%2Fannurev.pharmtox.47.120505.105159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="note"><p class="first last">See <a href="/doi/suppl/10.1021/acs.jmedchem.6b01496/suppl_file/jm6b01496_si_001.pdf" class="ext-link">Supporting Information</a> for platform, subtype and mouse cell line activities for <b>9</b>, <b>20</b>, and <b>32</b>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Pajouhesh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenz, G. R.</span><span> </span><span class="NLM_article-title">Medicinal chemical properties of successful central nervous system drugs</span> <span class="citation_source-journal">NeuroRx</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">541</span><span class="NLM_x">–</span> <span class="NLM_lpage">553</span><span class="refDoi"> DOI: 10.1602/neurorx.2.4.541</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=10.1602%2Fneurorx.2.4.541" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=16489364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=1%3ACAS%3A280%3ADC%252BD28%252FpvVKqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=541-553&author=H.+Pajouheshauthor=G.+R.+Lenz&title=Medicinal+chemical+properties+of+successful+central+nervous+system+drugs&doi=10.1602%2Fneurorx.2.4.541"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemical properties of successful central nervous system drugs</span></div><div class="casAuthors">Pajouhesh Hassan; Lenz George R</div><div class="citationInfo"><span class="NLM_cas:title">NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">541-53</span>
        ISSN:<span class="NLM_cas:issn">1545-5343</span>.
    </div><div class="casAbstract">Fundamental physiochemical features of CNS drugs are related to their ability to penetrate the blood-brain barrier affinity and exhibit CNS activity.  Factors relevant to the success of CNS drugs are reviewed.  CNS drugs show values of molecular weight, lipophilicity, and hydrogen bond donor and acceptor that in general have a smaller range than general therapeutics.  Pharmacokinetic properties can be manipulated by the medicinal chemist to a significant extent.  The solubility, permeability, metabolic stability, protein binding, and human ether-ago-go-related gene inhibition of CNS compounds need to be optimized simultaneously with potency, selectivity, and other biological parameters.  The balance between optimizing the physiochemical and pharmacokinetic properties to make the best compromises in properties is critical for designing new drugs likely to penetrate the blood brain barrier and affect relevant biological systems.  This review is intended as a guide to designing CNS therapeutic agents with better drug-like properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT_ncsy3yuEinl8icjszYl0fW6udTcc2eZp4JlEOv6Z4Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28%252FpvVKqsg%253D%253D&md5=0815084e2d107b9243b785d0782dfc3a</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1602%2Fneurorx.2.4.541&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1602%252Fneurorx.2.4.541%26sid%3Dliteratum%253Aachs%26aulast%3DPajouhesh%26aufirst%3DH.%26aulast%3DLenz%26aufirst%3DG.%2BR.%26atitle%3DMedicinal%2520chemical%2520properties%2520of%2520successful%2520central%2520nervous%2520system%2520drugs%26jtitle%3DNeuroRx%26date%3D2005%26volume%3D2%26spage%3D541%26epage%3D553%26doi%3D10.1602%2Fneurorx.2.4.541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="note"><p class="first last">Mouse GlyRα3β protein was not available. A strong correlation exists between human channel subtypes and human and mouse channels (see <a href="/doi/suppl/10.1021/acs.jmedchem.6b01496/suppl_file/jm6b01496_si_001.pdf" class="ext-link">Supporting Information</a> for data table of top leads).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="note"><p class="first last">ACD v10 values are provided.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Orr, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ripp, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballard, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henderson, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obach, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span> </span><span class="NLM_article-title">Mechanism-based inactivation (MBI) of cytochrome P450 enzymes: structure-activity relationships and discovery strategies to mitigate drug-drug interaction risks</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">4896</span><span class="NLM_x">–</span> <span class="NLM_lpage">4933</span><span class="refDoi"> DOI: 10.1021/jm300065h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300065h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjs1Wlur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4896-4933&author=S.+T.+Orrauthor=S.+L.+Rippauthor=T.+E.+Ballardauthor=J.+L.+Hendersonauthor=D.+O.+Scottauthor=R.+S.+Obachauthor=H.+Sunauthor=A.+S.+Kalgutkar&title=Mechanism-based+inactivation+%28MBI%29+of+cytochrome+P450+enzymes%3A+structure-activity+relationships+and+discovery+strategies+to+mitigate+drug-drug+interaction+risks&doi=10.1021%2Fjm300065h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism-Based Inactivation (MBI) of Cytochrome P450 Enzymes: Structure-Activity Relationships and Discovery Strategies To Mitigate Drug-Drug Interaction Risks</span></div><div class="casAuthors">Orr, Suvi T. M.; Ripp, Sharon L.; Ballard, T. Eric; Henderson, Jaclyn L.; Scott, Dennis O.; Obach, R. Scott; Sun, Hao; Kalgutkar, Amit S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4896-4933</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The importance of mitigating drug-drug interaction (DDI) risks, which arise from inhibition of major human cytochrome P 450 enzymes is a well-established component of the lead optimization process in drug discovery.  More recently, there has been much interest in clin. DDIs potentially arising via time- and concn.-dependent cytochrome P 450 inhibition, a phenomenon consistent with mechanism-based inactivation.  Inactivated P 450 is catalytically incompetent and must be replenished by newly synthesized protein.  Consequently, time-dependent inhibition of P450s presents a greater safety concern compared to reversible inhibition because of the increased propensity for pharmacokinetic interactions upon multiple dosing and the sustained duration of these interactions after discontinuation of the mechanism-based inactivator.  Mechanism-based or time-dependent P 450 inhibitors pose an addnl. risk of idiosyncratic drug toxicity since the mechanism of time-dependency often involves the formation of reactive metabolites, which can react with proteins other than the P 450 isoenzyme responsible for catalysis. in vitro time-dependent inhibition (TDI) of P 450 enzymes is now routinely assessed as part of lead optimization efforts in preclin. drug discovery.  However, identification of an in vitro TDI liability can raise several questions such as: What is the mechanism of TDI.  Does it involve the formation of reactive metabolites.  Is there a 1:1 correlation between P 450 TDI and RM formation (as measured from reactive metabolite trapping studies).  What is the likelihood that a P 450 time-dependent inhibitor will also cause toxicity.  What are the DDI risk mitigation options when dealing with P 450 inactivators in drug discovery - compd. progression or termination.  Several drugs exhibit in vitro TDI of P 450 enzymes, but only a fraction thereof causes clin. DDIs.  Hence, when do we initiate labor-intensive medicinal chem. efforts to design compds. devoid of P 450 TDI liability.  What are the best methods to precisely predict the likelihood of occurrence of clin. DDIs with drug candidates that inactivate P 450 enzymes.  What are (if any) the qualifying considerations for clin. progression of a P 450 time-dependent inactivator with projected clin. DDI risks.  In an effort to address these questions and hopefully provide answers to some of them, we embarked on the present venture wherein we highlight the current state-of-the-art knowledge in this field with a special emphasis on (a) available biochem. and mechanistic approaches in drug discovery to examine TDI of P 450 isoenzymes with new chem. entities, (b) structure-activity relationship studies with marketed drugs assocd. with DDIs via P 450 inactivation, (c) case studies of medicinal chem. tactics to abrogate P 450 inactivation liability, (d) strategies for progression of P 450 TDI-pos. drug candidates, and (e) the utility of in silico methodol., including the use of physiol.-based pharmacokinetic simulators, in drug discovery to predict the magnitude of clin. DDIs risks anticipated with new clin. candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDO60qqRvpS7Vg90H21EOLACvtfcHk0liGmIQKdEys0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjs1Wlur8%253D&md5=aa4aa4f633b3b4f73b3d79917327b0de</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm300065h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300065h%26sid%3Dliteratum%253Aachs%26aulast%3DOrr%26aufirst%3DS.%2BT.%26aulast%3DRipp%26aufirst%3DS.%2BL.%26aulast%3DBallard%26aufirst%3DT.%2BE.%26aulast%3DHenderson%26aufirst%3DJ.%2BL.%26aulast%3DScott%26aufirst%3DD.%2BO.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26atitle%3DMechanism-based%2520inactivation%2520%2528MBI%2529%2520of%2520cytochrome%2520P450%2520enzymes%253A%2520structure-activity%2520relationships%2520and%2520discovery%2520strategies%2520to%2520mitigate%2520drug-drug%2520interaction%2520risks%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4896%26epage%3D4933%26doi%3D10.1021%2Fjm300065h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="note"><p class="first last">Compound <b>14</b> was found to be unstable in neutral buffer (50% decomposition after 1 h at 37 °C), acidic buffer (pH = 2, immediate decomposition at room temperature), and basic buffer (pH = 11, 30% decomposition observed at 20 h at room temperature).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Huang, X.; Shaffer, P. L.; Ayube, S.; Bregman, H.; Chen, H.; Lehto, S. G.; Luther, J. A.; Matson, D. J.; McDonough, S. I.; Michelsen, K.; Plant, M. M.; Schneider, S.; Simard, J. R.; Teffera, Y.; Yi, S.; Zhang, M.; DiMauro, E. F.; Gingras, J.</span><span> </span><span class="NLM_article-title">Crystal structures of human GlyRα3 bound to a novel class of potentiators with efficacy in a mouse model of neuropathic pain</span>.  <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="refDoi"> DOI: 10.1038/nsmb.3329</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=10.1038%2Fnsmb.3329" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Huang%2C+X.%3B+Shaffer%2C+P.+L.%3B+Ayube%2C+S.%3B+Bregman%2C+H.%3B+Chen%2C+H.%3B+Lehto%2C+S.+G.%3B+Luther%2C+J.+A.%3B+Matson%2C+D.+J.%3B+McDonough%2C+S.+I.%3B+Michelsen%2C+K.%3B+Plant%2C+M.+M.%3B+Schneider%2C+S.%3B+Simard%2C+J.+R.%3B+Teffera%2C+Y.%3B+Yi%2C+S.%3B+Zhang%2C+M.%3B+DiMauro%2C+E.+F.%3B+Gingras%2C+J.+Crystal+structures+of+human+GlyR%CE%B13+bound+to+a+novel+class+of+potentiators+with+efficacy+in+a+mouse+model+of+neuropathic+pain.+Nat.+Struct.+Mol.+Biol.+10.1038%2Fnsmb.3329."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.3329&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.3329%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DX.%26atitle%3DCrystal%2520structures%2520of%2520human%2520GlyR%25CE%25B13%2520bound%2520to%2520a%2520novel%2520class%2520of%2520potentiators%2520with%2520efficacy%2520in%2520a%2520mouse%2520model%2520of%2520neuropathic%2520pain%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26doi%3D10.1038%2Fnsmb.3329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Berry, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Be, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, M. H.</span><span> </span><span class="NLM_article-title">Prediction of V(ss) from in vitro tissue-binding studies</span> <span class="citation_source-journal">Drug. Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">115</span><span class="NLM_x">–</span> <span class="NLM_lpage">121</span><span class="refDoi"> DOI: 10.1124/dmd.109.029629</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=10.1124%2Fdmd.109.029629" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2010&pages=115-121&author=L.+M.+Berryauthor=J.+Robertsauthor=X.+Beauthor=Z.+Zhaoauthor=M.+H.+Lin&title=Prediction+of+V%28ss%29+from+in+vitro+tissue-binding+studies&doi=10.1124%2Fdmd.109.029629"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1124%2Fdmd.109.029629&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.109.029629%26sid%3Dliteratum%253Aachs%26aulast%3DBerry%26aufirst%3DL.%2BM.%26aulast%3DRoberts%26aufirst%3DJ.%26aulast%3DBe%26aufirst%3DX.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DLin%26aufirst%3DM.%2BH.%26atitle%3DPrediction%2520of%2520V%2528ss%2529%2520from%2520in%2520vitro%2520tissue-binding%2520studies%26jtitle%3DDrug.%2520Metab.%2520Dispos.%26date%3D2010%26volume%3D38%26spage%3D115%26epage%3D121%26doi%3D10.1124%2Fdmd.109.029629" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Huang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janosky, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, M.-H. J.</span><span> </span><span class="NLM_article-title">Differential role of P-glycoprotein and breast cancer resistance protein in drug distribution into brain, CSF and peripheral nerve tissues in rats</span> <span class="citation_source-journal">Xenobiotica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">547</span><span class="NLM_x">–</span> <span class="NLM_lpage">555</span><span class="refDoi"> DOI: 10.3109/00498254.2014.997324</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=10.3109%2F00498254.2014.997324" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2015&pages=547-555&author=L.+Huangauthor=X.+Liauthor=J.+Robertsauthor=B.+Janoskyauthor=M.-H.+J.+Lin&title=Differential+role+of+P-glycoprotein+and+breast+cancer+resistance+protein+in+drug+distribution+into+brain%2C+CSF+and+peripheral+nerve+tissues+in+rats&doi=10.3109%2F00498254.2014.997324"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.3109%2F00498254.2014.997324&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F00498254.2014.997324%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DRoberts%26aufirst%3DJ.%26aulast%3DJanosky%26aufirst%3DB.%26aulast%3DLin%26aufirst%3DM.-H.%2BJ.%26atitle%3DDifferential%2520role%2520of%2520P-glycoprotein%2520and%2520breast%2520cancer%2520resistance%2520protein%2520in%2520drug%2520distribution%2520into%2520brain%252C%2520CSF%2520and%2520peripheral%2520nerve%2520tissues%2520in%2520rats%26jtitle%3DXenobiotica%26date%3D2015%26volume%3D45%26spage%3D547%26epage%3D555%26doi%3D10.3109%2F00498254.2014.997324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Jaggi, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, N.</span><span> </span><span class="NLM_article-title">Animal models of neuropathic pain</span> <span class="citation_source-journal">Fundam. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">28</span><span class="refDoi"> DOI: 10.1111/j.1472-8206.2009.00801.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=10.1111%2Fj.1472-8206.2009.00801.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=20030738" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhslKrsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=1-28&author=A.+S.+Jaggiauthor=V.+Jainauthor=N.+Singh&title=Animal+models+of+neuropathic+pain&doi=10.1111%2Fj.1472-8206.2009.00801.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Animal models of neuropathic pain</span></div><div class="casAuthors">Jaggi, Amteshwar Singh; Jain, Vivek; Singh, Nirmal</div><div class="citationInfo"><span class="NLM_cas:title">Fundamental & Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-28</span>CODEN:
                <span class="NLM_cas:coden">FCPHEZ</span>;
        ISSN:<span class="NLM_cas:issn">0767-3981</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Animal models are pivotal for understanding the mechanism of neuropathic pain and development of effective therapy for its optimal management.  A battery of neuropathic pain models has been developed to simulate the clin. pain conditions with diverse etiol.  The present review exhaustively discusses the methodol., behavioral alterations, limitations, and advantages of about 40 different animal models of neuropathic pain along with their modifications.  Development of these models has contributed immensely in understanding the chronic pain and underlying peripheral as well as central pathogenic mechanisms.  Furthermore, research has resulted in the development of new therapeutic agents for neuropathic pain management, and the preclin. data obtained using these animal models have been successively translated to effective pain management in clin. setup also.  As each animal model has been created with specific methodol. and results tend to vary largely with the slight changes related to methodol., therefore, it is essential that data from different models should be reported and interpreted in the context of the specific pain model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-2tLxHzZ1ubVg90H21EOLACvtfcHk0lgRY-4lIJTEOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhslKrsb4%253D&md5=85f8149349f673e11ecba18d4e94a599</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1111%2Fj.1472-8206.2009.00801.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1472-8206.2009.00801.x%26sid%3Dliteratum%253Aachs%26aulast%3DJaggi%26aufirst%3DA.%2BS.%26aulast%3DJain%26aufirst%3DV.%26aulast%3DSingh%26aufirst%3DN.%26atitle%3DAnimal%2520models%2520of%2520neuropathic%2520pain%26jtitle%3DFundam.%2520Clin.%2520Pharmacol.%26date%3D2011%26volume%3D25%26spage%3D1%26epage%3D28%26doi%3D10.1111%2Fj.1472-8206.2009.00801.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="note"><p class="first last">See <a href="/doi/suppl/10.1021/acs.jmedchem.6b01496/suppl_file/jm6b01496_si_001.pdf" class="ext-link">Supporting Information</a> for 2D NMR data.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="note"><p class="first last">To evaluate the conformational distribution of <b>32</b> and <b>9</b> in solution, a stochastic conformational search for each molecule was performed using the program <i>Molecular Operating Environment</i> (MOE), 2014.09; Chemical Computing Group Inc., 1010 Sherbooke St. West, Suite 910, Montreal, QC, Canada, H3A 2R7, 2015. MMFF94x force field, Generalized Born implicit solvation, RMSD limit 0.1 A, energy window 7 kcal, and the resulting conformations optimized on the quantum mechanics potential surface with Gaussian 09 (B3LYP/6-31G*) followed by a single point calculation using the IEFPCM aqueous solvation model and UFF cavity model. The global minima of <b>32</b> was assumed to be the bioactive conformation, and differed substantially from the global minima of <b>9</b>. The conformation of <b>9</b> which most closely matched the bioactive conformation was ∼3.08 kcal higher in energy as compared to the global minima of <b>9</b>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Frisch, M. J.; Trucks, G. W.; Schlegel, H. B.; Scuseria, G. E.; Robb, M. A.; Cheeseman, J. R.; Scalmani, G.; Barone, V.; Mennucci, B.; Petersson, G. A.; Nakatsuji, H.; Caricato, M.; Li, X.; Hratchian, H. P.; Izmaylov, A. F.; Bloino, J.; Zheng, G.; Sonnenberg, J. L.; Hada, M.; Ehara, M.; Toyota, K.; Fukuda, R.; Hasegawa, J.; Ishida, M.; Nakajima, T.; Honda, Y.; Kitao, O.; Nakai, H.; Vreven, T.; Montgomery, J. A.,  Jr.; Peralta, J. E.; Ogliaro, F.; Bearpark, M.; Heyd, J. J.; Brothers, E.; Kudin, K. N.; Staroverov, V. N.; Kobayashi, R.; Normand, J.; Raghavachari, K.; Rendell, A.; Burant, J. C.; Iyengar, S. S.; Tomasi, J.; Cossi, M.; Rega, N.; Millam, J. M.; Klene, M.; Knox, J. E.; Cross, J. B.; Bakken, V.; Adamo, C.; Jaramillo, J.; Gomperts, R.; Stratmann, R. E.; Yazyev, O.; Austin, A. J.; Cammi, R.; Pomelli, C.; Ochterski, J. W.; Martin, R. L.; Morokuma, K.; Zakrzewski, V. G.; Voth, G. A.; Salvador, P.; Dannenberg, J. J.; Dapprich, S.; Daniels, A. D.; Farkas, Ö.; Foresman, J. B.; Ortiz, J. V.; Cioslowski, J.; Fox, D. J.</span>,  <span class="citation_source-book">Gaussian 09</span>, <span class="NLM_edition">revision D.01</span>; <span class="NLM_publisher-name">Gaussian, Inc.</span>: <span class="NLM_publisher-loc">Wallingford CT</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=M.+J.+Frisch&author=G.+W.+Trucks&author=H.+B.+Schlegel&author=G.+E.+Scuseria&author=M.+A.+Robb&author=J.+R.+Cheeseman&author=G.+Scalmani&author=V.+Barone&author=B.+Mennucci&author=G.+A.+Petersson&author=H.+Nakatsuji&author=M.+Caricato&author=X.+Li&author=H.+P.+Hratchian&author=A.+F.+Izmaylov&author=J.+Bloino&author=G.+Zheng&author=J.+L.+Sonnenberg&author=M.+Hada&author=M.+Ehara&author=K.+Toyota&author=R.+Fukuda&author=J.+Hasegawa&author=M.+Ishida&author=T.+Nakajima&author=Y.+Honda&author=O.+Kitao&author=H.+Nakai&author=T.+Vreven&author=J.+A.+Montgomery&author=J.+E.+Peralta&author=F.+Ogliaro&author=M.+Bearpark&author=J.+J.+Heyd&author=E.+Brothers&author=K.+N.+Kudin&author=V.+N.+Staroverov&author=R.+Kobayashi&author=J.+Normand&author=K.+Raghavachari&author=A.+Rendell&author=J.+C.+Burant&author=S.+S.+Iyengar&author=J.+Tomasi&author=M.+Cossi&author=N.+Rega&author=J.+M.+Millam&author=M.+Klene&author=J.+E.+Knox&author=J.+B.+Cross&author=V.+Bakken&author=C.+Adamo&author=J.+Jaramillo&author=R.+Gomperts&author=R.+E.+Stratmann&author=O.+Yazyev&author=A.+J.+Austin&author=R.+Cammi&author=C.+Pomelli&author=J.+W.+Ochterski&author=R.+L.+Martin&author=K.+Morokuma&author=V.+G.+Zakrzewski&author=G.+A.+Voth&author=P.+Salvador&author=J.+J.+Dannenberg&author=S.+Dapprich&author=A.+D.+Daniels&author=%C3%96.+Farkas&author=J.+B.+Foresman&author=J.+V.+Ortiz&author=J.+Cioslowski&author=D.+J.+Fox&title=Gaussian+09"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DFrisch%26aufirst%3DM.%2BJ.%26btitle%3DGaussian%252009%26pub%3DGaussian%252C%2520Inc%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michelsen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaffer, P. L.</span><span> </span><span class="NLM_article-title">Crystal structure of human glycine receptor-alpha3 bound to antagonist strychnine</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">526</span><span class="NLM_x">, </span> <span class="NLM_fpage">277</span><span class="NLM_x">–</span> <span class="NLM_lpage">280</span><span class="refDoi"> DOI: 10.1038/nature14972</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=10.1038%2Fnature14972" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=26416729" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1Chu7jJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=526&publication_year=2015&pages=277-280&author=X.+Huangauthor=H.+Chenauthor=K.+Michelsenauthor=S.+Schneiderauthor=P.+L.+Shaffer&title=Crystal+structure+of+human+glycine+receptor-alpha3+bound+to+antagonist+strychnine&doi=10.1038%2Fnature14972"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of human glycine receptor-α3 bound to antagonist strychnine</span></div><div class="casAuthors">Huang, Xin; Chen, Hao; Michelsen, Klaus; Schneider, Stephen; Shaffer, Paul L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">526</span>
        (<span class="NLM_cas:issue">7572</span>),
    <span class="NLM_cas:pages">277-280</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Neurotransmitter-gated ion channels of the Cys-loop receptor family are essential mediators of fast neurotransmission throughout the nervous system and are implicated in many neurol. disorders.  Available X-ray structures of prokaryotic and eukaryotic Cys-loop receptors provide tremendous insights into the binding of agonists, the subsequent opening of the ion channel, and the mechanism of channel activation.  Yet the mechanism of inactivation by antagonists remains unknown.  Here we present a 3.0 Å X-ray structure of the human glycine receptor-α3 homopentamer in complex with a high affinity, high-specificity antagonist, strychnine.  Our structure allows us to explore in detail the mol. recognition of antagonists.  Comparisons with previous structures reveal a mechanism for antagonist-induced inactivation of Cys-loop receptors, involving an expansion of the orthosteric binding site in the extracellular domain (ECD) that is coupled to closure of the ion pore in the transmembrane domain (TMD).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVeTttGF4v77Vg90H21EOLACvtfcHk0lgRY-4lIJTEOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1Chu7jJ&md5=85f4a34b4d2dd7860e7c7683a13394f7</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1038%2Fnature14972&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature14972%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DMichelsen%26aufirst%3DK.%26aulast%3DSchneider%26aufirst%3DS.%26aulast%3DShaffer%26aufirst%3DP.%2BL.%26atitle%3DCrystal%2520structure%2520of%2520human%2520glycine%2520receptor-alpha3%2520bound%2520to%2520antagonist%2520strychnine%26jtitle%3DNature%26date%3D2015%26volume%3D526%26spage%3D277%26epage%3D280%26doi%3D10.1038%2Fnature14972" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="note"><p class="first last">The ligand conformation from the <b>32</b> complex crystal structure was optimized on the gas-phase quantum mechanics potential energy surface using Gaussian 09 (B3LYP/6-31G*) followed by a single-point calculation using the IEFPCM aqueous solvation model and UFF cavity model. The resulting conformation was identical to a conformation 0.05 kcal above the global minima of <b>32</b>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Cheng, C.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, S.-J.</span><span> </span><span class="NLM_article-title">The Friedlander synthesis of quinolines</span> <span class="citation_source-journal">Org. React.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">2</span><span class="refDoi"> DOI: 10.1002/0471264180.or028.02</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=10.1002%2F0471264180.or028.02" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1982&pages=2&author=C.-C.+Chengauthor=S.-J.+Yan&title=The+Friedlander+synthesis+of+quinolines&doi=10.1002%2F0471264180.or028.02"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1002%2F0471264180.or028.02&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F0471264180.or028.02%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DC.-C.%26aulast%3DYan%26aufirst%3DS.-J.%26atitle%3DThe%2520Friedlander%2520synthesis%2520of%2520quinolines%26jtitle%3DOrg.%2520React.%26date%3D1982%26volume%3D28%26spage%3D2%26doi%3D10.1002%2F0471264180.or028.02" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Fevig, J. M. F.; Jianxin; Ahmad; Saleem</span>. <span> </span><span class="NLM_article-title">Pyrrolo(oxo)isoquinolines as 5-HT ligands and their preparation, pharmaceutical compositions, pharmacological analysis and binding assay of 5-HT2 receptors for treatment of metabolic and central nervous system disorders</span>. US 20060014777,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=J.+M.+F.+Fevig&author=+Jianxin&author=+Ahmad&author=+Saleem&title=Pyrrolo%28oxo%29isoquinolines+as+5-HT+ligands+and+their+preparation%2C+pharmaceutical+compositions%2C+pharmacological+analysis+and+binding+assay+of+5-HT2+receptors+for+treatment+of+metabolic+and+central+nervous+system+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DFevig%26aufirst%3DJ.%2BM.%2BF.%26atitle%3DPyrrolo%2528oxo%2529isoquinolines%2520as%25205-HT%2520ligands%2520and%2520their%2520preparation%252C%2520pharmaceutical%2520compositions%252C%2520pharmacological%2520analysis%2520and%2520binding%2520assay%2520of%25205-HT2%2520receptors%2520for%2520treatment%2520of%2520metabolic%2520and%2520central%2520nervous%2520system%2520disorders%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Chen, Y.; Ren, W.; Meng, Q.; Ning, Z.; Rui, T.; Sun, B.; Wang, Q.; Yuan, X.; Yu, L.</span><span> </span><span class="NLM_article-title">Method for synthesis of (3a<i>S</i>,9b<i>R</i>)-<i>tert</i>-butyl-3,3a,4,5-tetrahydropyrrol[3,4-<i>c</i>]quinoline-2(9b<i>H</i>) ester</span>. CN 103073547,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=Y.+Chen&author=W.+Ren&author=Q.+Meng&author=Z.+Ning&author=T.+Rui&author=B.+Sun&author=Q.+Wang&author=X.+Yuan&author=L.+Yu&title=Method+for+synthesis+of+%283aS%2C9bR%29-tert-butyl-3%2C3a%2C4%2C5-tetrahydropyrrol%5B3%2C4-c%5Dquinoline-2%289bH%29+ester"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%26atitle%3DMethod%2520for%2520synthesis%2520of%2520%25283aS%252C9bR%2529-tert-butyl-3%252C3a%252C4%252C5-tetrahydropyrrol%255B3%252C4-c%255Dquinoline-2%25289bH%2529%2520ester%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Manzano, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rominger, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashmi, S. K.</span><span> </span><span class="NLM_article-title">Saturated abnormal NHC-gold(I) complexes: synthesis and catalytic activity</span> <span class="citation_source-journal">Organometallics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">2199</span><span class="NLM_x">–</span> <span class="NLM_lpage">2203</span><span class="refDoi"> DOI: 10.1021/om4000659</span> </span><div class="citationLinks">[<a href="/doi/10.1021/om4000659" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktFKnsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2013&pages=2199-2203&author=R.+Manzanoauthor=F.+Romingerauthor=S.+K.+Hashmi&title=Saturated+abnormal+NHC-gold%28I%29+complexes%3A+synthesis+and+catalytic+activity&doi=10.1021%2Fom4000659"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Saturated abnormal NHC-gold(I) complexes: synthesis and catalytic activity</span></div><div class="casAuthors">Manzano, Ruben; Rominger, Frank; Hashmi, A. Stephen K.</div><div class="citationInfo"><span class="NLM_cas:title">Organometallics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2199-2203</span>CODEN:
                <span class="NLM_cas:coden">ORGND7</span>;
        ISSN:<span class="NLM_cas:issn">0276-7333</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">New satd. abnormal N-heterocyclic carbene complexes of gold(I) [(1-R1-3-R2-4-R3-Im)AuX] (Im = 1,2-dihydro-4H-imidazol-5-yl; R1, R2 = tBu, CH2CH:CH2, iPr, CHMePh, CH2Ph, 2,6-iPr2C6H3; X = Cl, I) have been prepd. by a 1,3-dipolar cycloaddn. of an in situ generated azomethine ylides Me3SiCHR3NR2CH2OMe with an isocyanogold(I) halides R1NCAuX.  A series of different substituents on the nitrogen atom of the 1,3-dipole are tolerated without problem.  Substituents on a carbon atom of the 1,3-dipole are problematic in the case of the isocyanogold(I) chlorides; only low yields are obtained.  However, the corresponding isocyanogold(I) iodide shows good reactivity, and these abnormal N-heterocyclic carbenes bear the substituents R3 in a position α to the carbene carbon, as proven by a crystal structure anal. of one of the products.  Some of the new satd. abnormal N-heterocyclic carbene complexes were then tested in the gold-catalyzed phenol synthesis by recyclization of 2-furanmethyl propargyl ethers; moderate turnover nos. of 252-380 could be reached.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9GAvGgXq9l7Vg90H21EOLACvtfcHk0linwkG0ITMZWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktFKnsrs%253D&md5=f04200b42f0f4146bf28e333a53da190</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fom4000659&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fom4000659%26sid%3Dliteratum%253Aachs%26aulast%3DManzano%26aufirst%3DR.%26aulast%3DRominger%26aufirst%3DF.%26aulast%3DHashmi%26aufirst%3DS.%2BK.%26atitle%3DSaturated%2520abnormal%2520NHC-gold%2528I%2529%2520complexes%253A%2520synthesis%2520and%2520catalytic%2520activity%26jtitle%3DOrganometallics%26date%3D2013%26volume%3D32%26spage%3D2199%26epage%3D2203%26doi%3D10.1021%2Fom4000659" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Corey, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaykovsky, M.</span><span> </span><span class="NLM_article-title">Dimethyloxosulfonium methylide and dimethylsulfonium methylide. Formation and application to organic synthesis</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1965</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">1353</span><span class="NLM_x">–</span> <span class="NLM_lpage">1364</span><span class="refDoi"> DOI: 10.1021/ja01084a034</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja01084a034" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=1965&pages=1353-1364&author=E.+J.+Coreyauthor=M.+Chaykovsky&title=Dimethyloxosulfonium+methylide+and+dimethylsulfonium+methylide.+Formation+and+application+to+organic+synthesis&doi=10.1021%2Fja01084a034"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fja01084a034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01084a034%26sid%3Dliteratum%253Aachs%26aulast%3DCorey%26aufirst%3DE.%2BJ.%26aulast%3DChaykovsky%26aufirst%3DM.%26atitle%3DDimethyloxosulfonium%2520methylide%2520and%2520dimethylsulfonium%2520methylide.%2520Formation%2520and%2520application%2520to%2520organic%2520synthesis%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1965%26volume%3D87%26spage%3D1353%26epage%3D1364%26doi%3D10.1021%2Fja01084a034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5TIO" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5TIO','PDB','5TIO'); return false;">PDB: 5TIO</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5TIN" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5TIN','PDB','5TIN'); return false;">PDB: 5TIN</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i118"><a href="/doi/suppl/10.1021/acs.jmedchem.6b01496">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_47667"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.6b01496">10.1021/acs.jmedchem.6b01496</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline"><b>26</b>–<b>33</b>, detailed chiral separation conditions; AM-3607, a detailed suite of 1D and 2D NMR data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b01496/suppl_file/jm6b01496_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b01496/suppl_file/jm6b01496_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01496/suppl_file/jm6b01496_si_001.pdf">jm6b01496_si_001.pdf (1.62 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01496/suppl_file/jm6b01496_si_002.csv">jm6b01496_si_002.csv (2.45 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.6b01496&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b01496%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-3%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.6b01496" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679946c6ec103cd0","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
